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1 Introduction 
1.1 Natural products in drug discovery 
Numerous natural products, mostly of plant origin, are applied in medicine, such as 
morphine (Papaver somniferum), digitoxine (Digitalis lanata), salicin derivatives (Salix 
alba) and taxol (Taxus brevifolia). Additionally, the development of new drugs often 
relies on natural products as leading structures. This is corroborated by the vast 
number (over 50%) of clinically used drugs that are of natural origin (Newman et al., 
2003, Butler et al., 2004). 
Plants and microorganisms provide an immense reservoir of chemically diverse 
natural products with potent biological activity. Some of these are of utmost medical 
importance, e.g. lovastatin (Aspergillus nidulans), penicillin (Penicillum chrysogenum) 
and daunorubicin (Streptomyces peucetius) showing blood pressure lowering, 
antibiotic and anticancer activity. Biosynthetically, prominent classes of microbial 
secondary metabolites are the polyketides (PKs) and non-ribosomal peptides 
(NRPs).  
With more than 8000 compounds characterized to date, the members of the 
Actinomycetales are the declared star producers of secondary metabolites. However, 
in the last two decades the myxobacteria attracted much attention as an alternative 
source, as they are promising producers of compounds with both, unique structures 
and bioactivities (Weissman and Müller, 2009). 
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1.2 Myxobacteria: a unique source of natural products 
In 1892, Roland Thaxter discovered myxobacteria, a fascinating group of 
microorganisms with remarkable features. Social behavior, gliding on solid surfaces 
and formation of fruiting bodies under starvation are some of their noticeable 
features. Eponymous was the immense amount of polysaccharides they excrete, 
which is retrieved    “ yx ”, a word derived from t e   eek “ yx  ” and means slime 
or mucus (Dworkin, 2007). They are also known to posses the largest genomes 
amongst bacteria (9-13 Mbp) with a DNA of high GC content of 66-72 mol% 
(Reichenbach, 1999).  
Myxobacteria belong to the δ-subgroup of the gram-negative proteobacteria and are 
united in the order of Myxococcales, which is further divided into three suborders: 
Cystobacterineae, Sorangiineae and Nannocystineae. Soil, the bark of trees, 
decaying plant materials and the dung of herbivores are all habitats in which these 
bacteria occur. But beside the terrestial myxobacteria, there are also a few of marine 
origin mostly living in costal areas (Reichenbach, 1999; Iizuka et al., 2006).  
Almost all discovered natural products of myxobacterial origin have unique structures 
that were not found before in other bacteria. The Helmholtz Centre for Infection 
Research (Braunschweig, Germany) has isolated more than 7500 strains from the 
order of Myxococcales. Although there are more actinomycetes known to date than 
myxobacteria, the number of myxobacterial natural products is enormous as they 
yielded at least 100 natural product core structures and over 500 derivatives (Garcia 
et al., 2009). The biosynthetic capabilities of these microorganisms are tremendous. 
Moreover, many of these natural products have unique modes of action. The 
therapeutic spectra of myxobacterial natural products include antibacterial, antifungal, 
antiplasmodial and antitumor activity.  
The most prominent myxobacterial compounds are the epothilones from Sorangium 
cellulosum which possess antitumor activity. Epothilones’ mode of action is 
comparable to that of paclitaxel (Taxol®), where ß-tubulin is bound promoting tubulin 
polimerisation and hence, freezes microtubule dynamics in dividing cells. As cancer 
cells highly depend on cell division, which requires a functioning microtubule, the 
tubulin system represents an attractive target to defeat cancer cells (Bollag et al., 
1995, Goodin et al., 2004, Reichenbach and Höfle, 2008). The semisynthetic 
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epothilone B derivative ixabepilone (Ixempra®) is since 2007 available in the United 
States as a drug for breast cancer treatment (Conlin et al., 2007). Other 
myxobacterial secondary metabolites that interact with the cytoskeleton are tubulysin 
and disorazol, destabilizing the tubulin target, and rhizopodin that inhibits actin 
polymerization (Khalil et al., 2006, Elnakady et al., 2004, Hagelueken et al., 2009). 
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Figure  1.1 Myxobacterial compounds with antitumor activity: Rhizopodin from Stigmatella aurantiaca, 
tubulysin from Archangium geophyra, soraphen A, disorazole A and eopothilone B from Sorangium cellulosum. 
Around 30 % of myxobacterial compounds show antibacterial activity, such as 
corallopyronin, etnangien, myxopyronin, ripostatin and sorangicin, all inhibiting RNA-
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polymerase (Gerth et al., 2003; Weissman and Müller, 2010, Erol et al., 2010). 
Corallopyronin was recently tested in vivo in mice and has shown antibacterial 
activity against Wolbachia, endobacteria in filarial nematodes that cause lymphatic 
filariasis. It is a promising alternative to the standard treatment with doxycycline or 
rifampcin (Schiefer et al., 2012). 
Thuggacin interferes with the cellular electron-transport chain in the respiraton of 
Mycobacterium tuberculosis, the bacterium that causes tuberculosis (Steinmetz et al., 
2007). Inhibitors of the protein biosynthesis are the compounds angiolam, althiomycin 
and myxovalargin. Althiomycin interacts within the peptidyltransfer, whereas 
myxovalargin disrupts the binding of the aminoacly-tRNA. An additional effect of 
myxovalarginis is that it causes damages on the cell membrane. The cell wall 
biosynthesis is the target of the antiobiotic myxovirescin, where it inhibits the 
incorporation of N-acetyl-glucosamine (Weissman and Müller, 2010; Gerth et al., 
1982). 
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Figure  1.2 Myxobacterial compounds with antibacterial activity: Corallopyronin from Corallococcus 
coralloides, myxovirescin from Myxococcus virescens, thuggacin A and sornagicin A from Sorangium cellulosum. 
Antifungal activity was reported for more than 50% of the myxobacterial metabolites 
and is the most frequent observed bioactivity of these compounds. The mitochondrial 
respiratory chain is the main target of most of these natural products, among them 
are stigmatellin, myxothiazol, haliangicin and myxalamid. Other targets for antifungal  
NP from myxobacteria are the cell membrane integrity observed for ambruticin, 
jerangolid and pedein, or the nucleic acid and protein biosynthesis as observed for 
leupyrrin (Weissman and Müller, 2010; Baker and Alvi, 2004). 
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Figure  1.3 Myxobacterial compounds with antifungal activity: Myxothiazol from Myxococcus Xanthus, 
leupyrrin A1 and jerangolid from Sorangium cellulosum, stigamtellin A from Stigmatella aurantiaca. 
 
The immense diverse spectrum of myxobacterial compounds makes myxobacteria an 
important source of novel classes of secondary metabolites (Gerth et al., 2003). The 
vast majority of these diverse natural products are PKs and NRPs, whereas more 
than half of the isolated myxobacterial compounds contain elements of both, PKs and 
NRPs, and are therefore denoted as hybrid PK/NRP metabolites. Other bacterial 
producers of secondary metabolites, like the actinomycetes, synthesize prevalently 
pure PK or NRP compounds (Weissman and Müller, 2009).  
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Table  1.1 Myxobacterial secondary metabolites and their corresponding type of gene cluster 
Compound Type of gene cluster 
Ajudazol PKS/NRPS 
Althiomycin PKS/NRPS 
Ambruticin PKS/NRPS 
Aurachin PKS 
Aurafuron PKS 
Chivosazol PKS/NRPS 
Chondramid PKS/NRPS 
Chondrochloren PKS/NRPS 
Corallopyronin PKS/NRPS 
Crocacin PKS/NRPS 
Cystothiazol PKS/NRPS 
Disorazol PKS/NRPS 
DKXanthen PKS/NRPS 
Epothilon PKS/NRPS 
Etnangien PKS 
Jerangolid PKS 
Leupyrrin PKS/NRPS 
Melithiazol PKS/NRPS 
Myxalamid PKS/NRPS 
Myxochelin NRPS 
Myxochromide S PKS/NRPS 
Myxothiazol PKS/NRPS 
Myxovirescin PKS/NRPS 
Phenylnannolone A PKS 
Rhizopodin PKS/NRPS 
Saframycin NRPS 
Sorangicin PKS 
Soraphen  PKS 
Spirangien PKS 
Stigmatellin PKS 
Thuggacin PKS/NRPS 
Tubulysin PKS/NRPS 
The structures for over 60 myxobacterial compounds were already published, and for 
half of these compounds the corresponding gene clusters were elucidated (table  1.1). 
Among them are eight gene clusters encoding for a polyketide synthase (PKS) and 
two gene clusters encoding for a non-ribosomal peptide synthetase (NRPS), the vast 
majority however, encodes for a PKS/NRPS hybrid. 
These gene clusters have been identified either by screening of genomic libraries, 
transposon-mutagenesis or genome sequencing. Genome sequencing of 
Myxococcus xanthus, Sorangium cellulosum and Stigmatella aurantiaca revealed 
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that the number of gene clusters for secondary metabolites exceeds by far the 
number of identified metabolites. In fact, 8-9% of the genomes of S. cellulosum and 
M. xanthus encode secondary metabolites. This is twice the percentage found in the 
streptomycete S. coelicolor (Dworkin, 2007), which indicates that the potential of 
myxobacteria is enormous and far from utilized. 
  
Introduction 
 
9 
 
1.3 Biosynthesis of myxobacterial secondary metabolites  
Most of the structurally diverse myxobacterial natural products are synthesized by 
large multienzymes, i.e. polyketide synthases (PKSs), non-ribosomal peptide 
synthetases (NRPSs) or hybrids of both (Staunton and Weissman, 2001; Wenzel and 
Müller, 2009). The genes encoding for these biosynthetic machineries are usually 
clustered in microbial genomes, which simplifies the identification and elucidation of 
biosynthetic gene clusters. For the majority of myxobacterial PKSs and NRPSs a 
modular organization exists, where each module is responsible for the incorporation 
of one building block into the growing product chain. Each module is further 
subdivided into domains, enzymatic units that are responsible for loading, 
condensation and further modification of the extender unit. This one-to-one 
correspondence between the present domains and the biosynthetic transformation 
that takes place is termed “rule of colinearity” (Staunton and Weissman, 2001, Müller, 
2004, Buntin, 2010).  
During the assembly process, the substrates and intermediates of the natural product 
are covalently tethered to the carrier protein (CP) of the respective module through a 
thioester-linkage. For a functional enzymatic assembly line, the CPs have to be post-
translationally activated by a phosphopantetheinyl transferase (PPTase). PPTases 
transfer the 4’-phosphopantetheine moiety of coenzyme A (CoA) to the conserved 
serine residue of the inactive apo-CP, converting it to the active holo form (figure 
 1.4). Substrates and intermediates are bound to the terminal thiol group of the 
phosphopantetheine arm, activating them for the condensation reaction. With their 
long flexible phosphopantetheine arm, holo-CPs hand round the intermediates 
between the individual catalytic domains (Fischbach and Walsh, 2006, Byers and 
Gong, 2007). 
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Figure  1.4 Post-translational modification of a CP domain by a PPTase: The PPTase catalyzes the transfer 
of phosphopantetheine from coenzyme A to a conserved serine in the CP domain, converting the inactive apo 
form to the active holo-CP. 
1.3.1 Polyketide Synthases 
Polyketides are a diverse class of natural products with potent biological activity such 
as antibacterial, antifungal, anticholesterol, antiparasitic, anticancer and 
immunosuppressive properties. These structurally diverse natural products are all 
built by polyketide synthases (PKSs), multienzymes that are found in plants, fungi 
and bacteria. PKS are classified into various types, based on the architecture and 
mode of action of their assembly lines (Hertweck, 2009). Initially, they were divided 
into three major groups: type I, type II and type III PKS. The classification as type I 
and type II refers to that of the previously classified enzymes of fatty acid 
biosynthesis (Weissmann, 2009). Type I applies to linearly arranged catalytic 
domains within large multifunctional enzymes, whereas a dissociable complex of 
discrete monofunctional enzymes is found in type II PKS. The third group 
characterizes multifunctional enzymes of the chalcone synthase (CHS) type, mainly 
found in plants, but sometimes also in bacteria and fungi. Besides the enzyme 
structures, the mechanism of synthesis, is another characteristic to classify PKS 
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(table  1.2). Depending on whether a module is used only once or repeatedly, PKS 
are termed as either modular (non-iterative) or iterative (Hertweck, 2009).  
Table  1.2 Overview on the different types of PKSs (adapted from Hertweck, 2009 and Watanabe and 
Ebizuka, 2004) KS=ketosynthase, AT=acyltransferase, KR=ketoreductase, DH= dehydratase, 
ER=enoylreductase, ACP=acyl carrier protein, TE=thioesterase 
Type Protein structure 
Synthesis 
mechanism 
Found in 
Extender 
units 
Domains 
PKS I 
Single protein with 
multiple modules 
Modular Bacteria Various 
KS, AT, KR, 
DH, ER, ACP, 
TE 
PKS I 
Single protein with 
one module 
Iterative Mainly fungi Malonyl-CoA 
KS, AT, KR, 
DH, ER, ACP, 
TE 
PKS II 
Multiple proteins each 
with mono-functional 
active site 
Iterative Bacteria Malonyl-CoA 
KS, CLF, ACP, 
KR, ARO, CYC 
PKS III 
One protein with 
multiple modules 
Iterative 
Mainly plants, 
some bacteria 
& fungi 
Acyl-CoA, 
Malonyl-CoA 
KS, CHS/ STS 
 
In bacterial modular type I PKS the principle of colinearity allows the deduction of 
extension cycles from the number of modules, and can be used for the prediction of 
t e  et b l te’  b     b  kb  e  t u tu e. C  ve  ely    “ et  b   y t et      ly   ” 
 f t e    p u d’   t u tu e e  ble  t e p ed  t     f t e d         v lved in its 
biosynthesis. There are some exceptions, where single modules are used more than 
once or even are skipped. In trans-AT PKS systems, the modules lack the individual 
AT domain (Piel, 2002, Hertweck, 2009). For the iterative type I PKS, typical for fungi, 
the number of extension cycles is not predictable from the domain architecture of the 
protein. Although there is only one module that is used repeatedly, the degree of 
reduction may alternate as the corresponding domains are used variably. 
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Biochemistry in modular type I PKS 
A minimal elongation module in PKS consists of three essential core domains: a 
ketosynthase (KS), an acyltransferase (AT) and an acyl carrier protein (ACP). Initially 
the AT domains select their specific monomeric units and load them to the 
corresponding ACP domains. The ACP-bound intermediate from the upstream 
module is transferred to a conserved serine residue of the KS domain. The KS 
domain catalyzes the decarboxylative condensation, here the ACP-bound extender 
unit is decarboxylated and the resulting enolate attacks the upstream KS-bound acyl 
thioester, forming a C-C bond between the extender unit and the growing polyketide 
chain (figure  1.5). By this principle the growing chain is passed from module to 
module. 
In respect to the minimal PKS module, the architecture of loading modules can 
deviate. Most loading modules harbor a KSQ domain, that decarboxylates the starter 
unit, but lacks the condensation activity, due to an alteration in the active site. The 
active cysteine is in this case replaced by a glutamine (Q). Another type of loading 
modules comprise a didomain, consisting of an AT and an ACP domain, where the 
AT selects a short chain monocarboxylic acid, as observed for the erythromycin 
biosynthesis (Bisang et al., 1999, Staunton and Wilkinson, 1997, Hertweck, 2009). 
For a detailed introduction to diverse starter units and loading modules see also 
section 1.3.2. 
Introduction 
 
13 
 
HS
S
HS
O
R2
SH
O
R1
S S O
R2
O
R1
HS S
O
R1
S O
O
O
R2
SHS
O
R1
S O
O
O
R2
-CO2
HS
O
O
O
SCoA
R2
O
SCoA
R1
HS
HO HO
HS
O
O
R1
HS
O
O
O
O R2
loading module minimal extension module
5
loading module minimal extension moduleloading module minimal extension module
3
4
loading module loading module
1
2
ATKSAT ACPACP
loading module minimal extension module
ATKSAT ACPACP
ATKSAT ACPACPATKSAT ACPACP
ATKSAT ACP
minimal extension module
ACP ATKSAT ACPACP
minimal extension module
 
Figure  1.5 Schematic overview of PKS biochemistry: In the first step the AT domains from the loading module 
and first extension module select their respective acyl-CoA monomers and catalyze in the next step the 
transthiolation of these substrates to the neighboring ACP domains. The intermediate from the loading module is 
transferred to the KS of the elongation module (step 3); the subsequent decarboxylative condensation is 
catalyzed by the KS domain, forming a C-C bond between the upstream acyl thioester and the downstream 
enolate (adapted from Buntin, 2010) 
Extender units for modular type I PKS may vary; most frequent of all are malonyl-
CoA and methylmalonyl-CoA. Less common are extender units such as ethylmalonyl-
CoA and chloroethylmalonyl-CoA or the ACP-linked extender units: methoxymalonyl-
ACP, hydroxymalonyl-ACP and aminomalonyl-ACP (Chan et al., 2009). AT domains 
in extension modules show high selectivity towards a certain substrate. Sequence 
analysis of numerous AT domains revealed conserved amino acids motifs that can 
be correlated to substrate specificity (Yadav et al., 2003, Tsai and Smith, 2007). 
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Figure  1.6 Structures of coenzyme A, holo-ACP, and the associated extender units. The brackets around 
glyceryl-ACP denote that it is not a classic extender unit involved in decarboxylative Claisen condensation 
reactions (figure origin: Chan et al., 2009) 
For more structural diversity, a PKS extension module can be further equipped with 
modifying domains, such as ketoreductase (KR), dehydratase (DH) and 
enoylreductase (ER). The first reduction step is initiated by the KR domain that 
catalyzes the stereospecific and NADPH-dependent reduction of the ß-keto function 
to a ß-hydroxyl-moiety, which is followed by water elimination induced by the DH 
domain. The so obtained double bond is fully reduced to a saturated acyl chain by 
the presence of an ER domain. Whereas in fatty acid biosynthesis the full set of 
reduction steps takes place, in PKS biosynthesis different grades of reduction can 
occur, depending on the individual domains that are used. 
Distinct motifs in KR and ER domains were identified to determine the final 
stereochemistry of the respective chiral centre, making the prediction of the absolute 
configuration for a particular metabolite from the related gene sequence possible 
(Caffrey, 2003, Kwan et al., 2008, Kwan and Schulz, 2011). 
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Figure  1.7 Reductive processing of ß-keto-function induced by KR, DH and ER domains. Reductive 
changes on the keto-group are highlighted, the respective color corresponds to the enzyme, responsible for the 
functionality. KS=ketosynthase, AT=acyltransferase, KR=ketoreductase, ER=enoylreductase, DH=dehydratase, 
ACP= acyl carrier protein 
PKS biosynthesis is terminated in the last module of the assembly line by a 
thioesterase (TE) domain that releases the polyketide chain from the last ACP 
domain either by hydrolysis or cyclization (Du and Lou, 2009). 
Iterative type II PKS 
The iterative type II PKS consist of a set of discrete and usually monofunctional 
enzymes, froming a multienzyme complex. PKS II are known to produce aromatic 
polyketides in bacteria. This system is restricted to prokaryotes, thus fungal aromatic 
polyketides are generated by iterative type I PKS. A “     l P S”  n type II PKS 
comprises a KS (KSα) a chain length factor (CLF or KSβ) and an ACP. Accessory 
enzymes such as KR, cyclases (CYC) and aromatases (ARO) are responsible for 
further modifications def      t e   le ule’   t u tu e (Hopwood, 1997; Hertweck, 
2009; Tsai and Ames, 2009). 
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Figure  1.8 Polyketide biosynthesis in type II and type III PKS (adapted from Kira Weissman, 2009). For the 
iterative type II PKS the condensation reaction is catalyzed by KSα, whereas chain elongation factor 
KSβ acts as a decarboxylase. The ACP independent, iterative type III PKS acts directly on the CoA-
bound substrate. 
Type III PKS  
Type III PKS are remarkable multifunctional enzymes that complete with a single 
active site the entire biosynthesis, including decarboxylation, condensation and 
aromatization reactions. The homodimeric enzymes, which are also known as 
chalcone/stilbene synthases, elongate the PK chain in an ACP-independent way, 
assembling acyl-CoA bound extender units. This type of PKS was for long time 
believed to be restricted to plants, but recent studies discovered type III PKS also to 
be present in some bacteria and fungi (Hertweck, 2009). 
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1.3.2 Unusual starter units in PKSs 
Loading modules of type I PKS that utilize the common starter units: acetate or 
propionate, are divided into two major groups. The first type harbors a modified 
ketosynthase (KSQ) domain, an acyltransferase (AT) domain and an acyl carrier 
protein (ACP) domain. This KSQ domain is responsible for the decarboxylation of the 
dicarboxylated starter units, e.g. malonyl-CoA, which is loaded by the AT domain to 
the neighbored ACP domain. However, this modified KS lacks the condensation 
activity, due to an alteration in the active site, where a glutamine replaces the active 
cysteine. The second group is characterized by a loading AT (ATL) domain and a 
loading ACP (ACPL) domain. This loading didomain loads short-chain 
monocarboxylic acids, such as propionyl-CoA, as observed for the erythromycin 
biosynthesis (Moore and Hertweck, 2001). Recently, a third alternate strategy for the 
priming of acetate was reported by the Piel group, who observed a GCN5-related N-
acetyltransferase (GNAT) domain in the context of pederin biosynthesis (Piel et al., 
2004).  
Beside acetyl-CoA, there are numerous alternate starter units employed by PKS, and 
various strategies for their activation and loading are employed. Loading modules in 
type I PKSs, which utilize other starter units than acetyl-CoA, attach their specific 
primers generally in two different ways, based on the nature of the respective 
carboxyl group. Either CoA thioesters are used as starters and loaded to their 
corresponding PKSs by the erythromycin type loading module, the ATL-ACPL 
didomain. Or free carboxylic acids are activated and loaded by a NRPS-like 
adenylation-thiolation (A-ACP) didomain (figure  1.9) (Moore and Hertweck, 2002).  
A broad number of structurally diverse substrates are loaded in the fashion of the 
erythromycin loading didomain. Among them are substrates such as cylcohexanoyl-
CoA, isovaleryl-CoA and benzoyl-CoA, used for the priming of biosynthetic enzymes 
for molecules such as phoslactomycin, myxothiazole and sorpahen. For the priming 
of myxothiazole and soraphen the architecture of the loading modules deviates, as 
they harbor an additional AT domain, which is located adjacent to the other AT 
domain (Palaniappan et al., 2003, Silakowski et al., 1999, Wilkinson et al., 2001). 
Another deviation was observed for aureothin PKS from Streptomyces thioluteus, 
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where a single ACP domain is employed for the priming of p-nitrobenzoyl-CoA (He 
and Hertweck, 2003). 
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Figure  1.9 Loading modules in modular type I PKS. A: KSQ-AT-ACP loading domain loads malonyl-CoA, which 
is decarboxylated, and an acetate unit is attached. This type of loading module is employed in many PKS, i.e. in 
the formarion of tylosin. B: Priming of acetate by the use of an GNAT domain firstly described for pederin 
biosynthesis. C: The erythromycin-type loading didomain comprising an AT and an ACP domain loads CoA-
thioesters. D: NRPS-like adenylation-thiolation loading didomains load free acids as described for the rifampicin 
biosynthesis. Possible substrates for the different types of loading modules described for numerous polyketides 
are listed under each figure. 
The rifamycin and candicidin PKSs, each employ a NRPS-like (A-ACP) loading 
didomain for the priming of 3-amino-5-hydroxybenzoic acid (AHBA) and p-
aminobenzoate (PABA). A number of polyketides, such as ripostatin A, microcystin-
LR, nodularin and cryptophycin 1 load a C6C2-phenylalanine derived starter unit, 
employing an A-ACP didomain in the loading step. The C6C2-starter was believed to 
originate from phenylacetate, but this assumption could not be corroborated by 13C-
labeled feeding studies, as it was not incorporated into the structures of microcystin-
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LR, nodularin and cryptophycin 1. This indicates that phenylacetate is not a free 
intermediate and another substrate is probably loaded onto the A-ACP loading 
didomain. Thus, Hicks and co-workers performed studies on the loading didomain 
involved in the formation of microcystin-LR, the results of this study are discussed in 
section  5.3.2. A deviation of the A-ACP loading module was observed for the 
attachment of dihydrocyclohexene carboxylic acid in the rapamycin PKS, which bears 
an additional ER domain, reducing the double bond of the starter unit after its 
attachment to the PKS. 
In type II PKS acetate is mostly used as a starter unit, but there are some examples 
in literature for non-acetate starter units. Besides propionate and malonamate that 
are employed as starters in the formation of anthracyclines and tetracyclines, a set of 
short linear branched fatty acids, such as butyryl, valeryl or 4-methylvaleryl may 
serve as alternate starter units in PKS II. The loading of these short fatty acids is 
facilitated by a KS III component. Benzoyl-CoA is another possible starter unit, e.g. 
for the enterocin and wailupemycin biosynthesis (Piel et al., 2000, Kalitzis et al., 
2009). In this case, benzoate is activated by a CoA-Ligase to benzoyl-CoA, which 
can then be loaded to the KS. 
PKS of type III use usually starter units such as hydroxyl-substituted and non-
substituted cinnamoyl and benzoyl units, as well as activated fatty acids. The 
substrates are bound through a thioester-linkage to the Cys moiety of the catalytic 
triad Cys-His-Asn, which is located in the active site cavity and is connected to the 
substrate binding tunnel of the homodimeric protein. Substrate selection is directed 
by the spatial constraints of the substrate binding tunnel (Hertweck, 2009). 
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1.3.3 Non-Ribosomal Peptide Synthetases 
NRPSs are similarly to PKSs classified in three different types: linear NRPS, iterative 
NRPS and non-linear NRPS (Mootz et al., 2002). Linear NRPS (type A) shows the 
same modular character as modular type I PKS that means each module extends the 
peptide chain by one amino acid. Hence, the number of modules is equal to the 
number of amino acids in the corresponding peptide. In iterative NRPS (type B), 
modules or domains are used more than once, as observed for the enterobactin 
biosynthesis (Gehring et al., 1998). The non-linear NRPSs (type C) deviate from the 
canonical domain arrangement, present in type A and B NRPSs. Examples for type C 
NRPS are manifested in yersiniabactin, vibriobactin and bleomycin biosynthesis (Suo 
et al., 2001, Marshall et al., 2002, Shen et al., 2001). 
NRPS biochemistry 
Peptides that are non-ribosomally synthesized are often assembled in a similar way 
as polyketides in modular PKS. A minimal NRPS module consists of a condensation 
(C), an adenylation (A), and a peptidyl carrier protein (PCP) domain, which is also 
denoted as thiolation (T) domain. NRP biosynthesis starts with the selection and 
activation of the substrates, which is initiated by the A domain. The substrates that 
can be selected by A domains are not restricted to the 20 proteinogenic amino acids, 
but include also non-proteinogenic amino acids and aryl acids. Due to the huge pool 
of substrates, including more than 500 monomers that were identified to be part of 
NRPs, a high structural diversity within this class of natural compounds is possible 
(Strieker et al., 2010).  
Investigations on the substrate binding pocket of the phenylalanine-activating domain 
PheA from the gramicidin synthetase and sequence comparison with other A 
domains, led to the identification of 8-10 amino acid residues that portray the major 
determinants of substrate specificity in A domains (Stachelhaus et al., 1999, Challis 
et al., 2000). T e  de t f   t     f t    “   -  b     l   de”     l     lled 
“St   el  u    de” e  bled t e p ed  t     f  ub t  te  pe  f   ty  f A d       f   
unknown NPs. However, in some cases the extracted code can not be correlated to a 
certain amino acid, especially in the case of unusual substrates. Besides the specific 
selection of an individual amino acid, the A domain also activates the selected 
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substrate under ATP consumption to an aminoacyl-adenylate, which is then 
transferred to the corresponding PCP domain (figure 1.10). 
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Figure  1.10 Activation of a building block by the A domain in a minimial NRPS module: Selection and 
activation of a specific amino acid by the A domain (highlighted in pink) under ATP is consumption, with 
subsequent transfer of the aminoacyl group of the obtained aminoacyl-AMP to the PCP domain (highlighted in 
green). 
Peptide bond formation is catalyzed by the C domain, which possesses two binding 
pockets: an acceptor site and a donor site. The amino acid that is tethered to the 
upstream PCP is offered to the acceptor site, whereas the downstream PCP offers its 
covalently bound amino acid to the donor site of the C domain (Linne and Marahiel, 
2000). 
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Figure  1.11 Peptide bond formation in a minimal NRPS module initated by the condensation (C) domain 
(highlighted in blue). 
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Besides these essential core domains, the NRPS module may be accessorized with 
other modifying domains, responsible for epimerization, oxidation, methylation or 
heterocyclization of the respective amino acid, which increases the structural variety 
of the final products. For the formation of thiazoline or oxazoline rings the C domain 
is replaced by a heterocyclization (HC or CYC) domain, which catalyzes besides the 
peptide bond formation also a cyclization of threonine, serine or cysteine residues. 
These five-membered rings can be further oxidized by oxidation (Ox) domains to 
stable thiazole or oxazole heterocylces. Some NRP contain D-amino acids, which is 
mostly introduced by epimerization of an L-amino acid by the presence of an 
epimerization (E) domain located upstream the PCP domain. Selectivity for the 
correct enantiomer is controlled by the C domain that follows the E domain. 
Prevention of premature proteolytic breakdown of the peptides can be achieved 
through N- or C-methylation of amino acid residues. Methylation is introduced by the 
so called methyltransferase (MT) domains, transferring the methylgroup from an S-
adenosylmethionine (SAM) to the respective nitrogen or carbon atom. These are only 
some examples for modifications on the peptide backbone. The final domain in 
NRPS multienzymes is the TE domain, releasing the peptide chain from the 
assembly line either through hydrolysis or cylcisation, resulting in a linear or cyclic 
peptide. 
1.3.4 PKS/NRPS hybrids 
As modular NRPS and PKS system share catalytic and structural similarities, 
interaction between PKS and NRPS systems is possible (Du et al., 2001). Hybrid 
PKS/NRPS systems that generate mixed PK-NRP compounds are especially 
common in myxobacterial, firstly described for the myxothiazol gene cluster from 
Stigmatella aurantiaca (figure  1.12). As these hybrid assembly lines are involved in 
the biosynthesis of clinically valuable natural products, such as rapamycin, epothilone 
and bleomycin, modifications of these assembly lines through combinatorial 
biosynthesis       te   vely  tud ed f   t e b   y t e     f ep t  l  e (O’ C      et 
al., 2003, Richter et al., 2008). This requires deep knowledge on how these assembly 
lines work coordinate themselves at the PKS/NRPS interface. Two types of 
NRPS/PKS hybrid systems were described for the biosynthesis of mixed PK-NRP 
metabolites. In the first class, peptide and polyketide moieties are assembled 
independently and subsequently coupled by a discrete enzyme, as shown for the 
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coronatine biosynthesis (Rangaswamy et al., 1998). For the other type, there exists a 
functional interaction between NRPS and PKS modules. Most myxobacterial hybrid 
systems are of this type, where a PKS-bound ketide chain is elongated by a NRPS 
module or vice versa (Du and Shen, 2001). 
  
Figure  1.12 The mta gene cluster from Stigmatella aurantiaca, a NRPS/PKS mixed gene cluster 
responsible for the formation of myxothiazol. PKS parts of the gene cluster are colored in black, whereas 
NRPS parts are  shown in grey (figure origin: Perlova et al., 2006) 
The transfer of the intermediates along the PKS-NRPS or NRPS-PKS interfaces is 
mediated by intermodular communication via “interp lypept de l  ke  ”    “d  k    
d      ” f   t e    e  f P S  or so   e   lled “    u    t   -mediating (COM) 
d      ” in NRPS modules (Gokhale and Khosla, 2000, Broadhurst et al., 2003, 
Hahn and Stachelhaus, 2006). 
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1.4 Phenylnannolone A: a polyketide from Nannocystis pusilla 
Three representatives of a new class of compounds were isolated and decribed by 
our work group in 2008 (Ohlendorf et al., 2008): phenylnannolone A-C. They were 
isolated from Nannocystis pusilla B150, a myxobacterium from the intertidal region of 
Crete. Orange spherical agglomerates of the strain observed in liquid cultures and 
the nearly strout form of vegetative cells are some characteristic features of this 
microorganism, as well as agar corodation on solid cultures (figure  1.13).  
   
Figure  1.13 Nannocystis pusilla B150 in liquid culture (A) and on agar as solid culture (B). C shows the 
vegetative cells of N. pusilla B150  
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Figure  1.14 Molecular structures of phenylnannolone A, B and C isolated from N. pusilla B150 by 
B.Ohlendorf in 2008 
The main metabolite of this new class compounds is phenylnannolone A, which had 
shown inhibitory activity towards p-glycoprotein. The ABCB1 gene product p-
glycoprotein leads to the efflux of various drugs from the cell, i.e. antibiotic or 
A B C 
25x 1000x 
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anticancer drugs, and hence results in treatment failure. Therefore, therapy with the 
anticancer drug daunorubicin is not always successful, as daunorubicin-resistent 
tumor cells overexpress the ABC-transporter p-glycoprotein. The effect of 
phenylnannolone A on p-glycoprotein could not be measured with functional assays, 
as it quenched the fluorescence of daunorubicin and calcein.  Therefore it was 
assayed in an indirect way by an MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay on daunorubicin sensitive and resistant tumor 
cells for cytotoxicity. The colorimetric MTT assay determines the amount of living 
cells by measuring the aborbance of a formazan dye, which is only formed in viable 
cells. When tested alone no toxicity was observed, but together with daunorubicin the 
compound was able to reverse daunorubicin resistance in the cultured cancer cells. 
In fact, the combination of daunorubicin with phenylnannolone A resulted in a 10 fold 
reduction of the resistance factor in the resistant tumor cell line compared to the sole 
treatment with daunorubicin (figure  1.15). This result is comparable to the effect of p-
glycoprotein inhibitors of the 3rd generation, such as tariquidar (Fox et al., 2006, 
Ohlendorf, 2008). 
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Figure  1.15 Concentration effect curve of the cytostatic drug daunorubicin in resistant (squares) and 
sensitive (circels) cancer cells in presence (open symbols) or absence (closed symbols) of 
Phenylnannolone A (Ohlendorf et al., 2008) 
Phenylnannolone A was also tested for antimicrobial, antiplasmodial, cytotoxic and 
antiviral activity, but showed no activity in these bioassays, except a weak activity 
against the Influenza A virus. 
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The structure of the polyketide phenylnannolone A shows an unusal architecture. It is 
composed of an ethyl-substituted polyene chain, which is linked to a pyrone moiety 
on one side and to a phenyl ring on the other. These structural elements as such are 
not unusual, but the combination of these components was not described before. 
First investigations on the biosynthesis of phenylnannolone A with labeled precursors 
revealed acetate, butyrate and a phenylalanine-derived starter unit as building blocks 
for phenylnannolone A (figure  1.16). The labeling pattern for the starter unit was 
somehow remarkable, as it showed an unusual incorporation of a C-2 carbon atom 
derived from acetate in position 9 and suggested novel biochemical reactions 
(Ohlendorf et al., 2008). The incorporation of the butyrate unit and the three acetate 
units suggest that the lactone ring and the polyene chain up to the ethyl-side chain 
are formed by a PKS. However, the biosynthetic origin of the phenylalanine-derived 
starter unit and its loading can not be explained by the feeding studies.  
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Figure  1.16 Molecular structure of phenylnannolone A with biosynthetic building blocks (in bold). Feeding 
experiments in N. pusilla B150 with 
13
C-labeled building blocks showed incorporation of a phenylalanine derived 
starter unit, one butyrate and three acetate building blocks. Unprecedented and unusual is the incorporation of a 
C-2 of acetate in position 9 
It may be speculated, that biosynthesis is initiated by  a NRPS-like loading module of 
a PKS system, as described for the rifamycin biosynthesis (see also section  1.3.2, 
figure  1.9 D). The elucidation of the phenylnannolone A biosynthesis is the focus of 
the here presented investigations. 
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2 Scope of the study 
This study is focused on bioactive natural products from a Nannocystis species. 
Nannocystis spp. are myxobacteria, whose secondary metabolism has hardly been 
investigated. The recently described phenylnannolone A from N. pusilla B150 has 
been shown to have inhibitory activity towards p-glycoprotein, a membrane protein 
responsible for multi drug resistance (MDR) (Ohlendorf et al., 2008).  
The phenylnannolones represent a new class of compounds with an unusual 
structure composed of an ethyl-substituted polyene chain linked to a pyrone moiety 
on one side, and to a phenyl ring on the other. Feeding studies with labeled 
precursors revealed, besides three acetates, a butyrate and a phenylalanine-derived 
starter unit, also the incorporation of a C-2 carbon atom derived from acetate. This 
labeling pattern suggested novel biochemical reactions. From these results we can 
assume that the N. pusilla B150 genome harbors either a mixed NRPS/PKS system 
or a PKS gene cluster with a NRPS-like loading module to produce the 
phenylnannolones. 
The aim of the presented study was to elucidate the biosynthesis of phenylnannolone 
A, i.e. identification of the respective gene cluster.  
In order to achieve this goal two strategies were envisaged: 
1) The genome of N. pusilla B150 shall be sequenced to get access to the genetic 
information encoding the biosynthetic enzymes that are involved in the formation of 
the secondary metabolite phenylnannolone A. Bioinformatic analysis of the 
corresponding genetic information shall be facilitated by online databases, employing 
sequence homology searches against already identified genes or their encoded 
proteins. 
2) Construction of a genomic library of N. pusilla B150 and screening with suitable 
primers to identify the complete biosynthetic gene cluster of phenylnannolone A.  
In the final part of this study it was intended to characterize the putative biosynthetic 
enzymes in in vitro assays for their functionality and substrate selectivity. 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Chemicals and other materials 
Table  3.1 Chemical substances and solutions used in this work 
Substance Manufacturer 
Acetic acid 
KMF Laborchemie Handels GmbH 
(Darmstadt,Germany) 
Aceton-d 99,8% Deutero (Kastellaun, Germany) 
Agar Fulka Chemie GmbH (Buchs,Switzerland) 
Ammonium acetate Roth Chemie GmbH (Karlsruhe, Germany) 
Ammoniumperoxosulfate(APS) Roth Chemie GmbH (Karlsruhe, Germany) 
Ampicillin Roth Chemie GmbH (Karlsruhe, Germany) 
Bacto™ Casitone  
Becton, Dickinson and Company  
(Franklin Lakes, NJ, USA)  
Bis-acrylamide Roth Chemie GmbH (Karlsruhe, Germany) 
Boric acid Roth Chemie GmbH (Karlsruhe, Germany) 
Brilliant Blau R 250  Roth Chemie GmbH (Karlsruhe, Germany) 
Bromphenol blue Roth Chemie GmbH (Karlsruhe, Germany) 
BSA Bio-Rad Laboratories GmbH (Munich, Germany) 
CaCl2 x 2 H2O Merck KGaA (Darmstadt, Germany) 
Chloramphenicol Fulka Chemie GmbH (Buchs,Switzerland) 
Chloroform Roth Chemie GmbH (Karlsruhe, Germany) 
D(+)-Maltose x H2O Roth Chemie GmbH (Karlsruhe, Germany) 
dATP Fermentas GmbH (St. Leon Rot, Germany) 
DMSO Roth Chemie GmbH (Karlsruhe, Germany) 
dNTP Promega GmbH (Mannheim, Germany) 
Ethanol 99,8% p.a. Roth Chemie GmbH (Karlsruhe, Germany) 
Ethidium bromide Roth Chemie GmbH (Karlsruhe, Germany) 
Gel Loading Dye Fermentas GmbH (St. Leon Rot, Germany) 
Glycerol Roth Chemie GmbH (Karlsruhe, Germany) 
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GoTaq®Flexi Buffer (10x) Promega GmbH (Mannheim, Germany) 
Imidazole  Roth Chemie GmbH (Karlsruhe, Germany) 
Isoamyl alcohol Roth Chemie GmbH (Karlsruhe, Germany) 
Isopropanol Roth Chemie GmbH (Karlsruhe, Germany) 
MgCl2  x 6 H2O Merck KGaA (Darmstadt, Germany) 
MgSO4 x 7 H2O Merck KGaA (Darmstadt, Germany) 
N,N,N’,N’-tetraethylendiamin 
(TEMED) 
Roth Chemie GmbH (Karlsruhe, Germany) 
Na2-EDTA Roth Chemie GmbH (Karlsruhe, Germany) 
NaCl Merck KGaA (Darmstadt, Germany) 
NaOH Merck KGaA (Darmstadt, Germany) 
Ni-NTA agarose  Qiagen GmbH (Hilden, Germany) 
peqGOLD Agarose PEQLAB Biotechnologie GmbH (Erlangen, Germany) 
peqGOLD Low Melt-Agarose PEQLAB Biotechnologie GmbH (Erlangen, Germany) 
Phenol Merck KGaA (Darmstadt, Germany) 
Rotiphorese® Gel 30 Roth Chemie GmbH (Karlsruhe, Germany) 
SDS Roth Chemie GmbH (Karlsruhe, Germany) 
Sodium acetate Merck KGaA (Darmstadt, Germany) 
Tris Roth Chemie GmbH (Karlsruhe, Germany) 
Tris-HCl Roth Chemie GmbH (Karlsruhe, Germany) 
Tryptone/Peptone from 
Caseine 
Roth Chemie GmbH (Karlsruhe, Germany) 
Yeast extract Fluka Chemie GmbH (Buchs, Switzerland) 
 
Table  3.2  Technical equipment and other material used in this project 
Material Manufacturer 
Amicon Ultra centrifugal filters Millipore GmbH (Schwalbach, Germany)  
Autoclave 
Varioklav®, H+P Labortechnik AG (Oberschleißheim, 
Germany) 
Branson Sonifier 250  
G. Heinemann Ultraschall- und Labortechnik 
(Schwäbisch Gmünd, Germany)  
Biometra T3000 Thermocycler Biometra GmbH (Göttingen, Germany) 
BioRad PowerPacTM 300 Bio-Rad Laboratories GmbH (Hercules, U.S.A.) 
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Boekel Replicator Boekel Scientific (Feasterville, U.S.A.) 
Centrifuge Heraeus Biofuge 
fresco 
Thermo Fisher Scientific (Waltham, U.S.A.) 
Centrifuge Heraeus Contifuge 
Stratos 
Thermo Fisher Scientific (Waltham, U.S.A.) 
Centrifuge Heraeus Fresco 17 Thermo Fisher Scientific (Waltham, U.S.A.) 
Centrifuge tubes (15/50 ml) TPP AG (Trasadingen, Germany) 
CopyControlTM Induction 
solution 
Epicentre (Madison, U.S.A.) 
Eppendorf Centrifuge 5415 D Eppendorf (Hamburg, Germany) 
Eppendorf tubes 0.5, 1.5, 2 ml Eppendorf (Hamburg, Germany) 
Centrifuge tubes 15/50 ml TPP AG (Trasadingen, Germany)  
Gel chambers Horizon 58 and 
Horizon 11.14  
Life technologies (Karlsruhe, Germany)  
Incubator  Memmert GmbH + Co. KG (Schwalbach, Germany)  
Inolab pH meter  WTW GmbH (Weilheim, Germany)  
Intas iX Imager  
Intas Science Imaging Instruments GmbH  
(Göttingen, Germany)  
Kodak DC290  Kodak GmbH (Stuttgart, Germany)  
Laminar Airflow Clean Bench 
BSB 4A (Hera Safe, Class II)  
Heraeus (Hanau, Germany)  
Magnetic stirrer (IKA® RH 
basic)  
IKA® Werke GmbH & Co. KG (Staufen, Germany)  
Milli-Q® Water System  Millipore (Eschborn, Germany)  
Multitron incubation shaker IKA® Werke GmbH & Co. KG (Staufen, Germany) 
MS2 Minishaker IKA® Werke GmbH & Co. KG (Staufen, Germany) 
Nalgene cryogenic vials Nalgene Nunc International (Rochester, U.S.A.) 
Parafilm®  
Pechiney Plastic Packaging Company  
(Chicago, U.S.A.)  
Scale (Satorius BL 3100) Satorius AG (Göttingen, Germany) 
Scale (Satorius BP 221S) Satorius AG (Göttingen, Germany) 
Sterile filter (0.2 µm) Renner GmbH (Dannstadt, Germany) 
Thermomixer Eppendorf Eppendorf (Hamburg, Germany) 
Transferpette®-8 Brand GmbH + Co. KG (Wertheim, Germany) 
UV mini 1240 UV/VIS 
spectrometer 
Shimadzu (Kyoto, Japan) 
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UV cuvettes Ratiolab GmbH (Dreieich, Germany) 
Water bath (Haake DC10)  Thermo Haake GmbH (Karlsruhe, Germany) 
XCell SureLock® Mini-Cell  Invitrogen (Karlsruhe, Germany) 
1.5 mm cassettes for Mini Cell Invitrogen (Karlsruhe, Germany) 
 
3.1.2 Enzymes 
The enzymes used in the scope of this study are listed in table 1.3. Appropriate 
enzyme reaction buffers, which provide optimal reaction conditions as for 
polymerase, restriction and ligation were purchased together with the enzymes. 
Table  3.3 Enzymes used in the scope of this study 
Enzyme Manufacturer 
Agarase Fermentas GmbH (St. Leon Rot, Germany) 
GoTaq® Flexi DNA Polymerase (5 u/μl)  Promega (Mannheim, Germany)  
Lysozyme  Roth (Karlsruhe, Germany)  
Proteinase K  Roth (Karlsruhe, Germany)  
Restriction enzymes  
Fermentas GmbH (St. Leon Rot, Germany),  
Promega (Mannheim, Germany) 
RNase (DNase free)  Roth Promega (Mannheim, Germany)  
Fast-Link™ DNA Ligase  Epicentre (Madison, U.S.A.)  
T4-DNA-Ligase  Fermentas GmbH (St. Leon Rot, Germany)  
All enzymes were  ppl ed f ll      t e  e pe t ve    uf  tu e ’   e    e d t     
for use. Lysozyme and Proteinase K were used as stock solutions with 
concentrations of 100 mg/ml and 20 mg/ml, respectively. Restriction enzymes were 
purchased together with the appropriate reaction buffers and were used according to 
t e p  v ded    p  y’  p  t   l . 
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3.1.3 Molecular weight marker 
The following DNA standards listed in table 1.4 were used for gel electrophoresis.  
Table  3.4 Molecular weight marker applied for size estimation 
Molecular weight marker Manufacturer 
Gene RulerTM DNA Ladder Mix  Fermentas GmbH (St. Leon Rot, Germany)  
Lambda Mix Marker  Fermentas GmbH (St. Leon Rot, Germany)  
36 kb Fosmid Control DNA (100ng/ul)  Epicentre Biotechnologies (Madison, U.S.A.)  
PageRuler Unstained Protein Ladder  Fermentas GmbH (St. Leon Rot, Germany)  
 
3.1.4 Molecular biological kits 
Commercial molecular kits that were utilized in this work are listed in table 1.5. The 
application of the k t      pe f   ed      d    t  t e    uf  tu e ’     t u t    
manuals. 
Table  3.5 Molecular biological kits 
Molecular biological kit Manufacturer 
QIAquick PCR Purification Kit  Qiagen GmbH (Hilden, Germany)  
pGEM®-T Vector System I  Promega (Mannheim, Germany)  
PureYieldTMMiniprep System Promega (Mannheim, Germany) 
QIAGEN Plasmid Midi Kit  Qiagen GmbH (Hilden, Germany)  
QIAquick Gel Extraction Kit Qiagen GmbH (Hilden, Germany) 
QIAprep®Spin Miniprep Kit  Qiagen GmbH (Hilden, Germany)  
GeneJET™ Plasmid Miniprep Kit  Fermentas GmbH (St. Leon Rot, Germany)  
CopyControl™ Fosmid Library 
Production Kit  
Epicentre Biotechnologies (Madison, U.S.A.)  
Fast-Link™ DNA Ligation Kit  Epicentre Biotechnologies (Madison, U.S.A.)  
Quick Blunting Kit  New England Biolabs (Frankfurt, Germany)  
Wizard® Genomic DNA Purification Kit Promega (Mannheim, Germany) 
innuPREP Bacteria DNA Kit Analytic Jena (Jena, Germany) 
RTP® Bacteria DNA Mini Kit Invisorb/stratec molecular (Berlin) 
NucleoSpin® Tissue Machery and Nagel(Düren, Germany) 
Materials & Methods 
 
33 
 
NucleoTrap® Machery and Nagel(Düren, Germany) 
DNA Clean and ConcenttatorTM-5  Zymo Research Europe (Freiburg, Germany) 
Wizard® SV Gel and PCR Clean-Up 
System 
Promega (Mannheim, Germany)  
 
3.1.5 Bacterial strains 
Within this work, different E. coli host strains were utilized for transformation of 
various insert-vector constructs. The E. coli strains, their genotype and 
manufacturers are listed in table 6. 
Table  3.6 E. coli host strains applied in the presented study 
Strain Genotype Manufacturer 
XL1-blue E. coli 
recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)] 
Agilent Technologies 
Deutschland GmbH 
(Böblingen, Germany) 
Phage T1-Resistant 
TransforMax™ EPI- 
300™-T1R chemically 
competent E. coli 
F- mcrA D(mrr-hsdRMS-mcrBC) 
f80dlacZDM15 DlacX74 recA1 
endA1 araD139 D(ara, leu)7697 
galU galK λ- rpsL nupG trfA tonA 
dhfr 
Epicentre Biotechnologies 
(Madison, U.S.A.) 
One Shot® TOP10 
Chemically E. coli 
F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacΧ74 recA1 
araD139 Δ(araleu) 7697 galU galK 
rpsL (StrR) endA1 nupG 
Invitrogen 
(Karlsruhe, Germany) 
BL21 Star™ (DE3) One 
Shot® Chemically 
Competent E. coli - 
F- ompT hsdSB (rB-mB-) gal dcm 
rne131 (DE3) 
 
Invitrogen 
(Karlsruhe, Germany) 
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3.1.6 Vectors  
For several intended cloning purpose (construction of a genomic library or protein 
expression) DNA fragments were cloned into vectors with different properties. The 
following vectors listed in table 3.7 were used in this work. 
Table  3.7 Vectors used for cloning strategies 
Vector Selectable marker Size Reference 
pet151Topo ampicillin 5,7 kb 
Invitrogen (Karlsruhe, 
Germany) 
pGEM®-T Vector ampicillin 3 kb 
Promega (Mannheim, 
Germany) 
pCC1FOS™ Vector  chloramphenicol 8,1 kb 
Epicentre Biotechnologies 
(Madison, U.S.A.) 
 
Table  3.8 Constructs produced in this work 
Construct Applied vector Insert size Insert 
pet151AMPACP pet151Topo 2,2 kb 
AMP ligase(PCR product 
from fosmid 12A9) 
Sub12 pGEM®-T Vector 1 kb 
DNA fragment produced by 
sonication 
p21H12KS pGEM®-T Vector 0,7 kb 
KS domain (PCR product 
from fosmid 21H12) 
p12A9KS pGEM®-T Vector 0,7 kb 
KS domain (PCR product 
from fosmid 12A9) 
 
3.1.7 Fosmids 
T  e t bl       e      l b   y t e C pyC  t  l™ F    d L b   y P  du t      t     
used to generate 2290 recombinant fosmid clones. The approximate insert size of 
recombinant myxobacterial DNA amounts to 36 kb. The fosmid clones 21H12, 11A3 
and 12A9 were further investigated during this project. 
Table  3.9 Fosmids produced in this work, that were further investigated 
Construct Applied vector Insert size Insert 
21H12 pCC1FOS™ Ve t   36 kb 
DNA fragment from genomic 
DNA of N.pusilla 
11A3 pCC1FOS™ Ve t   36 kb 
DNA fragment from genomic 
DNA of N.pusilla 
12A9 pCC1FOS™ Ve t   36 kb 
DNA fragment from genomic 
DNA of N.pusilla 
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3.1.8 Phages 
Phages used for the packaging of concatemer DNA are named in table  3.10. 
Table  3.10 Phage extract used for fosmid library production 
Phage Type Manufacturer 
MaxPlax™ Lambda 
Packaging Extracts 
λ-phage 
Epicentre Biotechnologies 
(Madison, U.S.A.) 
 
3.1.9 Oligonucleotides 
In the presented work, several oligonucleotides were used as PCR primers, either 
specific or degenerated. They were designed from multiple sequence alignments. 
Table  3.12 shows the primers utilized and their corresponding melting temperatures 
(TM) as stated by the manufacturers. The primers were provided as lyophilized 
powders by Eurofins MWG Operon (Ebersberg, Germany) and were dissolved in TE 
buffe    dju ted t        e t  t     f 100 p  l/μl   d  t  ed  t -20 °C. In standard 
PCR reaction mixtures, the primers were used at working concentrations of 10-20 
p  l/μl. The base abbreviations were used according to the IUPAC nucleotide code 
listed in table  3.11. Inosine (I) was integrated as a spacer base to reduce the 
degradation rate of primers. 
Table  3.11 Abbreviations for bases according to IUPAC nucleotide code 
IUPAC   
nucleotide code 
Base 
 IUPAC   
nucleotide code 
Base 
A Adenine 
 
W A or T 
C Cytosin 
 
K G or T 
G Guanine 
 
M A or C 
T Thymine 
 
B C or G or T 
U Uracil 
 
D A or G or T 
R A or G 
 
H A or C or T 
S G or C 
 
V A or C or G 
Y C or T 
 
N any base 
 
Materials & Methods 
 
36 
 
Table  3.12 Oligonucleotides used in PCR studies 
Primer Sequence (5’- 3’) TM Reference 
T7 TAA TAC GAC TCA CTA TA 53 Promega 
SP6 TAT TTA GGT GAC ACT ATA G 48 Promega 
Epi-RP CTC GTA TGT TGT GTG GAA TTG TGA GC 63 Epicentre 
A3rev.1 CCT CCG GSI CSA CCG GSM IGC CSA AGG 72 
Erol et al., 
2010 
LGDD.S GCC GCC SAG SIY GAA GAA 46 
Erol et al., 
2010 
KS 1up MGI GAR GCI HWI SMI ATG GAY CCI CAR CAI MG 56 Beyer et al. 
KS d1 GGR TCI CCI ARI SWI GTI CCI GTI CCR TG 58 Beyer et al. 
pA AGA GTT TGA TCC TGG CTC AG 60 
Edwards et 
al. 1989 
pH AAG GAG GTG ATC CAG CCG CA 64 
Edwards et 
al. 1989 
1540.F CTC ACC ATT CAC GGC CAC CTG AG 66 this work 
1540.R CCC GCG GTG ACT GTC GAT TAT TC 64 this work 
NRPS-F1 
CGC TGA GCT TCG ACG CGT TCG TGT TCG 
AGC TGC TG 
75 this work 
NRPS-R1 
CGA ACA CCC CGA TCG GCG CCG GGT TGC 
CGC GG 
75 this work 
TE-fw1 CCR SCC KMK SGG SGG CAC G 70 this work 
TE-rev1 SAR YYG RCG CGC CAY CTC 62 this work 
revAMPPCP CTA GAT CAC CGC GAT CGG CTC GTC 68 this work 
forAMPPCP CAC CGC GTC AAT CCG GCC GCG AGT C 73 this work 
 
3.1.10 Water  
For the preparation of culture media, demineralized water was provided by a reverse 
osmosis system (IMB, Germany). A Milli-Q® Academic Water Purification System 
(Millipore GmbH, Germany) was used to generate ultra-pure water prepared from 
demineralized water. Milli-Q® water was used for all applications, if not specified 
otherwise. For PCR application, autoclaved Milli-Q® water was applied. 
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3.1.11 Culture Media 
Culture media were prepared with demineralized water prior to steam sterilization. 
The following table shows the composition of the used media. 
Table  3.13 List of media and their composition 
MD1+Glucose  
3g casiton  
0.7g CaCl2 x 2 H2O  
2g MgSO4, x 7 H2O  
2.2 g glucose x H2O adjust to pH=7.5 
 
 after sterilization add: 
 1ml/L trace element solution 
 1ml/L cyanocobalamine solution 
   
VY/2 Agar:   
50ml yeast suspension(10%)  
1.36 g CaCl2 x 2 H2O  
15g agar  
ad 1L H2O 
 
adjust to pH=7.2 
 after sterilization add: 
 1ml/L trace element solution 
 
 
Luria-Bertani (LB)-Medium   
10 g tryptone  
5 g yeast extract  
10 g NaCl  
ad 1 L H2O adjust to pH=7.5 
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LB-Agar  
10 g tryptone  
5 g yeast extract  
10 g NaCl  
15 g Agar   
ad 1 L H2O  
 
adjust to pH=7.5 
 
Trace element solution  
20 mg ZnCl2 5 mg LiCl 
100 mg MnCl2 x 4 H2O 20 mg KBr 
10 mg H3BO3 20 mg KJ 
10 mg CnSO4 10 mg Na2MoO4 x 2 H2O 
5 mg CoCl2 
 
5.2 g EDTA-Na2 x 2 H2O 
5 mg SnCl2 x 2 H2O ad 1 L H2O; solution was sterile filtrated 
 
Cyanocobalamine solution  
50 mg cyanocobalamine 
 
 
ad 100 ml H2O solution was sterile filtrated 
 
 
 
 
3.1.12 Antibiotics 
The antibiotics listed in table  3.14 were used as additives in culture media for the 
purpose of clone selection and for the antibiotic selectivity test described in section 
 3.2.2. The antibiotics were used as antibiotic stock solutions and were solved either 
in autoclaved Milli-Q® water ( 3.1.10) or in ethanol (i.e. chloramphenicol). 
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Table  3.14 List of antibiotics used as additive in culture media 
Antibiotics Manufacturer 
Ampicillin  Roth Chemie GmbH (Karlsruhe, Germany)  
Apramycin  Sigma-Aldrich Co. LLC (St. Louis, MO, USA)  
Carbenicillin  Roth Chemie GmbH (Karlsruhe, Germany)  
Chloramphenicol  Fluka Chemie GmbH (Buchs, Switzerland)  
Gentamycin  Fluka Chemie GmbH (Buchs, Switzerland)  
Kanamycin  Sigma-Aldrich Co. LLC (St. Louis, MO, USA)  
Nalidixinic acid  Roth Chemie GmbH (Karlsruhe, Germany)  
Streptomycin  Sigma-Aldrich Co. LLC (St. Louis, MO, USA)  
Tetracyclin  Fluka Chemie GmbH (Buchs, Switzerland)  
 
3.1.13 Buffers and solutions 
All buffers and solutions were prepared with ultra-pure water ( 3.1.10). Stock solutions 
not containing any organic solvents or thermo labile components were usually steam 
sterilized prior to use ( 3.2.1). 
Table  3.15 Buffers and solutions 
Buffers for DNA extraction:  
TE buffer SET buffer (Sambrook & Russell, 2001) 
10 mM Tris-HCl 
1 mM EDTA 
pH 8.0 
75 mM NaCl, 
25 mM EDTA 
10 mM Tris-HCl 
pH 7.5 
RNase A stock solution (DNase-free)  
50 mg lyophilised RNase A 
5 ml Tris-HCl (10 mM, pH 7.5) 
15 mM NaCl 
storage at –20 °C  
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Buffers for library construction:   
Phage dilution buffer (PDB)   
10 mM Tris-HCl  
100 mM NaCl 
10 mM MgCl2  
pH 8.3 
 
Buffers for plasmid and fosmid purification: 
Buffer P1  Buffer P2  
50 mM Tris-HCl  
10 mM EDTA 
100 μg/mL RNase A  
pH 8 
200 mM NaOH 
1% SDS 
Buffer P3  Buffer QBT (Equilibration buffer)  
3M potassium acetate  
pH 5.5 
750 mM NaCl 
50 mM MOPS (pH 7.0) 
including 15 % isopropanol  
   and 15 ml of 10% Triton X-100 solution (v/v) 
Buffer QC (Wash buffer) Buffer QF (Elution Buffer) 
1 M NaCl 
50 mM MOPS (pH 7.0)  
including 15 % isopropanol 
1.25 M NaCl 
4M Tris (pH 8.5)  
including 15 % isopropanol  
Buffers for gel electrophoresis:   
10 x TBE buffer  Modified 50 x TAE buffer ( 3.2.13.2) 
0.89 M Tris base 
20 mM EDTA 
0.87 M H3BO3 
 purified water ad 1000 ml  
2 M Tris-acetate 
50 mM EDTA (pH 8) 
6 x Gel loading buffer (Sambrook & Russell, 2001)  
40 g sucrose  
0.25 g bromophenol blue  
ad 100 ml purified water  
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Buffers for protein expression and A domain assay: 
10x glycine SDS electrophoresis buffer 
250 mM Tris, 2M glycine 
1% SDS,  
ad 1000 ml purified water 
adjust to pH 8.9 
 
Staining solution Destaining solution 
10% acetic acid 
50 % ethanol 
0.005% coomassie brilliant blue R-250 
7.5% acetid acid 
30%isopropanol 
10% Acetic acid 
20% Methanol 
50% Methanol 
5 % Acetic acid 
Protein lysis buffer Protein wash buffer 
50 mM NaH2PO4 
300 mM NaCl 
10 mM imidazole 
pH 8.0 
40 mM NaH2PO4 
300 mM NaCl 
20 mM imidazole 
pH 8.0 
Protein elution buffer A Domain buffer (Phelan et al., 2009) 
50 mM NaH2PO4 
300 mM NaCl 
pH 8.0;  
 
20 mM Tris-HCl (pH 7.5) 
5% glycerol 
1mM DTT 
 
Buffers QBT, QC and QF were supplied with the QIAGEN Plasmid Midi Kit (3.1.4). 
They were used for equilibration (QBT) and washing (QC) of the provided DNA 
purification columns as well as for the elution of purified DNA (QF). The procedure 
         ed  ut f ll      t e    uf  tu e ’  p  t   l. For gradual elution protein 
elution buffers with 100, 150, 200 and 300 mM imidazole were used. 
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3.1.14 Software and Databases 
Basic Local Alignment Search Tool (BLAST) is provided by the National Centre for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/pubmed). This 
software was applied to analyze nucleotide data for sequence similarities using blastx 
(nucleotide sequence is translated and compared to the amino acid sequences 
database). For further analysis of the amino acid sequences blastp (protein database 
using a protein query) was used. In order to analyze 16S rDNA, the database was 
searched using blastn (nucleotide query vs. nucleotide databases). 
 
Entrez Nucleotide Database is maintained by the National Centre for Biotechnology 
Information (NCBI) (http://www.ncbi.nlm.nih.gov/gene). This source is linked to 
numerous databases, e.g. GenBank, NCBI Reference Sequences (RefSeq), and the 
Protein Data Bank of the Research Collaboratory for Structural Bioinformatics (RCSB 
PDB). Therefore, it lends itself for detailed analysis of nucleotide and amino acid 
sequences and putative anticipation on their possible functions in secondary 
metabolites biosynthesis.  
 
ClustalW2 sequence analysis tool version 2.1 is provided by the European 
Bioinformatics Institute (EBI), (EMBL) (http://www.ebi.ac.uk/Tools/clustalw). This tool 
was used to generate multiple sequence alignments based on the Nucleotide 
Sequence Database, part of the European Molecular Biology Laboratory (EMBL).  
 
DNAtrans (DNA Translator) was developed and provided by Dr. Anke Schiedel 
(Pharmaceutical Chemistry, Bonn) and Jochen Bosmann. The program helps to 
clean up DNA sequences, translate them to protein sequence and to create 
complementary and reverse DNA sequences. With the primer check tool melting 
temperatures and GC content can be calculated. 
Clone Manager 9 is a purchased program with a set of tools for enzyme operations, 
cloning simulation, graphic map drawing, primer design and analysis and sequence 
alignments. Clone Manager 9 was mainly used for primer design and the simulation 
of cloning procedures. 
Pfam is a Sanger institute database of protein families that includes their annotations 
and multiple sequence alignments generated using hidden Markov models. 
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Artemis is a a free genome browser and annotation tool provided by Sanger institute 
that allows visualization of sequence features, next generation data and the results of 
analyses within the context of the sequence, and also its six-frame translation. This 
program was mainly used to identify open reading frames (ORFs) in the sequence 
data obtained from genome and fosmid sequencing. 
CLUSEAN (CLUster SEquence ANalyzer): This software enables fast access to 
sequence data from established databases like BLAST and HMMER (Weber et al., 
2009). It can be used to identify functional domains and conserved motifs in a given 
nucleotide or amino acid sequence. Furthermore, the software allowed searching 
whole genome assembly files as well as assembled contigs of the genome 
sequencing of N. pusilla B150.  
 
AntiSMASH (antibiotics&Secondary Metabolite analysis Shell) is a free online tool 
that allows the rapid genome-wide identification, annotation and analysis of 
secondary metabolite biosynthesis gene clusters in bacterial and fungal genomes 
(http://antismash.secondarymetabolites.org/). It integrates and cross-links with a 
large number of in silico secondary metabolite analysis tools that have been 
published earlier. AntiSMASH is powered by several open source tools: NCBI 
BLAST+,HMMer 3, Muscle 3, Glimmer 3, FastTree, TreeGraph 2, Indigo-depict, 
PySVG and JQuery SVG. 
 
ASMPKS (Analysis System for Modular Polyketide Synthesis) is an online tool, which 
provides overall management of information on modular PKS, including polyketide 
database construction, new PKS assembly, and chain visualization 
(http://gate.smallsoft.co.kr:8008/~hstae/asmpks/pks_prediction.pl). ASMPKS can 
predict functional modules for a submitted protein sequence, estimate the chemical 
composition of a polyketide synthesized from the modules, and display the carbon 
chain structure on the web interface. 
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Phylogeny.fr is a free, simple to use web service dedicated to reconstructing and 
analysing phylogenetic relationships between molecular sequences 
(http://www.phylogeny.fr/). It connects various bioinformatics programs to reconstruct 
a robust phylogenetic tree from a set of sequences (Dereeper et al., 2008, Dereeper 
et al., 2012 ). 
 
NaPDoS(Natural Product Domain Seeker) NaPDos is a bioinformatic tool for the 
rapid detection and analysis of secondary metabolite genes 
(http://napdos.ucsd.edu/). This tool is designed to detect and extract C- and KS- 
domains from DNA or amino acid sequence data, individual genes, whole genomes, 
and metagenomic data sets. 
 
Kodak 1D software version 3.5.4 and iX Imager software: These programs were 
provided together with the respective gel documentation system (Kodak Scientific 
Imaging Systems and Intas Gel iX imager) and were applied to edit digital photos of 
electrophoresis gels.  
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3.2 Molecular biological methods 
3.2.1 Sterilization of solutions and equipment  
To eliminate potential contaminations with foreign organisms, all heat resistant 
solutions, buffers and media were autoclaved for 20 min at 121°C and 2 bar 
atmospheric pressure in a Varioklav® steam sterilizer (table  3.1.1). Heat sensitive 
components of solutions were sterilized by filtration through membrane filters with a 
pore size of 0.22 μm (table  3.2). Steam heat sterilization was also applied for 
decontamination of glass and plastic ware and for inactivation of genetically modified 
organisms. 
3.2.2 Antibiotic selectivity test 
To evaluate the resistance of the bacterium towards several antibiotics, N. pusilla 
B150 was cultivated with several antibiotics. For this purpose, a kryo-culture of the 
strain 150 was cultivated on agar plates with VY/2 medium and grown for 7 days. 
Small pieces of agar, containing fruiting bodies of N. pusilla B150 were transferred to 
new V/Y2 agar plates complemented with several antibiotics. The growth of the strain 
on the agar plates was observed for 14 days with a stereo microscope (Stemi 2000-
C, Zeiss, Germany). 
For tests in liquid culture a pre-culture of 30 ml MD1-glucose medium was prepared, 
inoculating 100 µl of a kryo-culture of N. pusilla B150. After 7 days of growth under 
shaking of 140 rpm at 30°C, 5 ml of the pre-culture were inoculated in 100 ml MD1-
glucose medium and were cultivated on the same conditions. The growth of N. pusilla 
in liquid was tested respectively for chloramphenicol, streptomycin, tetracycline and 
carbenicillin. The liquid cultures were checked after 4 and 14 days for bacterial 
growth.  
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3.2.3 Isolation of chromosomal DNA 
For the isolation of genomic DNA from the myxobacterium N. pusilla B150 several 
molecular biological kits were tested. Amongst them Wizard® Genomic DNA 
Purification Kit (Promega), innuPREP Bacteria DNA Kit (analytic jena), RTP® Bacteria 
DNA Mini Kit (Invisorb), NucleoSpin® Tissue and NucleoTrap® (Machery and Nagel) 
(table  3.5). 
But the method described by Neumann et al., 1992 was mainly used to isolate 
genomic DNA from N. pusilla B150. Therefore the myxobacterial cells were cultivated 
for 7 days in 100 ml MD1+G-Medium (table  3.13) at 30°C and 140 rpm and 
subsequently harvested by centrifugation at 8000 rpm for 10 min at 4°C. The cell 
pellet was resuspended in 5 ml SET buffer. After addition of 500 µl SDS (10 %), 500 
µl lysozyme (40 mg/ml) and 275 µl proteinase K (20mg/ml) the cell solution was 
incubated at 55°C for 2 h and gently mixed by inverting every 15 min. An equal 
volume of phenol: chloroform: isoamyl alcohol (25:24:1) was added to the lysate 1.8 
ml 5 M NaCl and and gently mixed by inverting several times. Through centrifugation 
at 8000 rpm for 10 min phase separation was achieved and the aqueous phase was 
separated from the organic phase through gentle pipetting with cut tips. The 
procedure was repeated several times until the interphase remained clear. For 
removal of phenol residues in the aqueous phase, the same procedure was carried 
out with chloroform: isoamyl alcohol (24:1). 
The resulting aqueous sample containing the DNA was mixed with 1/10 volume of 3 
M sodium acetate (pH 5.2) and 2-2.5 volumes of ice-cold ethanol 98% (stored at -
20°C). After incubation of this mixture at -20°C overnight the precipitated DNA was 
centrifuged at 8500 rpm at 4°C for 45 min. The supernatant was decanted off and the 
DNA pellet dried at room temperature. The DNA was redissolved in TE buffer (pH 
8.0) (Table  3.13) containing RNase (20µg/ml) for RNA degradation. It was incubated 
at 37°C for 30 min and afterwards stored at 4°C. 
 
3.2.4 16S rDNA analysis 
A standard PCR reaction ( 3.2.7) was performed on isolated genomic DNA applying 
t e ‘u  ve   l’ eub  te   l p  e  p    pA/pH ( 3.1.9) to amplify the 16S rDNA 
(Edwards et al. 1989). The obtained PCR product with a size of 1500 bp was excised 
from an agarose gel and purified using the QIAquick Gel Extraction Kit ( 3.1.4). 
Subsequently, the purified amplificate was ligated into the pGEMT®-vector ( 3.2.8). 
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The obtained plasmid was sequenced with the T7-primer (3.1.9). With BLAST search 
a phylogenetic tree was generated and helped to identify the origin of the strain and 
to prove the purity of the isolated genomic DNA. 
 
3.2.5 Agarose gel electrophoresis  
Agarose gel electrophoresis was used to survey DNA manipulations such as 
preparative DNA isolation, restriction digests or PCR amplification. Standard gels 
were prepared by dissolving 1% peqGOLD Agarose in 1 x TBE buffer (table  3.1, 
table  3.15). Small gels were usually run for 40 min at a voltage of 120 V in Life 
Technologies Horizon® 58 chambers (table  3.2). Nucleic acid probes were mixed 
with gel loading dye before loading them into the slots. DNA standards were applied 
to each gel for size estimation. To reduce contamination with ethidium bromide in the 
laboratory, gels were stained subsequently to the separation run. The dye bath 
contained 100 ml ethidium bromide solution (10 mg/ml), the gels were stained for 1-3 
min, followed by a washing step in water for another 3-5 min. The ethidium bromide 
solution was saved to be reused several times. Nucleic acids with intercalated 
ethidium bromide could be visualized by UV illumination at 254 nm. Gels were 
digitally pictured using the Kodak DC 290 Zoom Digital Camera System, or 
alternatively the Intas Gel iX Imager (table  3.2). UV light exposure was kept to a 
minimum, to reduce photochemical damage of the DNA. 
 
3.2.6 DNA recovery form agarose gels 
For cloning procedures, stained PCR fragments of interest were directly cut out from 
electrophoresis-gels and purified using the QIAquick gel extraction kit following the 
   uf  tu e ’  p  t   l. Pu  f ed PCR   pl f   te   e e u u lly  l  ed    
sequencing vectors (pGEMT®) to analyze their nucleotide sequences by BLAST 
( 3.1.14). 
3.2.7 Polymerase chain reaction 
Polymerase chain reaction was used for the in vitro amplification of DNA sections. 
Therefore knowledge about the flanking regions from the sequence of interest is a 
necessity. Oligonucleotide primers are designed complementary to the opposite ends 
of the desired region. Periodically temperature change causes denaturation, 
annealing and elongation of the DNA in usually 25-30 cycles. The denaturation of the 
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double stranded DNA into single stranded DNA enables the primer to anneal and 
nucleic acid elongation, which is mediated by a polymerase ( 3.1.2), may proceed. 
This procedure enables exponential in vitro reproduction of a DNA-section and is 
therefore the method of choice for rapid amplification of nucleic acid fragments. 
Within this work, PCR was performed applying a T3 or a T-gradient thermocycler 
(table  3.2) according to the parameters and protocols described in sections 
 3.2.7.1and  3.2.7.2. 
3.2.7.1 PCR parameters 
For PCR amplification of template DNA, PCR-buffers supplied with the GoTaq® Flexi 
DNA Polymerase ( 3.1.2) were used to achieve optimal reaction conditions. To ensure 
hybridization of PCR-primers with their complementary sequence after denaturation, 
the temperature was adjusted to the calculated annealing temperatures of the 
primers. Elongation by Taq-polymerase was accomplished at 72 °C, whereby the 
required elongation time was estimated from the length of the target region (about 1 
min/kb). For DNA-extension, the polymerase recognizes the primers annealed to the 
DNA-te pl te   d  t  t  el    t       3’-direction using dNTPs provided in the 
reaction mixture. 
PCR amplification is depending on several factors as like the concentration of MgCl2, 
which affects polymerase activity or the choice of the annealing temperature, 
responsible for the specific hybridization of the primers to the DNA-template. Primer 
annealing occurs with less specificity at lower temperatures, which was beneficial in 
the case of homologous, degenerated primer pairs designed from sequence 
alignments ( 3.1.14). Optimization of the procedure was achieved for each PCR by 
adjusting the annealing temperature as well as the elongation time. Self-
complementarity of template DNA is usually less likely due to molar excess of 
oligonucleotides. Despite that, additives like DMSO are useful when working with 
GC-rich templates avoiding the formation of secondary structures in the 
polynucleotide molecules (Hung et al., 1990). 
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3.2.7.2 PCR protocol  
A standard PCR reaction mixture was composed as follows: 
components volume final concentration 
5x GoTaq® Flexi Buffer   4.0 μl 1x 
MgCl2  (25 mM) 1.0 μl 1.25 mM 
dNTP  (each 10 mM) 0.4 μl each 0.2 mM 
GoTaq-Polymerase  (5 unit/μl) 0.16 μl 0.08 unit 
Forward-Primer  (20 μM) 1.0 μl 0.5 μM 
Reverse-Primer  (20 μ ) 1.0 μl 0.5 μM 
DMSO  1.0 μl 0.5 % 
Template   1.0 μl  
H2O   ad 20.0 μl  
 
The typical PCR thermocycling was performed as described below: 
Step temperature time 
1. initial denaturation step 
2. primer annealing 
3. elongation 
4. denaturation 
5. final elongation 
6. end 
95 °C  5 min 
45-60 °C  0.5 min 
72 °C 30x 1-1.5 min 
95 °C  0.5 min 
72 °C  4 min 
4 °C  ∞ 
 
Steps 2 to 4 were repeated in a loop for 30 times, before proceeding with step 5. 
Annealing temperatures were chosen about five degrees below the lower Tm-value 
( 3.1.9) of one of the used oligonucleotides. 
 
3.2.8 Ligation of PCR Products 
PCR fragments produced by Taq-p ly e   e    d   3’-poly-A nucleotide overhang. 
Some customary cloning kits, like the pGEM®-T Vector System I (table  3.7), provide 
a vector, that is compatible to PCR products synthesized by Taq-polymerases. This 
cloning kit was utilized to directly ligate PCR fragments extracted from 
electrophoresis gels. A vector to insert ratio of 3:1 was favored in a total volume of 10 
μl. Usually, an incubation time of 1h at room temperature was sufficient before 
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proceeding with the transformation step. The following general pipetting scheme was 
applied for standard ligations: 
3.2.9 Restriction digestion  
Chromosomal or plasmid DNA samples were routinely subjected to restriction 
digestions with restriction endonucleases type II. These enzymes originally belong to 
the bacterial repertoire of defense mechanisms. They recognize certain DNA 
sequences, which are mostly palindromes enabling a cleavage of phosphodiester 
bonds at these specific restriction sites. Most of the restriction endonucleases 
generate sticky ends, while SmaI for example generates blunt ends. However, 
ligation reactions carried out with sticky ended restriction fragments are more 
efficient. For optimal conditions, the buffers provided with the restriction enzymes 
were included in the reaction mixtures. The duration of the restriction digest was 
depending on the nature and quality of template DNA as well as on the type of 
restriction enzyme applied. Generally, a reaction mixture included 10 units of enzyme 
per μg DNA in a total volume of 20 μl and was incubated either for 2 h or overnight at 
37 °C. 
3.2.10 Preparation of cells competent for DNA-transformation 
The E. coli strain XL-1 Blue (Stratagene, La Jolla, CA, USA) ( 3.1.5) with the following 
genotype was used for general cloning procedures: 
recA1 endA1 gyrA96 thi-1   dR17  upE44  elA1 l   [F´ p  A  l  IqZΔ 15 T 10 
(Tetr)] 
The preparation of chemically competent cells was followed using the method of 
Dagert and Ehrlich, 1974. An overnight pre-culture, prepared by inoculating 3 ml LB-
medium with a single E. coli colony followed by incubation at 37 °C and constant 
shaking at 180 rpm, was transferred into an Erlenmeyer flask containing 70 ml of 2 x 
YT-medium. The mixture was again grown at 37°C and shaked at 180 rpm until an 
Component  pGEM®-T Vector System I  
Buffer  5 μl (2 x Rapid Ligation Buffer)  
Vector  1 μl (p E ®-T)  
PCR product  3 μl  
Ligase  1 μl T4 DNA L    e  
Nuclease-free water   d 10 μl  
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OD600 of 0.3-0.4 was reached. At this point the cells were harvested by centrifugation 
for 10 min at 8,000 rpm and 4°C (Heraeus Contifuge Stratos) (table  3.2). To make 
the cells transformable, they were treated with ice cold CaCl2/MgSO4-solution (70mM 
CaCl2/ 20mM MgSO4) twice after resuspension. The first treatment was performed 
with 10 ml, the second one with 3.5 ml CaCl2/MgSO4-solution. Each time, the cell 
suspension was kept on ice for 30 min. Storage and deep-freezing of the competent 
E. coli cells was possible adding 875 µl steam sterilized glycerol to the cell 
suspension, without discernible loss of quality. After the addition of glycerol, the cell 
suspension was divided into aliquots of 100 µl and stored at -80°C. 
3.2.11 Transformation of host strains 
In vivo amplification of DNA sequences was achieved via insertion of a vector 
construct to competent E. coli XL1-Blue cells (3.1.5). The exponential growth of those 
E. coli cells leads then to the enrichment of vector DNA. An aliquot of competent cells 
( 3.2.10) was thawed on ice and 5-10µl of the ligation mixture ( 3.2.8) was added. After 
incubation on ice for 30 min, the probe was heat-shocked for 90 sec at 42°C to 
enable DNA uptake. In order to ensure that the delivered plasmid DNA was kept 
inside the E. coli transformants, the cell suspension was again placed on ice for 2 
min. To initiate cell growth, 300-600 µl of sterile LB-medium was added and a 
following incubation was carried out for 1h at 37 °C using the Thermomixer 
Eppendorf (table  3.2). Depending on the applied vector, an antibiotic selection was 
performed spreading 100-200 µl of this pre-culture on LB agar plates supplemented 
with appropriate antibiotics. The plates were incubated overnight at 37 °C using an 
incubator ( 3.1.1). Subsequently to plasmid isolation ( 3.2.12), the transformation of the 
vector construct was confirmed via PCR ( 3.2.7). 
3.2.12 Plasmid isolation from transformed E. coli  
The vector construct was isolated from transformed E. coli cells ( 3.2.11) using the 
GeneJETTM Plasmid Miniprep Kit or PureYieldTMMiniprep System ( 3.1.4). For the 
isolation of plasmid DNA from PCR positive clones, cultures in a scale of 3 ml were 
sufficient. After inoculation of LB-medium supplemented with an appropriate 
antibiotic, the culture was grown overnight in a test tube at 37 °C under constant 
shaking at 180 rpm. Cells were then harvested by centrifugation at 13,000 rpm for 2 
min in 1.5 ml tubes ( 3.1.1). Subsequently, the pellets were resuspended in buffer 1 
( 3.1.12) by vigorous vortexing applying the MS2 Minishaker ( 3.1.1). Cell lysis was 
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achieved by addition of buffer 2 ( 3.1.12), followed by incubation for not more than 2 
min while gently inverting the tube several times. After addition of the neutralization 
solution (buffer 3) ( 3.1.12), precipitated proteins and non-circular DNA were pelleted 
by centrifugation at 13,000 rpm for 15 min. The supernatant was purified with 
 uppl ed   lu    f ll      t e    uf  tu e ’  instructions. 
 
3.2.13 Construction of a genomic library 
3.2.13.1 LMP agarose gel electrophoresis  
Size selection of sheared DNA fragments, required for the construction of a fosmid 
library, was achieved via preparative gel extraction. High molecular genomic DNA 
could not be extracted in using the usually applied QIAquick gel extraction Kit, as this 
method is only recommended for DNA fragments between 70 bp and 10 kb. 
Therefore an agarose with a low melting point, in this case the peqGOLD Low Melt 
Agarose ( 3.1.1), was used to recover the genomic DNA. According to the 
   uf  tu e ’     u l   el   e e p ep  ed   t  TAE ele t  p   e    buffe  ( 3.1.12). 
For separation of DNA fragments in the range of 35-40 kb, a 0.9 % LMP agarose gel 
was chosen. The 50 x TAE stock solution was diluted to 1 x concentration. 1.8 g of 
LMP agarose was suspended in 200 ml of 1 x TAE buffer using a magnetic stirrer 
( 3.1.1). The suspension was heated to ebullition using a microwave until the agarose 
was completely dissolved. The LMP agarose solution was allowed to cool for 20 min 
to a temperature of about 50°C. In a Horizon® 11.14 chamber, the LMP gel was 
poured and cooled at 4°C for 1 hour to achieve optimal consistence. The nucleic acid 
solution was mixed with gel loading dye ( 3.1.3) and pipetted into the gel slots. For 
size estimati      le ul    e   t    ke      t e  e eRule ™ DNA L dde    x  t e 
Lambda Mix Marker and the 36 kb Fosmid Control DNA ( 3.1.3), supplied with the 
C pyC  t  l™ F    d L b   y P  du t      t ( 3.1.4) , were used. In a first turn, the 
gel was run for 10 min at 60 V to assure that the DNA was transferred to the gel 
matrix. Subsequently, the voltage was lowered to 15-30 V and the gel electrophoresis 
was carried out overnight. For preparative isolation of the desired band, only the 
lanes with the molecular weight markers were stained with ethidium bromide, in order 
to prevent damages to the genomic DNA by intercalation. 
 
Materials & Methods 
 
53 
 
3.2.13.2 DNA extraction from LMP agarose 
DNA ext   t    f    L P       e  el      pe f   ed    f ll      t e p  v de  ’ 
recommends. Guided by the stained band of the Fosmid Control DNA ( 3.2.13.1), the 
desired band of about 36 kb had to be excised from the gel using a clean scalpel. To 
minimize UV light exposure to the band of interest, the latter was masked with a 
sheet of alu foil. The cut out gel slices were molten at 70 °C for 15 min and 
transferred to water bath of 42 °C for additional 10 min. According to the 
   uf  tu e ’  p  t   l  1 u  t  f agarase ( 3.1.2) was added per 100 mg of molten 
LMP agarose. After repeated pipetting, the mixture was incubated at 42 °C for 2h 
followed by a heat inactivation of the enzyme for 10 min at 70°C. The mixture was 
divided into aliquots of 500µl volume, the tubes were then chilled on ice for 5 minutes 
and subsequently centrifuged for 25 min at 10.000 rpm and 4°C to separate 
undigested agarose from the sample. 90 % of the supernatant, in this case 1.25 ml, 
were pipetted in a sterile 15 ml Falcon to precipitate the DNA. This was achieved in 
adding 125 µl sodium acetate (3M, pH 5,3) and 3.75 ml pure isopropanol to the 
solution. Incubation for 10 min at room temperature and centrifugation at 6000 rpm 
resulted in a DNA pellet that was washed with 70% ethanol. The air-dried pellet was 
then solved in 20µl water or EB-Buffer ( 3.1.12). 
3.2.13.3 End-repair of size selected DNA 
Before cloning the size-selected high-molecular DNA fragments into the pCC1FOS 
vector ( 0), blunt ends of those DNA fragments were required, as the pCCFOS1 
vector itself already provides blunt ends. For this purpose the Quick Blunting Kit 
( 3.1.4) was u ed      d    t  t e    uf  tu e ’  p  t   l. A  t  d  d  e  t    
mixture contained the following components: 
Purified DNA (up to 5 μg)  1-19 μl 
10 x Blunting Buffer  2.5 μl 
1 mM dNTP Mix  2.5 μl 
Blunt Enzyme Mix  1.0 μl 
Sterile distilled water   d 25 μl 
Since the DNA fragments were sheared during DNA extraction, an incubation time of 
30      t      te pe  tu e         e  f ll      t e    uf  tu e ’  
recommendations. Subsequently, the enzyme mix was inactivated by heating at 70°C 
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for a duration of 10 min. The reaction mixture containing the blunt end DNA could be 
directly used for ligation into the pCC1FOS fosmid vector. 
3.2.13.4 Ligation of end-repaired DNA into the pCC1Fos vector 
F   t e     t u t     f    e      l b   y  t e C pyC  t  l™ F    d L b   y 
Production Kit ( 3.1.4)      ppl ed   t   pe   l  e   d t  t e    uf  tu e ’  
instructions. For blunt end ligation, the molar ratio of the cloning vector to the desired 
insert DNA has to be taken into account, whereby a 10:1 molar ratio of the 
C pyC  t  l™ pCC1FOS ve t   ( 0) to insert DNA is recommended. 
A 10 μl  e  t    v lu e     p petted      PCR tube      d    t  t e following 
scheme: 
Blunt end DNA (~ 250 µg of approx. 36 Kb DNA)  1.5 μl 
10 x Fast-Link Ligation Buffer  1 μl 
10 mM ATP  1 μl 
CopyControl pCC1FOS vector (500µg/µl)  1 μl 
Fast-Link DNA Ligase  1 μl 
H2O 4.5 µl 
 
The reaction mixture can be scaled-up, if the ligation effectiveness is limited due to 
low quality of insert DNA. To calculate the number of clones (N) necessary to cover 
the whole N. pusilla genome by 36 kb fragments with a given probability (P), the 
following equation was applied: 
N = ln (1-P ) / ln (1-f ) P= 99.9 % 
N = ln (1-0.99) / ln (1-0.0045) = 1021 f = 36 kb/8 x 103 kb = 0.0045 
N = ln (1-0.99) / ln (1-0.0040) = 1149 f = 36 kb/9 x 103 kb = 0.0040 
 
Figure  3.1 Formula to calculate the number of clones required for fosmid library 
In this formula, f is the proportion of the genome present in one clone (Clarke & 
Carbon, 1976). The size of myxobacterial genomes varies from 8 to 13 Mb 
(Myxococcus xanthus, Goldmann et al., 2006; Sorangium cellulosum, Schneiker et 
al., 20071; Plesiocystis pacifica, Shimkets et al., 2010, Stigmatella aurantiaca, 
Huntley et al., 20112). As most myxobacterial genomes have genome sizes between 
8 and 9 Mp, we estimate N. pusilla B150 to range in this area and thus the number of 
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required clones was estimated to vary between 1021 and 1149 clones. Based on 
empirical experiences, this value was doubled, and thus around 2,300 clones should 
be  uff   e t t   ep e e t t e    le  e   e. A    d    t     uf  tu e ’  d t     
single ligation reaction is imputed to produce 103-106 clones. Therefore, only one 
reaction mixture was set up for ligation. The mixture was incubated overnight at 4 °C. 
Subsequently, the Fast-L  k™ DNA L    e         t v ted f   10      t 70 °C. T e 
concatemer formation during ligation is essential for the following lambda packaging 
step into phage coats ( 3.2.13.6). 
3.2.13.5 Preparation of EPI300-T1R competent E. coli cells 
The provided E. coli  t     T    f    x™ EPI-300™   uppl ed       ly e  l  t  k 
solution, was plated on a LB agar plate (without antibiotics). The colonies were grown 
overnight at 37 °C in an incubator (table  3.2). A pre-culture was prepared in an 
Erlenmeyer flask containing 5 ml of sterile 100 mM MgSO4 solution and 45 ml of 
sterile LB medium. After inoculation with a single colony of the plating bacterial strain, 
the culture was shaken overnight at 160 rpm and 37 °C. A second Erlenmeyer flask 
contained 40 ml of autoclaved LB medium supplemented with 5 ml of 100 mM 
MgSO4 solution and 5 ml of sterile filtrated 2 % maltose solution was prepared. The 
medium was inoculated with 5 ml of the EPI300-T1R overnight pre-culture and 
shaken at 180 rpm at 37 °C until an OD600 of 0.8 was reached. The cells were then 
centrifuged and resolved in 35 ml of 10mM MgSO4, resulting in an OD600 of 0.5. The 
competent cells could then be stored for up to three days at 4°C. 
3.2.13.6 Packaging of fosmid clones 
Just like cosmids, fosmids also contain at least one phage lambda cos site, 
 e     zed by λ p   e p  t  le . C    te e  zed DNA, achieved through former 
ligation, may be then pack  ed by t e λ p   e   f t e   xPl x™ L  bd  
Packaging Extracts ( 3.1.8). The infective phage particles were used to transfect 
special E. coli  ell  (T    f    x™ EPI-300™;  3.1.5). For the packaging reaction, 
t e    uf  tu e ’  p  t   l     f ll  ed. F     e l   t     e  t       e tube  f t e 
  xPl x™ L  bd  P  k      Ext   t      t   ed      e. I  ed  tely  25 μl  e e 
transferred to a 1.5 ml Eppendorf tube, which was subsequently stored at -80 °C until 
u e. T e l   t     e  t    (10 μl)      dded t  t e  e        25 μl  f t e   xPl x™ 
Packaging Extract, which was kept on ice for the whole time. The solution was then 
mixed by gentle pipetting (with cut tips), avoiding the introduction of air bubbles, as 
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this might damage the phages. The mixture was held at 30 °C for 1.5 hours in an 
incubator ( 3.1.1). This incubation step was repeated after thawing and adding the 
 e   d   lf  f t e   xPl x™ P  k      Ext   t. T e   xtu e     t e  d luted    
Phage Dilution Buffer (PDB) ( 3.1.12) to a final volume of 1 ml. 25 µl of chloroform 
were added to prevent bacterial contaminations and the tube was inverted gently 
several times. The final solution was then stored at 4 °C until use. For long term 
storage at -80°C, sterile glycerol was added to a final concentration of 20%. 
To determine an appropriate titer for easier clone picking, a 1:10, 1:50 and a 1:104 
d lut     f t e p  k       e  t     e e   de    PD . 100 μl  f e    dilution were 
  xed   t  100 μl  f    pete t EPI300-T1R cells ( 3.2.10).The mixture was 
incubated for 30 min at 37 °C to allow the phage particles to infect the E. coli cells 
and to transfer the linear fosmid DNA to the cell interior by transduction. The infected 
EPI300-T1R cells were spread on LB agar plates containing the selective marker 
chloramphenicol in a final concentration of 12.5 µg/ml. The plates were incubated at 
37 °C overnight. Inside the E. coli cells, the cohesive ends (cos sites) enable the 
circulization of the linear DNA to form a plasmid bearing a 36 kb fragment of the 
genomic DNA of N. pusilla B150. In contrast to cosmids, the pCC1FOS vector does 
not have the drawback of partial deletion of the insert DNA, because it contains a 
single copy origin of replication based on the F plasmid. A second origin of replication 
oriV requires induction of desired clones to high copy number to obtain high yield of 
DNA. This procedure is described in  3.2.15. 
3.2.13.7 Plating the genomic library  
For each dilution prepared in 3.4.14.6, the colonies per LB plate were counted to 
determine the appropriate amount of host cell suspension for plating. The 1:10 
dilution yielded about 100 colony forming units (cfu) per plate, and therefore this 
dilution was chosen to plate the fosmid library. Altogether, 2,290 colonies were 
cultivated on LB plates containing chloramphenicol (12.5 μg/ml). 29 microtiter plates, 
each having 96 wells, were prepared to contain 100 μl of LB liquid medium and 12.5 
μg/ml chloramphenicol in every well using the Transferpette®-8 multipipette ( table 
 3.2). The clones were picked and suspended in the wells of the microtiter plates 
using tooth picks. Afterwards, the plates were incubated overnight at 37 °C. Copies 
of the produced cultures were made using the Boekel Replicator (table  3.2). For long 
term storage, an equal volume of 100 % glycerol was added to the bacterial culture 
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and mixed by pipetting applying the Transferpette®-8 (table  3.2) prior to freezing at -
80° C. To facilitate pipetting of the highly viscous glycerol the eppendorf pipette tips 
were cut prior to sterilization. 
3.2.14 Screening of the fosmid gene library  
The fosmid gene library was screened by whole cell PCR for the presence of NRPS 
A domain positive clones using specific primer pairs designed from PCR fragments, 
obtained in performing a PCR with general NRPS A domain. In order to make the 
fosmid DNA accessible for the Taq-polymerase, a heating step has to be integrated 
in the standard PCR program described in 3.4.9.2. This denaturation step at the 
beginning of the PCR procedure was performed at 97 °C for 20 min to initiate cell 
lysis (whole cell PCR). To identify the gene encoding a phenylalanine activating 
NRPS A domain the primer pair A3rev.1/ LGDD.S was used in a PCR on genomic 
DNA ( 3.1.9). From the obtained sequence the primer pair NRPS-F1/NRPS-R1(table 
 3.12) was deduced and applied for the screening of the fosmid library. To facilitate 
fast screening of the library, all 96 clones of each microtiter plate were united in 0.5 
ml Eppendorf tubes (p-pool). Standard PCR reactions ( 3.2.7) were set and performed 
with 1 μl of each pool at the appropriate annealing temperature including an initial 
heating step for cell breakage as described above. PCR probes were subsequently 
analyzed by agarose gel electrophoresis ( 3.2.5). Localization of single clones in 
positive pools was achieved by splitting the p-Pool into 8 sub-pools each containing 
12 clones (the clones of one line of the microtiter plate). Subsequently, the right clone 
was localized in one of the 8 pools by PCR of the 12 single clones (one line). 
 
Figure  3.2 Screening schemata: 96 clones were combined in a plate pool (p-pool), a positive p-pool was then 
divided in 8 sub-pools à 12 clones. In case of a positive sub-pool the 12 single clones were analyzed respectively. 
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3.2.15 Induction and isolation of identified positive clones  
For the isolation of great amounts of fosmid DNA from PCR positive clones, it was 
necessary to induce a promoter (oriV) by  dd t     f t e C pyC  t  l™   du t    
  lut                uppl ed   t  t e C pyC  t  l™ F    d L b   y P  du t    Kit 
( 3.1.4). This induction step initiates expression of the trfA gene product, which 
enables the amplification of fosmid clones at high copy number. A pre-culture was set 
by supplementing 5 ml of LB medium with 12.5 mg/ml chloramphenicol in a test tube. 
After inoculation with a single fosmid clone, the culture was shaken overnight at 180 
rpm and 37 °C. 45 ml of fresh, sterile LB medium containing 12.5 mg/ml 
chloramphenicol were mixed with 5 ml of the pre-culture. 50 μl of the 1000 x 
C pyC  t  l™   du t      lut    (Ep  e t e    d      U.S.A.)  e e  dded t  t e 
mixture and subsequently shaken overnight at 30 °C and 180 rpm. Fosmid isolation 
was accomplished by applying the QIAgen Plasmid Midi Kit following the 
   uf  tu e ’     t u t       u l ( 3.1.4). 
3.2.16 Genome sequencing using the 454 sequencing procedure  
Within this study, results of a 454 sequencing performed for the N. pusilla B150 
genome were analyzed ( 4.5). The sequencing was carried out by GATC Biotech AG 
(Konstanz, Germany) using 5 µg of DNA. In this method, the genomic DNA is 
fragmented, ligated to universal adapter primers and subsequently linked to beads at 
a dilution that promotes one DNA molecule per bead. These bead-DNA complexes 
are then encapsulated into emulsion based droplets. By emulsion PCR, the DNA 
fragments are enriched within these droplets. The beads are then allotted to 
individual picotiterplate wells, in which a bioluminescence method, referred to as 
pyrosequencing is performed. In this process, nucleotides are not added coincidently 
as done in dideoxy sequencing methods (Sanger method and variants thereof) but 
successively. If a matching nucleotide is added, a cascade of enzymatic reactions 
visualizes the formation of ATP from pyrophosphate via a light emitting conversion of 
luciferin into oxyluciferin (Metzker, 2010, Sanger et al., 1977). 
3.2.17 Isolation, cultivation and long term storage of myxobacteria 
The myxobacterial strain 150 was isolated by B. Ohlendorf from a soil sample, 
collected from the intertidal region of Crete (Ohlendorf et al., 2008). For bacterial 
growth 250 µl of a kryo-culture of N. pusilla B150 was placed on VY/2 agar plates. 
For cultivation in liquid medium, slices of agar, containing fruiting bodies of the 
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myxobacterium, were inoculated in MD-1 glucose medium (table  3.13) and grown at 
30 °C for 7 days under shaking conditions of 140 rpm. For long term storage the 
liquid bacterial cultures were mixed with an equal volume of 1 % casitone. This 
mixture was stored at -80°C. 
3.2.18 Cultivation and long term storage of recombinant E. coli strains 
For plasmid preparations E. coli strain XL1-Blue was cultivated in LB medium 
   t         p   ll   (100 μ / l)  t 37 °C   d 180  p  f   12  . E. coli XL1 Blue MR 
was cultivated in LB medium at 37 °C and 180 rpm for about 4 h. For long term 
storage an equal volume of 100 % glycerol was added to the bacterial culture, and 
the mixture was stored at – 80 °C. 
3.2.19 Determination of bacterial cell density 
The bacterial growth in liquid culture was followed by measuring the optical density at 
600 nm (OD600) with a spectrophotometer (UV mini 1240, table  3.2). The optical 
density or turbidity of a cell suspension is directly related to the cell number. An 
OD600 of 1.0 at an optical path length of 1 cm corresponds to approximately 8 x 10
8 
cells (Eckert and Kartenbeck, 1997). The sensitivity of this method is limited to about 
107 cells per ml for most bacteria.  
3.2.20 Determination of nucleic acid concentration and purity of DNA 
To quantify obtained nucleic acids and determine the quality of DNA solutions, the 
OD was measured at the wavelengths 260 nm (A260) and 280 nm (A280) using a 
UV/VIS spectrophotometer (table  3.2). The OD value at 260 nm (A260) refers to the 
amount of DNA or RNA in the solutions to be quantified. The Lambert-Beer law 
describes the linear relation between the concentration of an absorbing material and 
its light absorption at a given wavelength. This linear correlation is only valid for 
absorption values between 0.2 and 1.2. Therefore, highly concentrated DNA 
solutions had to be diluted to an appropriate measurable concentration. The true 
concentration of the original nucleotide solution was then extrapolated by including 
the dilution factor (DF) in calculations. The absorption coefficient is a material-
dependent parameter that describes the specific absorption of the respective 
material. For solutions containing double stranded DNA, an average extinction 
  eff   e t  f 50 (μ / l)-1 cm-1 was applied (Sambrook & Russell, 2001).  
Materials & Methods 
 
60 
 
The concentration of nucleic acids was calculated according to the following 
equation: 
conc.nucleic acid = DF x A260 x 50 μ / l 
Aromatic amino acids of proteins show significant absorption at 280 nm and therefore 
the ratio of A260/A280 is a common value to specify the purity of a DNA solution. A 
ratio value of 2.0 indicates 100% nucleic acids and 0 % proteins. A260/A280 values 
between 1.8 and 2 are favorable for DNA used in downstream applications. 
 
3.2.21 Heterologous expression of proteins 
For the in vitro investigation of protein functions the protein of interest was 
overexpressed in a heterologous host. Therefore, the DNA sequence of the protein is 
inserted into an expression vector that usually contains an inducible promoter as well 
as an affinity tag such as 6xHis (consisting of 6 successive histidines). For the 
expression vector pet151/D-TOPO® the 6xHis-tag is expressed at the N-terminus of 
the protein, which facilitates the purification via affinity chromatography (3.6.3). 
The DNA sequence of the protein of interest was amplified by PCR ( 3.2.7) using a 
pfu-Polymerase to generate a PCR product with blunt-ends. The pet151/D-TOPO® 
vector is a topoisomerase I activated expression vector that enables fast and 
directional cloning of blunt-end PCR fragments. The forward primer for the AMP-ACP 
PCR product was set at the start of the ORF, so that the start codon of the protein 
was in-frame with the 6x-his tag on the plasmid. The generated plasmid was first 
transformed into One Shot® TOP10 Chemically Competent E. coli cells ( 3.1.5). To 
exclude the possibility of mutations in the reading frame, the chosen clones were 
submitted for sequencing. Plasmid DNA was isolated from confirmed clones and 
transformed into BL21 Star™(DE3) O e S  t® Chemically Competent E. coli cells.  
For a pre-culture, 10 ml LB medium with 100 µl/ml ampicillin were inoculated with 
500 µl of transformed cells and grown overnight at 37 °C. For the main culture, 100 
ml LB medium containing 100 µl/ml ampicillin were inoculated with 2 ml of the 
overnight culture. After inoculation, the main culture was grown to an OD600 of ~ 0.5. 
Protein expression was induced by adding IPTG to a final concentration of 0.1–1.0 
mM. Generally, cultivation was carried out for 4h at 18-37°C or overnight at 16°C. 
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3.2.22 Cell lysis by sonication 
Cells from protein expression were harvested by centrifugation at 8,500 rpm for 5 min 
at 4°C using 50 ml centrifugation tubes ( 3.1.1). The cell pellet was resuspended in 2-
5 ml lysis buffer and placed on ice. Cells were lysed with the help of a Branson 
Sonifier 250, set to output level 4, 50% duty cycle. The samples were sonified 4-5 
times with ten pulses each. Between the pulses the cells were placed back on ice to 
avoid overheating of the sample. Cell debris and insoluble parts were pelleted by 
centrifugation for 10 min at 8,500 rpm and 4°C. The supernatant containing the 
soluble proteins and the pellet were collected. 
3.2.23 Purification of recombinant proteins by Ni-NTA-columns 
Proteins harboring a His-tag can easily be purified by affinity chromatography on a 
Ni-NTA matrix. The histidine residues are bound by the matrix, while other proteins 
elute. Unspecifically bound proteins can be eluted by increasing concentrations of 
imidazole, which competes with the histidines for the binding. The six histidines of the 
tag ensure that the target protein only elutes at high concentrations. For the affinity 
chromatography a gravity-flow column with 1 ml Ni-NTA-agarose was prepared and 
equilibrated with 4 ml lysis buffer. The lysate was applied on the column and allowed 
to pass the matrix. The column was washed twice with 4 ml washing buffer. Elution 
was carried out in five steps each with 500 µl of elution buffer with 100, 150, 200, 300 
and 500 mM imidazole. All fractions were collected in 1.5 ml eppendorf tubes and 
stored on ice to prevent protein degradation. 
3.2.24 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
This method allows the analytical separation of proteins according to their size. In a 
denaturing approach the proteins are boiled and treated with mercapto-ethanol to 
remove any disulfide-bonds. During electrophoresis the unfolded proteins are 
covered with the negatively charged sodium dodecyl sulfate (SDS), which masks the 
inherent charge of the protein, thus allowing a strict separation by molecular weight. 
The separating gel is formed by radical polymerization of bis-acrylamide to 
polyacrylamide, which forms a molecular sieve. The concentration of polyacrylamide 
can be chosen in dependence of the analyzed protein size. For a better focusing of 
protein bands discontinuous gels were used, where the separating gel is covered 
with a low concentrated stacking gel. The reaction mix is given below. After 
polymerization was initiated by the addition of ammoniumperoxosulfate (APS) and 
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N N N’ N’-tetraethylendiamin (TEMED), the gel was pipetted between two plates with 
a spacer distance of 1.5 mm. During polymerization, the separating gel was covered 
with isopropanol to ensure a smooth surface. Isopropanol was removed before the 
addition of the stacking gel.  
SDS-stacking gel (5%)    SDS-separating gel (12%)    
Tris/HCL pH 6.8 (1M)  375 μl Tris/HCL pH 6.8 (1M)  2500 μl 
SDS (10%)  30 μl SDS (10%)  100 μl 
Bis-acrylamide (30%)  510 μl Bis-acrylamide (30%)  4000 μl 
Water  2040 μl Water  3300 μl 
APS (10%)  30 μl APS (10%)  100 μl 
TEMED  3 μl TEMED  4 μl 
 
For each gel run, the reservoirs of the electrophoresis assembly were filled with fresh 
1x SDS gel electrophoresis buffer. Protein samples were mixed with 4x denaturing 
loading buffer and boiled at 90°C for 5 min, before loading them on the gel. 
Electrophoresis was performed in a XCell SureLock® Mini-Cell ( 3.1.1) at 100 V until 
the samples reached the separating gel, then voltage was increased to 130 V. As a 
reference, a molecular size marker ( 3.1.3) was loaded in one well. After 
electrophoresis the gels were analyzed by coomassie-staining. 
3.2.24.1 Coomassie-staining 
Staining with coomassie brilliant blue was used to analyze the protein bands on a 
polyacrylamide gel. Gels were immersed in the staining solution ( 3.1.13) and shortly 
heated in a microwave oven for quicker staining and subsequently incubated several 
minutes on a horizontal shaker. Destaining of the background colour was performed 
by shaking with destaining solution ( 3.1.13) for several hours or even over night. The 
gels were documented with the Intas iX Imager ( 3.1.1). 
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3.2.25 Concentration of purified proteins and buffer exchange  
Imidazole, which was used for the elution of the protein from Ni-NTA columns, may 
interfere with following enzyme assays. Thus, Amicon Ultra centrifugal filters were 
used to remove imidazole from the purified protein from heterologous expression 
( 3.2.21) and to concentrate the latter. The exchange of buffer was performed in 
several centrifugation steps with 50 mM Tris/HCl (pH8), following t e    uf  tu e ’  
instructions. With a start volume of 3.5 ml purified protein ( 3.2.23), the sample was 
concentrated with Amicon Ultra centrifugal to 500 µl of purified protein. 
3.2.26 ATP- PPi exchange assay 
As the adenylation of amino acids requires ATP, the functionality of the A domain can 
be investigated with an ATP-PPi exchange assay, described by Phelan and 
colleagues in 2009. It  e  u e  t e     u pt     f γ-18O4-labelled ATP and the 
formation of 16O4-ATP by an excess of unlabelled PPi. The resulting mass shifts are 
detected by MALDI-TOF-MS. Incubation with different substrates and comparison of 
the ATP-PPi exchange rate allows determination of the substrate specificity of the 
studied domain. The assays were performed with the help of Max Crüsemann in the 
laboratory of Jörn Piel ’ group (Kekulé-institute for Organic Chemistry and 
Biochemistry, University of Bonn, Germany) according to the described method. For 
this purpose 2 µl of the purified A domain ( 3.2.25) were incub ted   t  1    γ-18O4-
ATP, 5 mM PPi, 5 mM MgCl2 and 1 mM substrate,       e  t    v lu e  f 6 μl f   90 
min at RT. Exchange rate by MALDI-TOF-MS was determined by comparison of the 
  t    f γ-16O4-ATP (m/z 506) to the sum of all ATP species, including unlabelled (m/z 
506), partially labeled (m/z 508, 510, 512), fully labeled (m/z 514), and monosodium-
coordinated ions (m/z 528, 530, 532, 534, 536). Determination of percent exchange 
was normalized with the following modifier: 
% exchange = (100/0.833) x 
16O/(18O+16O) 
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4 Results 
4.1 Isolation and cultivation of the myxobacterial strain 150 
The bacterial strain 150, collected from the intertidal region of Crete, was previously 
isolated on WCX / E. coli plates and identified as a bacteriolytic myxobacterium 
(Ohlendorf, 2008). This bacterium with the strain collection number 150 showed 
some features that indicated that the microorganism belongs to the genus of 
Nannocystis. Some of these prominent characteristics include the almost spherical 
form of the vegetative cells, the ability to corrode agar and to swarm in colonies. 16S 
rDNA analysis was performed to identify this myxobacterial strain on the species 
level ( 4.3). 
The myxobacterium was cultivated in MD1 liquid medium supplemented with glucose 
(Behrens et al., 1976) ( 3.1.11). It grows slowly in form of orange spherical 
agglomerates and is best harvested for DNA isolation after approximately seven days 
of cultivation in liquid medium. 
4.2 Isolation of genomic DNA from myxobacterial strain 150 
Genomic DNA from the bacterium was isolated for the purpose of taxonomic 
identification, PCR screening studies, genomic library construction and whole 
genome sequencing. DNA isolation turned out to be extremely tedious, resulting 
mostly in sheared, small DNA fragments.  
Several molecular biological kits were tested, as well as the standard isolation 
procedure with phenol-chloroform ( 3.2.3). The tested molecular biological kits from 
Promega, Machery-Nagel, Fermentas, Invisorb and Analytic Jena ( 3.1.4) resulted 
mostly in sheared DNA, too small for the construction of a genomic library or whole 
genome sequencing. Even modifying the duration and speed of the centrifugation 
step did not improve DNA quality, when using molecular biological kits.  
The phenol-chloroform extraction technique resulted in less sheared DNA, especially 
after modifying this procedure. Decreased centrifugation speed and cut tips were the 
key to larger DNA fragments, crucial for the establishing of a fosmid library. A 
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modified protocol of the standard procedure was therefore used for the isolation of 
genomic DNA ( 3.2.3). 
4.3 Strain identification of myxobacterial strain 150 
For the phylogenetic identification of the investigated strain, a 16S rDNA analysis 
was carried out. For this the primer pair pA/pH (Edwards et al. 1989) was used in a 
PCR with genomic DNA of the myxobacterial strain ( 3.2.3). The so obtained 1.5 kb 
DNA fragmentwas then analyzed using nBLAST ( 3.1.14). The 16S rDNA sequence 
( 8.4) of the myxobacterial strain was closely related to that of Nannocystis pusilla 
strain DSM 14622T (GenBank accession: FR749907.1) with an identity between the 
two sequences of 98%. This outcome supports the previous classification ( 4.1; 
Ohlendorf, 2008) of this strain to the genus of Nannocystis. Whereas B. Ohlendorf 
however suggested the species to be N. exedens, the current result points towards 
N. pusilla B150. Construction and screening of a fosmid library  
4.4 Fosmid library production 
To elucidate and investigate the complete sequence for the biosynthetic gene cluster 
of phenylnannolone A, the construction of a genomic library was necessary 
( 3.2.13).In general the required number of recombinants in a library depends on the 
genome size of the particular organism and on the insert size of the DNA cloned into 
the fosmids ( 3.2.13.4).The genome size of myxobacteria varies between 8 and 13 Mb 
(Myxococcus xanthus, Goldmann et al., 2006; Sorangium cellulosum, Schneiker et 
al., 2007; Plesiocystis pacifica, Shimkets et al., 2010, Stigmatella aurantiaca, Huntley 
et al., 2011), and most of the already sequenced myxobacteria have genome sizes 
between 8 and 10 Mb. Thus, it was estimated that 2,300 clones were sufficient for a 
complete coverage of the genome (Sambrook & Russell, 2001; Clarke & Carbon, 
1976). It was decided to use a fosmid vector, i.e. pCC1FOS, for the library 
production. Fosmid vectors contain in contrast to cosmid vectors two origins of 
replication, the F plasmid, a single-copy origin of replication, and oriV, the high-copy 
origin of replication. The advantages of these two features are on the one hand to 
maintain the clone with a single-copy of the recombinant, and on the other hand 
there is the possibility to induce positive clones to a high copy number to obtain high 
yields of fosmid DNA. 
Results 
 
66 
 
During the DNA isolation procedure the chromosomal DNA was sheared, so that the 
isolated DNA revealed a size of approximately 35-40 kb. This was verified by 
agarose gel analysis ( 3.2.5) using fosmid control DNA ( 3.1.3), supplied with the 
C pyC  t  l™ F    d L b   y P  du t      t ( 3.1.4), as a marker. DNA fragments 
smaller than 25 kb should be avoided, as the possibility of chimeric clones is then 
increased. This is undesired as it may impede the localization and mapping of genes 
( ee    uf  tu e ’     u l). Another issue that makes small DNA inserts 
undesirable is that they remain unrecognized by phages, and thus would skirt the 
process of packaging DNA pieces into phage particles. 
Size selecting the sheared DNA by excising it from a LMP agarose gel (figure  4.2) 
( 3.2.13.1) and subsequent purification (digest of the agarose and precipitation of 
DNA) led to DNA fragments of approximately 36 kb. The following end repair of the 
size selected DNA fragments resulted in blunt ends, required for the ligation into the 
pCC1FOS vector. 
 
Figure  4.1 Gel extraction from LMP agarose: 120 μl of genomic DNA of N. pusilla B150 were size selected with 
36 kb fosmid control DNA as marker (left picture). The right picture shows purified and end repaired genomic DNA 
fragments with an average size of 36 kb. The 36 kb fosmid control DNA marker was loaded on the gel in 
concentrations of 10 ng and 100 ng to estimate of the preparated DNA concentration. 
After several attempts the blunt end ligation of the prepared genomic DNA fragments 
into the fosmid vector was successful. Several modifications in duration and 
temperature in the ligation step were tested as the described conditions of two hour 
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ligation at room temperature did not result in a successful ligation. Slow ligation over 
night at 4°C seemed to solve the problems with the ligation step ( 3.2.13.4). 
 
Figure  4.2 Agarose gel electrophoresis of the successful ligation (lig29) of N. pusilla B150 DNA into pCC1FOS 
vector. To detect a successful ligation the fosmid control DNA marker (36 kb) and the pCC1FOS vector were also 
applied to the gel besides the ligation reaction. 
The ligation reaction was stopped by heat inactivation and then packaged into the 
phage heads using the M xPl x™ L  bd  P  k      Ext   t     f ll      t e 
corresponding instructions ( 3.2.13.6). To determine the adequate titer of the phage 
particles  t e t    fe t     f    pete t EPI300™-T1R E. coli cells with neat and 
diluted phage particles was necessary. The infected E. coli cells were spread on LB 
plates and selected with chloramphenicol, as the fosmid vector carries a gene (cat) 
for resistance ( 3.1.7). In counting the number of clones on each plate, the titer of a 
1:10 dilution, calculated in cfu/ml (Colony forming units), could be set as 105 cfu/ml.  
A number of 100 clones per plate was desirable, to facilitate the isolation and storage 
preparations for the fosmid clones. This was achieved in using the 1:10 dilution of the 
phage particles, so that 2,300 fosmid clones with an average insert length of 36 kb 
were generated from the N. pusilla B150 genome. 
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4.5 Genome sequencing 
A step towards the identification of the gene cluster for phenylnannolone A 
biosynthesis, was a whole genome sequencing, performed by GATC biotech 
( 3.2.16). Sequence data were obtained with the Roche Genome Sequencer FLX 
Titanium (F. Hoffmann-La Roche AG, Basel, Switzerland). Raw sequences were 
assembled and resulted in 3804 contigs with an average contig size of 3 kb. The 
largest contig assembled had a size of 68 kb. The number of aligned bases was 
166.220.937. These data would offer a 16.6 fold coverage of the N. pusilla genome 
with the imputed genome size of 10 Mb (4.4.1). The contigs were analyzed via 
BLAST search. In this analysis eleven contigs containing gene sections encoding 
NRPS adenylation (A) domains were identified. Subsequently their substrate 
specificity was predicted with the NRPSpredictor ( 3.1.14).  
Table  4.1 Selected and relevant contigs from 454 sequencing of the N. pusilla genome. BLAST / CLUSEAN 
search analysis revealed the putative function of the gene products for these contigs. The substrate specificity for 
the NRPS adenylation (A) domains was predicted by the NRPSpredictor / CLUSEAN. KS=ketosynthase domain 
PCP= peptidyl carrier protein, C= condensation domain, TE=thioesterase domain. 
Contig 
Size  
(kb) 
Putative function 
Putative specificity        
of A domain 
1153 6.4 PCP , C , A , PCP, C , A Leu; Tyr (His) 
3732 4.9 A , PCP , C , A Ser; Tyr (Val) 
770 5.0 C , A , PCP , C Ser 
1648 1.9 A , PCP , C Ser (Cys) 
544 4.7 A , PCP , TE no prediction 
845 7.1 A , PCP , TE Ile 
3177 1.1 A Cys 
2768 0.7 A Pro (Cys) 
3602 1.8 C , A Tyr (Val) 
1592 1.5 A , PCP Phe 
1241 3.0 A , PCP, KS Pro 
Only one of the examined contigs, contig 1592, comprised sequences for an A 
domain specific for the activation of phenylalanine and considered most interesting in 
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the light of the phenylnannolone A structure. Further analysis for PKS genes in the 
454 assembly revealed contigs with DNA information for ketosynthase, 
acyltransferase, dehydratase, ketoreductase and thioesterase domains, which is 
listed in table  4.2. As the contigs had only a size of 1-2 kb, they encoded merely one 
or two PKS domains.  
Table  4.2 Analysis of 454 assembly on PKS genes: PKS genes were grouped according to their corresponding 
function. 
PKS 
domain 
Ketosynthase Acyltransferase Dehydratase Ketoreductase Thioesterase 
Number of 
contigs 
15 9 4 4 3 
The presence of three PKS-TE domains indicates that at least three gene clusters, 
encoding for either a PKS or a NRPS/PKS hybrid, are present on the N. pusilla 
genome.  
Feeding experiment with 13C labeled acetate and butyrate suggested large parts of 
the phenylnannolone A structure to be derived from a PKS (Ohlendorf et al., 2008). 
Thus, the last domain of the biosynthetic machinery is probably a PKS-TE domain. 
As the analysis of the 454 assembly revealed three contigs encoding PKS-TE 
domains, the domain order of these contigs was examined (table  4.3).  
Table  4.3 PKS domain order of contigs encoding for PKS-TE domains 
Contig PKS domain order 
1642 AT – ACP - TE 
3326 AT – ACP - TE 
1540 KR – ACP - TE 
The domain order on contig 1540 with a ketoreductase domain (KR), an acyl carrier 
protein (ACP) and a thioesterase domain was coincident with our hypothesis of the 
phenylnannolone A biosynthesis. The domain order of the other contigs identified to 
encode for a PKS-TE did not fit the hypothesis. This is due to the fact that they lack a 
reductive domain, necessary for the formation of the last double bond in of 
phenylnannolone A biosynthesis. 
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4.6 Screening for NRPS/PKS encoding genes in the fosmid library 
Previous feeding experiments (Ohlendorf et al., 2008)8 with 13C labeled precursors 
showed the incorporation of acetate and butyrate, but also of phenylalanine into 
phenylnannolone. Thus, a mixed NRPS/PKS system was suggested to be 
responsible for the formation of this natural product. 
A degenerated primer pair LGDD.S/A3rev.1 ( 3.1.9) deduced from the alignment of 
several sequences encoding for NRPS-A domains was used for a PCR with genomic 
DNA of N. pusilla B150. Analyzing the so obtained sequences revealed a sequence 
for a phenylalanine activating A domain. From this sequence a specific primer pair 
NRPS-F1/ NRPS-R1 ( 3.1.9) was deduced, used for the detection of this genetic 
region in the fosmid library. The fosmid gene library was screened by whole cell 
PCR. To facilitate the screening procedure 98 fosmid clones were combined in a 
pool. For the entire fosmid library 24 pools were generated and screened in a first 
step. Subsequently, a positive pool was then analyzed in detail ( 3.2.14). Amongst the 
2300 fosmid clones, two fosmid clones, 11A3 and 21H12, could be identified carrying 
the gene encoding for a phenylalanine activating A domain. Due to the NRPS/PKS 
nature of the suspected phenylnannolone A cluster, degenerated KS primers KS 
1up/KS d1 ( 3.1.9) were used in a PCR with DNA from fosmid 11A3 and 21H12. For 
both fosmid clones distinct DNA fragments (700bp), identified to encode for a 
ketosynthase, could be amplified.  
 
Figure  4.3 Fosmid library screening for NRPS A domains and PKS KS domains. A) PCR-screening for a 
NRPS A domain resulted in a PCR product with 400 bp for the positive control (pos.) and fosmid clone 11A3 (11). 
B) Fosmids 11A3 and 21H12 were screened with degenerated primers for a KS domain. Both fosmids harbor  a 
KS, as amplificates of 700 bp were achieved. 
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The fosmid library was also screened for a thioesterase encoding gene. Such a gene 
had been identified on contig 1540 from the 454 genome sequencing ( 4.5). The 
fosmid library was thus screened with the specific primer pair 1540.F/1540.R ( 3.1.9) 
for the TE domain of contig 1540 and scored three fosmid clones: 12A9, 17E11 and 
7C6. Those clones were then analyzed in a second PCR with the previously used KS 
primer (3.1.9) for existing ketosynthase domains, necessary for the PKS assembly 
line. 
 
 4.4 Screening the fosmid library for sequences encoding a TE domain: A specific primer pair was deduced 
from the sequence of a TE domain from contig 1540. PCR resulted in a product with 800 bp length, positive for 
three fosmid clones 12A9, 17E11 and 7C6. These  fosmids were subsequently tested with degenerated primers 
for a KS domain, and only one fosmid clone, 12A9, was positive for a KS, as an amplificate of 700 bp was 
achieved. 
For the fosmid clone 12A9 a specific DNA fragment could be amplified through PCR. 
Sequence analysis of construct pKS12A9, containing the 700 bp amplificate verified 
the presence of a ketosynthase gene section. Thus a further investigation on this 
fosmid clone followed. 
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4.7 Fosmid sequencing 
4.7.1 End sequencing of fosmids  
Since fosmids 12A9, 21H12 and 11A3 were found to contain NRPS and PKS 
encoding sequences, the end sequences of the myxobacterial DNA in these fosmids 
were analyzed. Therefore, an end sequencing reaction was performed at GATC 
Biotech AG. The investigated fosmid clones 12A9, 21H12 and 11A3 were sequenced 
with two primers, T7 a forward primer that binds to a T7 promoter site and Epi-RP a 
reverse sequencing primer ( 3.1.9). The obtained sequences were translated into 
amino acid sequences and analyzed via BLAST ( 3.1.14). The BLAST results are 
listed in the table below (table  4.4 ) showing the highest identity with homologous 
proteins from GenBank. 
Table  4.4 BLAST search results for the end sequencing of fosmids 12A9, 21H12 and 11A3 with forward (T7) and 
reverse (Epi-RP) sequencing primers. The obtained sequences were searched for identities with contigs from the 
454 assembly  
Sequencing 
primer 
Fosmid 
clone 
Putative function 
Identity of 
aligned 
amino 
acids 
Genbank  
acession 
number 
Contig 
T7 12A9 SRPBCC superfamily protein 
59/147 
(40%) 
YP_299911.1 2843 
Epi-RP 12A9 SARP family transcriptional regulator 
44/154 
(29%) 
YP_004813558.1 1429 
T7 21H12 hypothetical protein 
144/235 
(61%) 
YP_001612581.1 289 
Epi-RP 21H12 
succinate dehydrogenase, 
cytochrome b558 subunit 
52/163 
(32%) 
EFW42511.1 none 
T7 11A3 
uncharacterized peroxidase-related 
enzyme 
58/128 
(45%) 
ZP_06975623.1 1794 
Epi-RP 11A3 hypothetical protein 
54/94 
(57%) 
YP_001618118.1 289 
For all of the three fosmid clones the end sequencing revealed that the borders of 
their DNA inserts are not part of genes involved in secondary metabolism, thus the 
conclusion was that the respective biosynthetic genes are completely located on the 
fosmids. The obtained sequences were searched for identities with contigs from the 
454 assembly of the whole genome sequencing. Identical sequences for the border 
regions from fosmid 11A3 (Epi-RP) and 21H12 (T7) are present on contig 289, 
located in a distance of 800 bps from each other. As no contig could be identified for 
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the other end of fosmid 21H12, suggestions about the distance of those gene 
sections on the genomic level were not possible.  
4.7.1.1 Comparison of fosmids 11A3 and 21H12 
PCR studies showed for both of the fosmid clones, 11A3 and 21H12, the presence of 
genes for an NRPS adenylation and a PKS ketosynthase domain. Also, in both cases 
end sequencing of the fosmids evidenced that genes for the mixed NRPS/PKS 
system are not present at the borders of the fosmid insert and are completely located 
in midst of the DNA section.  
To compare these fosmid clones with each other and to prove that they share nearly 
the same sequence information a restriction digest of the isolated fosmid DNA was 
undertaken (figure  4.5).  
 
 
Figure  4.5 Restriction digest of fosmid 11A3 and 21H12  
The agarose gel displays restriction digests of fosmid 11A3 with BamHI (1) and ApaI (3) as well as the restrictions 
for the fosmid 21H12 with BamHI (2) and ApaI (4) and the undigested fosmid DNA of both fosmids 11A3 (5) and 
21H12 (6). The Gene Ruler
TM
 DNA Ladder Mix (7) is shown for size estimation. 
The restriction digest showed many identical DNA fragments for the fosmid clones 
11A3 and 21H12, thus only one fosmid clone, F21H12, was chosen to be further 
investigated. 
     1       2      3      4      5     6      7               
kb 
10 
 3 
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4.7.2 Complete sequencing of fosmid 21H12 and 12A9 
The contig sizes of the 454 genome sequences were too small to delineate the 
complete biosynthetic gene cluster. Thus, it was decided to sequence fosmid 21H12, 
shown to encode a NRPS A domain, specific for phe activation, as well as a KS 
domain, which suggested a mixed NRPS/PKS system. In addition to this another 
fosmid clone believed to harbor a PKS gene cluster was sequenced, i.e. fosmid 
12A9, known to encode KS and TE domains. Complete sequencing of fosmid 21H12 
and 12A9 was performed by IIT-Biotech GmbH (Bielefeld, Germany). For this 
purpose HT (high-throughput)-libraries with insert lengths of 500 bp were constructed 
and subsequently analyzed in a pyrosequencing reaction on a Roche GS FLX 
Titanium +. Sequence data previously identified from the 454 genome sequencing 
and PCR studies on the fosmid clones 21H12 and 12A9 ( 4.7.1.1) were supported 
and completed in the fosmid sequencing analysis. The sequences obtained in the 
pyrosequencing were assembled, and this resulted for fosmid12A9 in one contig of 
45720 kb and for fosmid 21H12 in two contigs with 32221bp and 6755bp. To obtain a 
continuous sequence for the latter, PCR was performed to close the gap. 
The sequence for fosmid 12A9 revealed 12 open reading frames (ORF) ( 4.8.1) of 
which two, phn1 and phn2, are putatively involved in the biosynthesis of 
phenylnannolone A ( 4.8). The fosmid sequencing of clone 21H12 revealed sb1, a 
gene encoding for a NRPS/PKS mixed system of an unknown natural product ( 4.9). 
4.8 Elucidation of the putative phenylnannolone A biosynthetic gene 
cluster 
4.8.1 Sequencing results for fosmid 12A9 
The sequencing result of fosmid 12A9 revealed 12 ORFs, of which two, phn1 and 
phn2, are putatively involved in the biosynthesis of phenylnannolone A. These 
biosynthetic genes, i.e. phn1 and phn2 are surrounded by genes for hypothetical 
proteins of unknown function (orf2 - orf10). A gene for a transcriptional regulator is 
displayed in orf1. The gene product for phn1 showed in a BLAST analysis an identity 
of 70% to a ß-subunit of a propionyl-CoA carboxylase, known for acting as a 
carboxyl-transferase in precursor supply for fatty acid or polyketide biosynthesis. With 
an identity of 47% phn2 could be identified as a gene encoding for a polyketide 
Results 
 
75 
 
synthase, consisting of a whole assembly line with five modules. The BLAST search 
results are shown in table  4.5 
Table  4.5 BLAST search results for sequences of fosmid clone 12A9. The deduced amino acid sequences of 
ORFs found on fosmid 12A9 were aligned with homologous proteins by BLAST. The genes putatively responsible 
for the phenylnannolone A biosynthesis are highlighted and marked with bold letters. 
Gene 
Size 
(kb) 
Highest homology 
(protein level) 
Putative function 
Identity of 
aligned 
amino 
acids
1
 
GenBank 
accession 
number 
orf1 1.7 
SARP family transcriptional regulator 
[Streptomyces violaceusniger Tu 4113] 
transcriptional 
regulator  
44/154 
 (29%) 
YP_004813558.1 
orf2 1.7 
hypothetical protein M23134_06735 
[Microscilla marina ATCC 23134] 
ANK superfamily 
SMI1-KNR4 family 
protein  
48/117  
(41%) 
ZP_01694204.1 
orf3 1.3 
unnamed protein product 
 [Oikopleura dioica] 
ANK superfamily 
protein 
35/106  
(33%) 
CBY24175.1| 
orf4 0.5 
unnamed protein product  
[Sorangium cellulosum 'So ce 56'] 
SMI1-KNR4 family 
protein 
86/124 
(69%) 
YP_001613106.1 
orf5 0.6 
hypothetical protein PPSIR1_23304 
 [Plesiocystis pacifica SIR-1] 
unknown 
43/103 
(42%) 
ZP_01910555.1 
orf6 2.1 
sigma-24 (FecI-like) protein  
[Plesiocystis pacifica SIR-1] 
RNA-Polymerase 
79/185 
(43%) 
ZP_01911328.1 
orf7 0.3 
unnamed protein product 
 [Sorangium cellulosum 'So ce 56'] 
unknown 
42/99 
(42%) 
YP_001611977.1 
orf8 0,8 
hypothetical protein STIAU_4586 
[Stigmatella aurantiaca DW4/3-1] 
unknown 
45/141 
(32%) 
ZP_01464984.1 
orf9 0.8 
hypothetical protein Lnog2_01990 
[Leptospira noguchii str. 2006001870] 
unknown 
71/267 
(27%) 
ZP_09260961.1 
phn1 1.7 
propionyl-CoA carboxylase, β-subunit 
[Plesiocystis pacifica SIR-1] 
Carboxyl-
Transferase 
373/535 
(70%) 
ZP_01908434.1 
phn2 22 
beta-ketoacyl synthase  
[Streptomyces violaceusniger Tu 
4113] 
PKS 
2174/4630 
(47%) 
YP_004817600.1 
orf10 1.2 
unnamed protein product  
[Ralstonia eutropha JMP134] 
SRPBCC 
superfamily 
protein 
59/147 
(40%) 
YP_299911.1 
1
:  ratio of identical amino acids (first value) to all compared amino acids (second value)  
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4.8.2 Phn1, a Carboxyl Transferase 
BLAST search analysis revealed for the gene product of phn1 an identity of 70% to a 
putative ß-subunit of a propionyl-CoA carboxylase from Plesiocystis pacifica SIR-1. 
Indeed, all proteins in table  4.6, homologous to Phn1, are from myxobacterial origin 
and showed identities of 69-70%. Carboylases are known to act as a carboxyl-
transferase in precursor supply for fatty acid or polyketide biosynthesis. The carboxyl 
transferases as acyl-CoA carboxylases are described to carboxylate either acetyl-
CoA, propionyl-CoA or butyryl-CoA to malonate, methylmalonate or ethylmalonate, 
respectively. Acyl-CoA carboxylases accepting acetyl-CoA as a substrate are called 
acetyl-CoA carboxylase. Propionyl-CoA carboxylases accept several substrates, 
predominantly propionyl-CoA (Arabolaza et al., 2010).  
Table  4.6 BLAST search results for phn1: The deduced amino acid sequences of phn1 were aligned with 
homologous proteins by BLAST.  
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
propionyl-CoA carboxylase, beta subunit 
[Plesiocystis pacifica SIR-1] 
373/535 
(70%) 
435/535 
(81%) 
ZP_01908434.1 
propionyl-CoA carboxylase subunit beta 
[Myxococcus xanthus DK 1622] 
341/493 
(69%) 
407/493 
(83%) 
YP_629373.1 
propionyl-CoA carboxylase beta chain 
[Stigmatella aurantiaca DW4/3-1] 
343/493 
(70%) 
407/493 
(83%) 
ZP_01461629.1 
propionyl-CoA carboxylase subunit beta 
[Myxococcus fulvus HW-1] 
338/493 
(69%) 
407/493 
(83%) 
YP_004663613.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets 
 
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
There are three conserved residues in the beta subunit of propionyl-CoA 
carboxylases: glycine (419), aspartate (422) and serin (426). Important for the 
substrate specificity is the aspartate (D) residue. For phn1 this residue comprises an 
alanine instead of the conserved aspartate, this mutation is discussed to direct 
substrate specificity towards butyryl-CoA (Arabolaza et al., 2010). 
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M. xanthus G A Y D V M A S 417 
M. fulvus G A Y D V M A S 417 
S. aurantiaca G A Y D V M A S 419 
P. pacifica G A Y D V M A S 441 
Phn1 G A Y A V M S S 457 
 * 
  
* 
   
*  
 
Figure  4.6. Multiple sequence alignment of Phn1 with amino acid sequences of propionyl-CoA 
carboxylases from Plesiocystis pacifica SIR-1, Myxococcus xanthus DK 1622, Stigmatella aurantiaca 
DW4/3-1 and Myxococcus fulvus HW-1. GenBank accession numbers are given in table  4.6. 
Conserved residues are highlighted and marked with an asterisk. 
4.8.3 A Polyketide Synthase assembly line encoded by phn2 
The BLAST analysis of the gene phn2 revealed 47% identity to a beta-ketoacyl 
synthase from Streptomyces violaceusniger Tu 4113. The beta-ketoacyl synthase 
(KS) is a part of a PKS and responsible for the formation of polyketides.  
Table  4.7  BLAST search results for the gene phn2. The deduced amino acid sequence for this gene was aligned 
with the respective homologous proteins by BLAST ( 3.1.14).  
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned amino 
acids
2
 
GenBank 
accession 
number 
beta-ketoacyl synthase 
[Streptomyces violaceusniger Tu 4113] 
2174/4630 
(47%) 
2752/4630 
(59%) 
YP_004817600.1 
beta-ketoacyl synthase 
[Micromonospora sp. L5] 
2132/4607 
(46%) 
2694/4607 
(58%) 
YP_004085506.1 
beta-ketoacyl synthase 
[Micromonospora aurantiaca ATCC 27029] 
2127/4628 
(46%) 
2697/4628 
(58%) 
YP_003835580.1 
short-chain dehydrogenase/reductase SDR 
[Streptomyces bingchenggensis BCW-1] 
2157/4689 
(46%) 
2746/4689 
(59%) 
ADI05097.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
Phn2 has a gene size of 22 kb and its gene product consists of 5 modules: A loading 
module and four modules for the extension of the polyketide chain. The loading 
module comprises an AMP-ligase and an ACP domain, followed by the first 
extending module with a KS, AT, DH, KR and ACP domain. The same domain 
structure is given for the third module, whereas the fourth module lacks the reductive 
domains DH and KR. The last module shows again the same domain architecture as 
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module 1 and 2, with the difference of an additional downstream TE domain, 
responsible for the release of the molecule. 
All domains encoded by phn2 are examined in detail (see  4.8.3.1- 4.8.3.7) and 
grouped according to their function, i.e. AMP-ligase, ACP, KS, AT, DH, KR and TE 
domains. 
 
       
ATKS
DH KR
ATKS
DH KR
AT ATKS
DH KR
AMP KSACP ACP ACP ACP ACP TE
 
22 kb 
Figure  4.7 Phn2, a PKS gene encoding 5 PKS modules AMP=AMP-ligase, ACP=acyl carrier protein, 
KS=ketosynthase domain, AT=acyltransferase domain, DH=dehydratase domain, KR=ketoreductase domain, 
TE=thioesterase 
  
loading 
module 
module 1 
module 2 module 4 
module 3 
phn2 
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4.8.3.1 AMP-ligase 
The first domain encoded by the phn 2 gene was analyzed by BLAST search as well 
as Pfam, and showed the highest homology to an AMP-dependent synthetase/ligase 
from Nostoc punctiforme PCC 73102. Detailed results are listed in table  4.8.  
Table  4.8 BLAST search results for the first domain encoded by the phn2 gene. The deduced amino acid 
sequence for this domain was aligned with the respective homologous proteins by BLAST ( 3.1.14). 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
AMP-dependent synthetase and ligase 
[Nostoc punctiforme PCC 73102] 
219/461 
(48%) 
285/461 
(62%) 
YP_001865690.1 
AMP-dependent synthetase and ligase 
 [Cyanothece sp. ATCC 51142] 
211/461 
(46%) 
289/461 
(63%) 
YP_001805172.1 
amino acid adenylation domain-containing protein 
[Acetonema longum DSM 6540] 
221/462 
(48%) 
286/462 
(62%) 
ZP_08622841.1 
Long-chain-fatty-acid--CoA ligase 
[Cyanothece sp. ATCC 51472] 
210/459 
(46%) 
291/459 
(63%) 
ZP_08974929.1 
AMP-dependent synthetase and ligase  
[Cyanothece sp. ATCC 51142] 
208/449 
(46%) 
288/449 
(64%) 
YP_001801621.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
AMP-binding enzymes belong to the ANL superfamily (Pfam: CL0378) and catalyze 
the initial adenylation of a carboxylate to form an acyl-AMP intermediate. This 
reaction is followed by the formation of a thioester (Guilck, 2009). A multiple 
sequence alignment of homologous protein sequences reveals the presence of the 
typical three conserved motifs reported for the AMP-ligases.  
The first highly conserved consensus region [T/S/G]-[S/G]-G-[S/T]-[T/S/E]-[G/S]-X-
[P/M]-K-[G/L/F] (Chang et al., 1997) was identified in Phn2 as T-S-G-S-T-G-D-P-K-G 
(motif I). 
Motifs II and III, which are [Y/L/W/F]-[G/S/M/W]-X-[T/A]-E and [Y/F/L]-[R/K/X]-[T/S/V]-
G-D could also be identified as Y-G-M-A-E and L-R-T-G-D. Crystal structure analysis 
of the firefly luciferase, belonging to the same ANL superfamily, showed the 
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involvement of the three conserved motifs in substrate binding (Ingram-Smith et al., 
2006). 
Motif I 
C. sp. 51142 L A F L Q Y T S G S T G N P K G V 202 
C. sp. 511472 I A F L Q Y T S G S T G N P K G V 203 
N. punctiforme L A F L Q Y T S G S T G T P K G V 182 
A. longum  L A F L Q Y T S G S V G I P K G V 186 
Phn2 L A T L I Y T S G S T G D P K G V 145 
Motif II 
C. sp.  51142 Y P C Y G M A E A 350 
C. sp.511472 Y P C Y G M A E A 351 
N. punctiforme Y P C Y G M A E T 330 
A. longum  Y P C Y G M A E A 334 
Phn2 Y P C Y G M A E A 293 
Motif III 
C. 51142 F L R T G D L G 463 
C. 511472 F L R T G D L G 466 
N. punctiforme F F R T G D L G 441 
A. longum  F L R T G D L G 446 
Phn2 Y L R T G D L G 417 
 
Figure  4.8 Multiple sequence alignment of amino acid sequences of AMP-synthetases and ligases from Phn1 (N. 
pusilla) , Nostoc punctiforme, Cyanothece sp. and Acetonema longum. Motif I-III show highly conserved regions 
for the AMP-synthetases/ligases. GenBank accession numbers are given in table  4.8  
AMP-ligases and NRPS A domains are biochemically closely related in that both 
activate acids to their derivatives. For the NRPS A domains, there are apart from the 
three already mentioned motifs at least five additional ones (Konz and Marahiel, 
1999). These could not be identified for the first domain encoded by phn2 (see also 
 4.9.2.2).  
The NRPSpredictor can be useful for the prediction of substrate specificity of A 
domains in NRPS, for the AMP-ligase of Phn2 no precise prediction could be made. 
Nevertheless, the analysis with the NRPSpredictor2 revealed the substrate of this 
enzyme to be probably similar to phenylalanine (40%, see Appendix).  
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4.8.3.2 Acyl Carrier Proteins (ACPs) 
For the PKS gene product Phn2 five domains were identified as acyl carrier protein 
domains, namely ACPLM, ACP1, ACP2, ACP3 and ACP4. ACPLM is the acyl carrier 
protein of the loading module (LM), whereas ACP1 to ACP4 are the respective 
proteins of extension modules 1 to 4. ACP domains are responsible for the delivery of 
intermediates to the various catalytic domains. The conserved residue for the ACP is 
a serine, t e put t ve 4’-phosphopantetheine binding site (Findlow et al., 2003). This 
could be identified for all of the ACP domains present in this PKS gene. BLAST 
results revealed identities to ACP domains from Actinomycetes (ACPLM), S. 
cellulosum (ACP1, ACP2, ACP3) and even to one of fungal origin (ACP4). The 
respective results are listed in table  4.9 and table  4.10. 
Table  4.9 BLAST search result for ACPLM The deduced amino acid sequences of the ACP domain of the 
loading module was aligned with homologous proteins by BLAST.  
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
acyl transferase 
[Catenulispora acidiphila DSM 44928] 
34/62 
(55%) 
74/124 
(60%) 
YP_003117673.1 
lasalocid modular polyketide synthase 
[Streptomyces sp.] 
35/69 
(51%) 
42/62 
(68%) 
ZP_07291842.1 
polyketide synthase 
[Streptomyces cattleya NRRL 8057] 
35/68 
(51%) 
48/68 
(71%) 
YP_004912779.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
ACP3 G M N S L M A V Q 34 
ACP1 G L D S L M A V E 37 
ACP2 G L D S L M A V D 37 
AmbB G L D S L T A V E 46 
JerB G L D S L T A V E 46 
ACPLM G F D S L A A V E 29 
ACP4 G V D S L M A F E 30 
 
   
* 
     
 
 
Figure  4.9 Multiple sequence alignment of amino acid sequences of ACP domains from Streptomyces sp. (JerB) 
and Sorangium cellulosum (AmbB). GenBank accession numbers are given in table  4.9 and table  4.10. 
Conserved residues are highlighted and marked with an asterisk. Suffixey indicate the module number. 
LM=loading module. 
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Table  4.10 Blast search results for the ACP domains of modules 1-4 encoded by the PKS gene phn2. The 
deduced amino acid sequences of the ACP domains were aligned with homologous proteins by BLAST 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
 2
 
GenBank 
accession number 
ACP1 
AmbB  
[Sorangium cellulosum] 
47/74 
(64%) 
57/74 
(77%) 
ABK32256.1 
 
JerB 
 [Sorangium cellulosum] 
47/74 
(64%) 
57/74 
(77%) 
ABK32288.1 
 
JerD  
[Sorangium cellulosum] 
46/70 
(66%) 
53/70 
(76%) 
ABK32290.1 
ACP2 
JerB  
[Sorangium cellulosum] 
46/74 
(62%) 
58/74 
(78%) 
ABK32288.1 
 
AmbB 
 [Sorangium cellulosum] 
46/74 
(62%) 
58/74 
(78%) 
ABK32256.1 
 
JerC  
[Sorangium cellulosum] 
43/74 
(58%) 
56/74 
(76%) 
ABK32289.1 
ACP3 
JerE 
 [Sorangium cellulosum] 
45/72 
(63%) 
59/72 
(82%) 
ABK32291.1 
 
TgaC 
 [Sorangium cellulosum] 
47/72 
(65%) 
59/72 
(82%) 
ADH04641.1 
 
polyketide synthase 
[Sorangium cellulosum] 
45/70 
(64%) 
57/70 
(81%) 
CAL58682.1 
ACP4 
Beta-ketoacyl synthase 
[Cordyceps militaris CM01] 
22/48 
(46%) 
32/48 
(67%) 
EGX96860.1 
 
ATP-dependent serine activating enzyme 
[Xanthomonas fuscans 
subsp. aurantifolii str. ICPB 11122] 
25/64 
(39%) 
41/64 
(64%) 
ZP_06703845.1 
 
hypothetical protein LEMA_P006610.1 
[Leptosphaeria maculans JN3] 
25/66 
(38%) 
40/66 
(61%) 
CBY01874.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The analysis with the CLUSEAN Software ( 3.1.14) helped to answer the question 
whether the first ACP after the AMP-ligase, i.e. ACPLM, is an acyl carrier protein, or a 
peptidyl carrier protein (PCP). With a score of 78.5 for this phosphopantetheine 
binding enzyme the domain was annotated as an acyl carrier protein. In contrast the 
score for a PCP domain was only 57.5.   
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4.8.3.3 Ketosynthase domains (KS) 
The homodimeric KS domains in PKS assemblies are responsible for the formation of 
a carbon-carbon-bond. The mechanism for this reaction is a Claisen condensation 
that requires the triad C-H-H, catalyzing the steps of acyl transfer, decarboxylation 
and condensation (Zhang et al., 2006).  
For Phn2 four KS domains were identified with identities of over 60% when compared 
with corresponding enzymes of bacteria of the order Actinomycetes. The result of the 
BLAST analysis (table  4.11) showed for KS1, KS2 and KS3 highest homologies to 
proteins of type I modular PKS found in bacteria belonging to the Streptomycetes, 
Saccharomonospora and Saccharopolyspora. For KS4 high identities with 
homologous proteins of the modular PKS genes tugA and tgaC from Chondromyces 
crocatus and Sorangium cellulosum, all belonging to the order of Myxobacteria, were 
observed. Multiple sequence alignment of the deduced protein sequences of the KS 
domains proved the presence of the highly conserved catalytic triad C-H-H for all four 
KS domains (Zhang et al., 2006). 
KS2  D T A C S S S L 179 
KS3  D T A C S S S L 176 
KS1  D T A C S S S L 178 
TugD  D T A C S S S L 176 
KS4  E T A C S S S L 171 
  
   
* 
    
 
 
 
 
 
Figure  4.10 Multiple sequence alignment of amino sequences of KS domains from Phn2 and TugD 
(Chrondromyces crocatus). GenBank accession numbers are given in table  4.11. Conserved residues are 
highlighted and marked with an asterisk. 
 
 
 
KS2 V E A H G T G 313 
KS3 V E A H G T G 310 
KS1 V E A H G T G 312 
TugD V E A H G T G 310 
KS4 V E C H G T G 305 
 
   
* 
   
 
KS2 N L G H T Q A 351 
KS3 N L G H T Q A 348 
KS1 N L G H T Q A 352 
TugD N L G H T Q A 348 
KS4 N I G H L E F 345 
 
   
* 
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Table  4.11 BLAST analysis revealed homologous proteins for KS domains of Phn2 (KS1-KS4)  
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
KS1 
type I PKS modular polyketide synthase 
[Saccharopolyspora erythraea NRRL 2338] 
271/431 
 (63%) 
327/431 
(76%) 
ZP_06568061.1 
 
lasalocid modular polyketide synthase 
[Streptomyces lasaliensis] 
278/433 
 (64%) 
334/433 
(77%) 
CAQ64692.1 
 
modular polyketide synthase 
[Streptomyces bingchenggensis BCW-1] 
292/426 
 (69% 
340/426 
(80%) 
ADI12313.1 
KS2 
modular polyketide synthase 
[Streptomyces bingchenggensis BCW-1] 
294/428 
(69%) 
346/428 
(81%) 
ADI12313.1 
 
modular polyketide synthase 
[Streptomyces avermitilis MA-4680] 
287/429 
(67%) 
337/429 
(79%) 
NP_822727.1 
 
6-deoxyerythronolide-B synthase, partial 
[Saccharomonospora paurometabolica YIM 
90007] 
261/425 
(61%) 
310/425 
(73%) 
ZP_09035064.1 
KS3 
modular polyketide synthase 
[Streptomyces bingchenggensis BCW-1] 
291/426 
(68%) 
343/426 
(81%) 
ADI12313.1 
 
lasalocid modular polyketide synthase 
[Streptomyces lasaliensis] 
276/426 
(65%) 
328/426 
(77%) 
CAQ64692.1 
 
6-deoxyerythronolide-B synthase, partial 
[Saccharomonospora paurometabolica YIM 
90007] 
262/425  
(62%) 
310/425 
(73%) 
ZP_09035064.1 
KS4 
TugD 
[Chondromyces crocatus] 
286/424 
(67%) 
328/424 
(77%) 
ADH04660.1 
 
TgaC 
[Sorangium cellulosum] 
291/427 
(68%) 
327/427 
(77%) 
ADH04641.1 
 
polyketide synthase 
[Sorangium cellulosum] 
285/424 
(67%) 
324/424 
(76%) 
CAL58684.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
A phylogenetic tree was constructed with Phylogeny.fr in a multiple sequence 
alignment of protein sequences of ketosynthase domains from N. pusilla (KS1-KS4) 
and a ketosynthase domain from TugD, the latter being part of a PKS from 
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Sorangium cellulosum. KS2 and KS3 show the highest similarity to each other. KS1 is 
also very closely related to the latter, whereas KS4 seems to be closer related to a 
KS domain from TugD. 
 
Figure  4.11 Phylogenetic tree of KS domains obtained from a multiple sequence alignment with 
phylogeny.fr. KS domains from N. pusilla (KS1-KS4) and from S. cellulosum (TugD) were aligned in a multiple 
sequence alignment. The distance of tree arms shows the respective phylogenetic relation. 
4.8.3.4 Acyltransferase domains 
Acyltransferase domains (AT) are responsible for the selection of extender units used 
in a PKS assembly line, and for the transfer of the latter onto the phosphopantetheine 
arm of the ACP domain. For Phn2 four AT domains could be identified with identities 
of over 50% when compared with corresponding enzymes of bacteria of the order 
Myxobacteria, except AT4. The latter domain is more related to that of bacteria from 
the Actinomycetes. The result of the BLAST analysis is shown in table  4.12.  
The catalytic serine, positioned in the highly conserved motif GHSxG and the 
conserved histidine from the conserved motif xAxH catalyze in a ping-pong bi-bi 
catalytic mechanism the transfer of acyl moieties (Ruch and Vagelos, 1973, Smith 
and Tsai, 2007). The presence of these highly conserved motifs could be proved in a 
multiple sequence alignment for all of the AT domains from Phn2. As all 
acyltransferase domains were categorized as active domains, the sequence 
elements important for the substrate activity were investigated. 
Sequence analysis of numerous AT domains revealed conserved amino acids motifs 
that can be correlated to substrate specificity (Yadav et al., 2003, Smith and Tsai, 
2007). In this aspect the best characterized extender units are the bicarboxylic 
malonyl-CoA and methylmalonyl-CoA. Three conserved motifs in AT domains are 
described to obtain informations about substrate specificity towards malonyl-CoA or 
methylmalonyl-CoA. 
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Table  4.12  BLAST analysis revealed homologous proteins for AT domains from Phn2 (AT1-AT4).  
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
AT1 
TgaA  
[Sorangium cellulosum] 
169/295 
 (57%) 
201/295  
(68%) 
ADH04639.1 
 
polyketide synthase type I  
[Stigmatella aurantiaca DW4/3-1] 
156/296 
 (53%) 
196/296 
 (66%) 
YP_003954820.1 
 
oxidoreductase, zinc-binding dehydrogenase 
family [Stigmatella aurantiaca DW4/3-1] 
156/296  
(53%) 
196/296 
 (66%) 
ZP_01467322.1 
AT2 
type I modular polyketide synthase  
[Streptomyces bingchenggensis BCW-1] 
169/300 
 (56%) 
203/300  
(68%) 
ADI03772.1 
 
polyketide synthase 
 [Polyangium cellulosum] 
173/301 
 (57%) 
208/301  
(69%) 
CAD43450.1 
 
amino acid adenylation protein  
[Haliangium ochraceum DSM 14365] 
169/298 
 (57%) 
208/298 
(70%) 
YP_003267364.1 
AT3 
polyketide synthase 
 [Polyangium cellulosum] 
178/303 
 (59%) 
212/303  
(70%) 
CAD43450.1 
 
polyketide synthase  
[Polyangium cellulosum] 
178/303 
 (59%) 
212/303 
 (70%) 
CAD43451.1 
 
amino acid adenylation protein  
[Haliangium ochraceum DSM 14365] 
173/299 
 (58%) 
211/299 
 (71%) 
YP_003267364.1 
AT4 
modular polyketide synthase  
[Streptomyces avermitilis MA-4680] 
169/302 
(56%) 
207/302 
(69%) 
NP_821594.1 
 
modular polyketide synthase  
[Streptomyces avermitilis] 
169/302 
(56%), 
207/302 
(69%) 
BAB69303.1 
 
beta-ketoacyl synthase, partial 
[Saccharomonospora azurea SZMC 14600] 
162/301 
(54%), 
203/301 
(67%) 
EHK81054.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The conserved region for motif I in ATs is completely different for methylmalonyl-CoA 
as a substrate ([R/Q/S/E/D]-V-[D/E]-V-V-Q), when compared to the one for malonyl-
CoA (Z-T-X-$-[A/T]-[Q/E]). The abbreviations Z and $ in motif I (malonyl-CoA) stand 
for a hydrophilic (Q) and an aromatic residue (Y, H), respectively (Yadav et al., 2003). 
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AT2, AT3 and AT4 showed the conserved motif I for malonyl-CoA (QTLYTQ and 
QTGHTG), whereas AT1 shared more amino acids with the methylmalonyl-CoA motif 
(RIEVVQ).  
 
 
 
Motif II 
      
 Motif III      
 
      
       
AT2 G H S V G 92  AT2 H A F H 193 
AT3 G H S V G 92  AT3 H A F H 193 
AT4 G H S V G 93  AT4 H A F H 194 
AT1 G H S Q G 91  AT1 C A T H 192 
TgaA G H S Q G 86  TgaA Y A S H 187 
 
  
* 
   
     *  
  
Figure  4.12 Multiple sequence alignment of amino sequences of AT domains from Phn2 and TgaA (S. 
cellulosum). Conserved residues from the highly conserved motifs are highlighted and the catalytic serine and 
histidine are marked with an asterisk. Amino acids identical in all compared sequences are shaded in red and 
violet (methylmalonyl-CoA motif); identities for up to three compared amino acids are highlighted in rose.  
The second motif (motif II), described as GHSxG, is highly conserved. Sequence 
alignments and crystal structure indicate that hydrophobic residues as valine, leucine 
or isoleucine in position five(x) refers to a malonyl-specific AT, whereas less bulky 
residues as glutamine or methionine are observed for the other AT domains 
(Haydock et al., 1995, Smith and Tsai, 2007). For three of the four AT domains, i.e. 
AT2, AT3 and AT4, the presence of valine in the GHSVG motif suggests substrate 
specificity towards malonyl-CoA, whereas the first AT domain (AT1) seems to 
possess a different substrate specificity.  
The xAxH motif (motif III) with a conserved histidine is present in methylmalonyl-
specific AT domains described as YASH motif and for the malonyl-specific AT as 
HAFH motif. As the previous sequence motifs of AT2-AT4 already showed a bias for 
malonyl-CoA as a possible substrate, the HAFH motif, present for AT2, AT3 and AT4, 
Motif I        
 
 AT1 R I E V V Q 
60 
 TgaA R A S V V Q  
        
 
 AT2 Q T L Y T Q 
62 
 AT3 Q T L Y T Q 
62 
 AT4 Q T G H T Q 
63 
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confirms this suggestion. The CATH motif for the AT1 domain is an as yet 
undescribed motif for an AT. 
A phylogenetic tree was built with phylogeny.fr in a multiple sequence alignment of 
protein sequences of the AT domains AT1-AT4 from N. pusilla and an AT domain 
from TgaA of Sorangium cellulosum, as well as putative AT domains from Haliangium 
ochraceum and S. cellulosum. AT2 and AT3 show the highest similarity to each other, 
AT4 is also very closely related to them, whereas AT1 seems to be closer related to 
the AT domain from TgaA. The AT domain from TgaA is reported to select and 
transfer a methylmalonyl-CoA to the adjacent ACP domain. AT domains from H. 
ochraceum and S. cellulosum are more related to AT2, AT3 and AT4 as they 
putatively share the same substrate specificity for malonyl-CoA. The latter was 
already deduced from sequence motif HAFH. 
 
Figure  4.13 Phylogenetic tree of AT domains obtained from a multiple sequence alignment with 
phylogeny.fr. AT domains from N. pusilla (AT1-AT4), H .ochraceum and S. cellulosum were aligned in a multiple 
sequence alignment. The distance of tree arms shows the respective phylogenetic relation  
AT1 domain loading ethylmalonyl-CoA 
BLAST search (table  4.12) showed that AT1 is closely related to an AT domain from 
TgaA, a PKS gene from S. cellulosum. This AT domain is localized in the second 
module of the thuggacin A biosynthesis in S. cellulosum and is reported to recognize 
a methylmalonate as its substrate (Buntin et al., 2010). Multiple sequence alignment 
(figure  4.12) revealed for the AT1 domain three conserved motifs: motif I (RIEVVQ), 
motif II (GHSQG) and motif III (CATH). Motif I and motif II matches more a 
methylmalonate-CoA-specific AT. Motif III does not fit the methylmalonate-CoA-
specific motif YASH. Previous feeding experiments in N. pusilla B150 with labeled 
precursors showed, that the ethyl side chain of phenylnannolone A is derived from a 
butyrate unit. Therefore, ethylmalonyl-CoA was suggested to be the favored 
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substrate for the acyltransferase AT1. Yadav et al. claim the third amino acid (residue 
200) in motif III to be crucial for the substrate prediction, especially for the distinction 
between malonyl-CoA and methylmalonyl-CoA. In malonyl-C A  pe  f   AT’    e  due 
200 comprises a phenylalanine, in contrast to this methylmalonyl-C A  pe  f   AT’  
harbor a serine in this position. Serine is a less bulky amino acid, which enables the 
binding of methylmalonyl-CoA (Yadav et al., 2009). Ethylmalonyl-CoA specific ATs 
harbor at this position small amino acids, i.e. glycine, threonine, serine and alanine 
(figure  4.14). For AT1, this amino acid is a threonine, just as in ethylmalonate specific 
ATs from oligomycin and ascomycin biosynthesis. A multiple sequence alignment 
could also show a close phylogenetic relationship between AT1 and other 
ethylmalonate specific ATs, from biosynthetic gene clusters of phoslactomycin, 
monensin and ascomycin. These results support the theory that AT1 accepts 
ethylmalonyl-CoA as its preferred substrate. 
 
11  58 59 60 61 62 63  90 91 92 93 94  117  198 199 200 201  
OlmA3 AT8 (Oligomycin) Q  R I E V I Q  G S S Q G  R  V P T H  
IdmL-AT3 (Indanomycin) Q  R I E V L Q  G H S Q G  R  V A S H  
TiaA2-AT4 (Tiacumicin) Q  R I D V V Q  G S S Q G  R  V A S H  
TylG-AT6 (Tylosin) Q  R V D V V Q  G H S Q G  R  T A G H  
ConE-AT10 (Concanamycin) Q  R I D V V Q  G H S Q G  R  V A G H  
Cfa-AT2 (Crononatine) Q  R I D V V Q  G H S Q G  R  V A G H  
MonA IV-AT5 (Monensin) Q  R I D V V Q  G H S Q G  R  V A G H  
Plm-AT4 (Phoslactomycin) Q  E V D V L Q  G H S Q G  R  I A A H  
Phn1-AT1 (Phenylnannlone) Q  R I E V V Q  G H S Q G  R  C A T H  
FkbB-AT4 (Ascomycin) Q  R V D V V H  G H S Q G  R  C P T H  
 
  motif I  motif II    motif II 
 
Figure  4.14 Multiple sequence alignment of ethylmalonyl-CoA specific ATs 
Computational analysis with AntiSMASH, where AT substrate prediction is based on 
two methods: the twenty four amino acid signature sequence for active site described 
by Yadav et al. and the pHMM based method of Minowa et al., yielded contradictory 
predicti   . T e f  e   t   t  Y d v’   et  d p   t     d  e t     f  et  xy  l  yl-
C A    e e         ’   et  d p ed  t e t e   et yl  l  yl-CoA (score: 175.2) or 
ethylmalonyl-CoA (score: 173.9) as possible substrate (figure  8.3). 
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4.8.3.5 Ketoreductase domains 
Ketoreductase domains (KR) of modular polyketide synthases, belong to the short-
chain dehydrogenase/reductase (SDR) superfamily of enzymes and catalyze the 
stereospecific reduction of the ß-keto function to a ß-hydroxyl group. This NADPH 
dependent reduction occurs three times in the biosynthesis for phenylnannolone A, 
supposedly by KR1, KR2 and KR3. The KR domains of Phn2 were analyzed with 
BLAST (results see table  4.14) and in a multiple sequence alignment and were 
characterized by the consensus Rossmann fold motif GxGxxG, which is required for 
NADPH binding, and the catalytic triad K-S-Y (Smith and Tsai, 2007). All KR domains 
of the phenylnannolone A gene cluster posses this typical NADPH-binding motif 
(figure  4.15). The identification of several conserved motifs in KR domains, allowing 
the stereochemical prediction (‘A-’    ‘ -type’) of the resulting hydroxyl bearing 
carbon atom (see table  4.13), helped to characterize KR1 and KR2 as B1-type 
ketoreductase domains. Such a B1-type KR domain followed by a DH domain results 
in a trans double bond by syn dehydration. KR4 could not be definitely classified by 
the conserved motifs to one of the B-type ketoreductases as the conserved motif 
LDD was not present. The activity of this KR domain is, however given as it harbors 
the Rossmann fold motif and the catalytic triad K-S-Y (Figure  4.15) (Caffrey et al., 
2003, Reid et al., 2003, Tsai and Ames, 2009, Kwan and Schulz, 2011). 
Table  4.13 KR signature sequences described by Kwan and Schulz (2011) 
type Conserved residues Resulting intermediate 
A1 W141 (2R,3S) 4 hydroxy-2-methylacyl 
A2 W141x x x x H146 (2S,3S) 4 hydroxy-2-methylacyl 
B1 L93D94D95 ;P144 x x x N148 (2R,3R) 4 hydroxy-2-methylacyl 
B2 L93D94D95 ;P144 x x x N148 x x P151 (2S,3R) 4 hydroxy-2-methylacyl 
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Table  4.14 Blast search results for the KR domains of the PKS gene Phn2  
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino acids
2
 
GenBank 
accession 
number 
KR1 
polyketide synthase  
[Streptomyces platensis] 
117/180  
(65%) 
137/180  
(76%) 
BAH02271.1 
 
FosE 
 [Streptomyces pulveraceus] 
115/181 
 (64%) 
134/181 
 (74%) 
AEC13071.1 
 
polyketide synthase pks17 
[Mycobacterium tuberculosis 
CDC1551A] 
108/178 
 (61%) 
132/178  
(74%) 
EGB28539.1 
KR2 
polyketide synthase  
[Streptomyces platensis] 
116/180 
 (64%) 
137/180  
(76%) 
BAH02271.1 
 
FosE 
 [Streptomyces pulveraceus] 
116/181 
 (64%) 
135/181 
 (75%) 
AEC13071.1 
 
polyketide synthase pks17 
[Mycobacterium tuberculosis 
CDC1551A] 
110/178  
(62%) 
133/178 
 (75%) 
EGB28539.1 
KR4 
StiD protein  
[Stigmatella aurantiaca] 
98/194 
 (51%) 
127/194 
 (65%) 
CAD19088.1 
 
6-deoxyerythronolide-B synthase 
 [Paenibacillus curdlanolyticus YK9] 
91/194 
 (47%) 
123/194 
 (63%) 
ZP_07386547.1 
 
lichenysin synthetase A 
 [Acetonema longum DSM 6540] 
92/194 
 (47%) 
123/194 
 (63%) 
ZP_08622844.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
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Motif I          Motif II     
               
KR1 G T G E L G 13   KR1 L D D 92 
KR2 G T G E L G 13   KR2 L D D 92 
FosE G T G D L G 24   FosE L D D 105 
KR4 G L G G I G 13   KR4 A T G 108 
StiD G L G D L G 164   StiD A N P 261 
 #  #   #     # # #  
 
                        Motif III 
                         
      KR1 
 R A K V D 112  KR1 S S V A G V I G S A G Q A N Y A A A N 151 
KR2 
 R A K V D 112  KR2 S S V A G V I G S A G Q A N Y A A A N 151 
FosE  R A K A D 125  FosE S S V A G V F G G A G Q A N Y A A A N 164 
KR4 
 R P K L Q 128  KR4 S S A A A L I P S P L V G A Y A A A N 167 
StiD  R S K A E 279  StiD S S G S A L M S S P L L G G Y A A A N 318 
    *      *              * 
   
# 
  
Figure  4.15 Multiple sequence alignment of KR domains from Phn2 and from Streptomyces pulveraceus (FosE) 
revealed the conserved sequence motifs I-III (highlighted in red and marked with a number sign) and the catalytic 
triad with the residues K-S-Y( highlighted in rose and marked with an asterisk).  
A phylogenetic tree (figure  4.16) built with Phylogeny.fr in a multiple sequence 
alignment of protein sequences of ketoreductase domains from N. pusilla (KR1, KR2, 
KR4) and KR domains from Streptomyces pulveraceus (FosE) and Stigmatella 
aurantiaca (StiD), showed high similartity between KR1 and KR2. KR4 seems not 
closely related to KR1 and KR2, but similar to StiD, involved in stigmatellin 
biosynthesis in Stigmatella aurantiaca (Gaitatzis et al., 2002). The ketoreductase 
domain from StiD and KR4 from Phn2 lack both the tryptophan (W), which is found in 
most of the KR domains from the A-type.  
 
Figure  4.16 Phylogenetic tree of KR domains obtained from a multiple sequence alignment with 
phylogeny.fr 
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4.8.3.6 Dehydratase domains 
The dehydratase domains are responsible for double bond formation in the growing 
polyketide chain. The dehydration of the ß- yd  xyl    up t     α ß u   tu  ted 
moiety is catalyzed through a catalytic dyad of histidine (H44) and aspartate (D206) 
conserved in the active site motif LxxHxxxGxxxxP and Dxxx[Q/H] (Tsai and Ames, 
2009). BLAST search results and multiple sequence alignment (results see table  4.15 
and figure  4.17) showed that the catalytic activity is given for all three DH domains of 
the Phn2 protein, as the conserved histidine and aspartate are present for DH1, DH2 
and DH4. The highly conserved active site motif Dxxx(Q/H) could be characterized for 
all DH domains. For motif LxxHxxxGxxxxP mutations of the conserved leucine (DH2) 
and glycine (DH1 and DH4) were observed. Glycine (G
48) is responsible for the ‘  t-
dog-folding’ t  t e  ble  v   de  W  l    te   t     bet ee     t d  e (H44) and 
proline (P53) of the conserved region. For the DH1 domain this gylcine is replaced by 
a aspartate, for DH2 it is substituted with a glutamate. The effect of these mutations 
for the folding of the respective proteins is not predictable yet. 
 
 Motif I    Motif II  
 
              
         
DH1 W L K D H R V L D L L L V P 42 
 DH1 D A A L H 202 
DH2 W F T E H R V F E T T L V P 41 
 DH2 D A A L H 205 
DH4 W L R D H R V A G S V I L P 42 
 DH4 D G C G Q 210 
EpoC W L G D H R V Q G A V V F P 43  EpoC D A C F Q 182 
 
 
# 
  
* 
   
# 
    
#    *    #  
 
Figure  4.17 Multiple sequence alignment of DH domains from Phn2 and from EpoC (S. cellulosum) revealed the 
conserved sequence motifs I and II (highlighted in violet and marked with a number sign) and the catalytic dyad 
with the residues H and D (highlighted in red and marked with an asterisk).  
 
Figure  4.18 Phylogenetic tree of DH domains obtained from a multiple sequence alignment with 
Phylogeny.fr 
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A phylogenetic tree (figure  4.18) built with Phylogeny.fr in a multiple sequence 
alignment of protein sequences of dehydratase domains from N. pusilla (DH1, DH2, 
DH4) and KR domains from Sorangium cellulosum (EpoC) and Saccharopolyspora 
spinosa, showed that DH1 and DH2 show more homology to each other than to DH4, 
which is more related to a KR domain from EpoC. 
 
Table  4.15 Blast search results for the DH domains of the polyketide synthase Phn2  
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino 
acids
1
 
Positives of 
aligned 
amino 
acids
2
 
GenBank 
accession 
number 
DH1 
predicted protein  
[Streptomyces sp. AA4] 
77/165 
 (47%) 
104/165 
 (63%) 
ZP_07281889.1 
 
beta-ketoacyl synthase, partial 
[Saccharopolyspora spinosa NRRL 18395] 
82/165  
(50%) 
99/165 
 (60%) 
ZP_08880287.1 
 
polyketide synthase extender module 2 
[Saccharopolyspora spinosa] 
82/165 
 (50%) 
99/165  
(60%) 
AAG23265.1 
DH2 
modular polyketide synthase [Streptomyces 
clavuligerus ATCC 27064] 
73/163  
(45%) 
100/163  
(61%) 
ZP_06769490.1 
 
type I polyketide synthase  
[Streptomyces clavuligerus ATCC 27064] 
73/163 
(45%) 
100/163  
(61%) 
ZP_08214249.1 
 
polyketide synthase extender module 2 
[Saccharopolyspora spinosa] 
77/163  
(47%) 
93/163  
(57%) 
AAG23265.1 
DH3 
polyketide synthase 
 [Streptomyces longisporoflavus] 
54/181  
(30%) 
87/181  
(48%) 
ACR50774.1 
 
EpoC  
[Sorangium cellulosum] 
57/171  
(33%) 
85/171  
(50%) 
AAF62882.1 
 
EpoC  
[synthetic construct] 
57/171 
 (33%) 
85/171  
(50%) 
ABB92692.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
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4.8.3.7 Thioesterase domain 
For the last domain of Phn2 the BLAST search (results see table  4.16) uncovered a 
thioesterase domain belonging to the prolyl oligopeptidase family, a family member of 
the AB hydrolase clan (pfam: CL0028). The active site triad S-D-H of TE domains is 
reported to catalyze the hydrolytic release of the polyketide (PK) chain that may 
result in an open-chained or in a cyclic PK. Serine, the first catalytic residue, is 
conserved in the motif G-X-S-X-G. The catalytic aspartate is located 28 amino acids 
upstream to this active site. The third catalytic residue is located 77 amino acids 
upstream to the aspartate. For the TE domain from Phn2 the catalytic triad and the 
conserved motif could be identified in a multiple sequence alignment (figure  4.19). 
Table  4.16 BLAST search results for the TE domain in the gene product of phn2 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids 
Positives of 
aligned 
amino acids 
GenBank 
accession number 
polyketide synthase type I 
[Saccharopolyspora erythraea NRRL 2338] 
99/220 
(45%) 
132/220 (60%) YP_001104811.1 
prolyl oligopeptidase family protein 
[Pseudoxanthomonas suwonensis 11-1] 
68/206 
(33%) 
103/206 (50%) YP_004147749.1 
prolyl oligopeptidase family protein [Xanthomonas 
oryzae pv. oryzicola BLS256] 
57/171 
(33%) 
98/207 
(47%) 
AEQ94842.1 
prolyl oligopeptidase family protein 
[Stenotrophomonas sp. SKA14] 
75/235 
(32%) 
114/235 (49%) ZP_05136892.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
 
Figure  4.19 Multiple sequence alignment of the TE domain of Phn2 (N. pusilla) and homologous proteins from 
Saccharopolyspora erythraea, Pseudoxanthomonas suwonensis and Xanthomonas oryzae pv. oryzicola revealed 
the catalytic triad with the residues S-D-H (highlighted in red and marked with an asterisk) and the conserved 
sequence motifs (highlighted in rose and marked with a number sign)  
 
P. suwonensis    G A S Y G 72    V Y D L P 100    G H G F 177 
X. oryzae    G A S D G 72    V Y D L D 100    G H G F 177 
TE (N. pusilla)    G T S R G 78    F Y D P L 106    G H D I 196 
S. eryhtraea    G T S R G 60    L Y D P G 88    G H D N 146 
    # 
 
* 
 
#       *        *    
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4.9 The biosynthetic NRPS/PKS-type gene sb1 
4.9.1 Sequencing result for the fosmid 21H12 
The sequencing result of fosmid 21H12 revealed 17 open reading frames (ORF). 
Amongst these ORFs is sb1, a gene encoding a mixed NRPS/PKS system, putatively 
involved in the biosynthesis of an unknown natural product. This biosynthetic gene 
(sb1) is surrounded with genes for hypothetical proteins of unknown function (orf2, 
orf3, orf5, orf8, orf9, orf11, and orf16), as well as transcriptional regulator and sensor 
proteins (orf6, orf7, orf12, orf13, and orf14), a cytochrome P450 enzyme (orf15) and 
a peroxidase-related enzyme (orf4). The gene for a succinate quinone 
oxidoreductase (orf1) on the boundary to the fosmid vector might be involved in 
primary metabolism. The BLAST search results for all of the ORFs are imaged in 
table  4.17. The gene product for sb1 showed in the BLAST analysis an identity of 
39% to a NRPS/PKS from Myxococcus xanthus DK 1622.  
Table  4.17 BLAST search results for fosmid sequences of clone 21H12. The deduced amino acid sequences 
of open reading frames found on fosmid 21H12 were aligned with homologous proteins by BLAST. The results for 
the gene of the mixed NRPS/PKS system are in bold and highlighted in blue. 
Gene 
Size 
(kb) 
Highest homology 
(protein level) 
Putative 
function 
Identity of 
aligned 
amino acids
1
 
GenBank 
accession 
number 
orf1 0.5 
predicted protein  
[Capsaspora owczarzaki ATCC 30864] 
Succinate: 
quinone 
oxidoreductase 
52/163 
 (32%) 
EFW42511.1 
orf2 0.3 
hypothetical protein PPSIR1_34148  
[Plesiocystis pacifica SIR-1] 
unknown 
36/53 
(68%) 
ZP_01911596.1 
or3f 0.5 
unnamed protein product 
 [Mycobacterium ulcerans Agy99] 
unknown 
39/102  
(38%) 
YP_907810.1 
orf4 0.6 
uncharacterized peroxidase-related 
enzyme [Ktedonobacter racemifer DSM 
44963] 
Peroxidase 
related enzyme 
81/171  
(47%) 
ZP_06975623.1 
orf5 0.8 
putative toxin-antitoxin system, toxin 
component [Streptomyces hygroscopicus 
ATCC 53653] 
unknown 
141/284 
(50%) 
ZP_07294672.1 
orf6 0.4 
ArsR family toxin-antitoxin system, 
antitoxin component [Streptomyces 
hygroscopicus ATCC 53653] 
Transcriptional 
regulator 
79/104 
(76%) 
ZP_07294673.1 
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orf7 0.5 
hypothetical protein SPV1_00677 
[Mariprofundus ferrooxydans PV-1] 
Sensor globin 
protein (gene 
regulation) 
60/138 
(43%) 
ZP_01453014.1 
orf8 0.4 
roadblock/LC7 family protein 
 [Roseiflexus sp. RS-1] 
unknown 
65/116 
 (56%) 
YP_001275112.1 
orf9 1.0 
unnamed protein product 
 [Sorangium cellulosum 'So ce 56'] 
unknown 
41/112 
 (37%) 
YP_001618803.1 
orf10 1.1 
short-chain dehydrogenase/reductase 
SDR [Variovorax paradoxus S110] 
DH/KR 
28/84  
(33%) 
YP_002942254.1 
orf11 1.9 
serine/threonine protein kinase 
[Haliangium ochraceum DSM 14365] 
unknown 
97/371  
(26%) 
YP_003266021.1 
sb1 10.3 
non-ribosomal peptide 
synthetase/polyketide synthase 
[Myxococcus xanthus DK 1622] 
NRPS/PKS 
1235/3160 
(39%) 
YP_631961.1 
orf12 0.7 
hypothetical protein HMPREF0005_05065  
[Achromobacter xylosoxidans C54] 
glutathione S-
transferase 
139/208 
(67%) 
EFV87494.1 
orf13 0.6 
transcriptional regulator, TetR family 
protein [Labrenzia alexandrii DFL-11] 
Transcriptional 
regulator 
82/190 
 (43%) 
ZP_05112352.1 
orf14 5.4 
ATP-binding region ATPase domain 
protein [Microcoleus vaginatus FGP-2] 
Proteinkinase 
677/1779 
(38%) 
ZP_08494285.1 
orf15 1.3 
cytochrome P450 
 [Ktedonobacter racemifer DSM 44963] 
CYP450 
159/409 
(39%) 
ZP_06973265.1 
orf16 1.9 
unnamed protein product  
[Sorangium cellulosum 'So ce 56'] 
unknown 
374/582 
(64%) 
YP_001612581.1 
1: ratio of identical amino acids (first value) to all compared amino acids (second value)  
 
4.9.2 Analysis of sb1, a NRPS/PKS mixed biosynthetic gene  
The sequencing of the fosmid clone 21H12 revealed a gene encoding for a mixed 
NRPS/PKS multi-enzyme as the BLAST search results in table  4.17 and table  4.18 
show. The NRPS/PKS gene sb1 comprises 10 kb sequence information. The 
corresponding gene product consists of 3 modules: The first two modules belong to 
the NRPS part, whereas the third module forms the PKS part. Module1 and module 2 
reveal the same domain architecture consisting of a condensation (C), an adenylation 
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(A) and a peptidyl carrier protein (PCP) domain. Module 3 shows the architecture of a 
minimal PKS module with a ketosynthase, an acyltransferase, an acyl carrier protein 
and a thioesterase domain. The diverse domains encoded by sb1 are examined in 
detail (see  4.9.2.1- 4.9.2.4) and grouped according to their function, i.e. C, A, PCP, 
KS, AT, and TE domains. 
Table  4.18 BLAST search results for the gene sb1. The deduced amino acid sequence for this gene was 
aligned with the respective homologous proteins by BLAST ( 3.1.14). 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned amino 
acids
2
 
GenBank 
accession 
number 
non-ribosomal peptide synthetase/ polyketide 
synthase [Myxococcus xanthus DK 1622] 
1236/3165 
(39%) 
1695/3165 
(54%) 
YP_631961.1 
nonribosomal peptide synthetase/ polyketide 
synthase hybrid [Lysobacter lactamgenus] 
1252/3113 
(40%) 
1670/3113 
(54%) 
ABB80392.1 
non-ribosomal peptide synthetase/+polyketide 
synthase [Myxococcus fulvus HW-1] 
1054/2634 
(40%) 
1434/2634 
(54%) 
YP_004668379.1 
hypothetical protein PAU_02675 [Photorhabdus 
asymbiotica subsp.asymbiotica ATCC 43949] 
1048/3092 
(34%) 
1534/3092 
(50%) 
YP_003041510.1 
amino acid adenylation domain protein 
[Methylobacter tundripaludum SV96] 
861/1975 (44%) 
1172/1975 
(59%) 
ZP_08782282.1 
1: ratio of identical amino acids (first value) to all compared amino acids (second value) (percentage in brackets). 
2: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
 
       10 kb 
Figure  4.20 Modular NRPS/PKS hybrid encoded by sb1 consisting of two NRPS modules and one PKS 
module: C= condensation domain, A= adenylation domain, PCP= peptidyl carrier protein, KS= ketosynthase 
domain, AT= acyltransferase domain, TE= thioesterase domain. 
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4.9.2.1 Condensation domains 
The gene product of sb1 features two C domains located in the first and second 
module of the NRPS/PKS system. The C domains were analyzed in a BLAST search 
(see table  4.19). The first C domain (C1) is related to an amino acid adenylation 
domain protein from Fischerella sp. and to two unnamed protein products from 
Sorangium cellulosum. The second C domain (C2) is related to the same unnamed 
protein product from Sorangium cellulosum as C1, but with a higher identity (43%). It 
shows also similarities to peptide synthetases from different Ralstonia solanacearum 
strains.  
Table  4.19 BLAST search results for C domains of sb1 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino 
acids
1
 
Positives of 
aligned 
amino 
acids
2
 
GenBank 
accession number 
C1 
amino acid adenylation domain protein 
[Fischerella sp. JSC-11] 
86/302 
(28%) 
139/302 
(46%) 
ZP_08985494.1 
 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
85/269 
(32%) 
122/269 
(45%) 
YP_001617472.1 
 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
94/280 
(34%) 
131/280 
(47%) 
YP_001610982.1 
C2 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
137/319 
(43%) 
187/319 
(59%) 
YP_001610982.1 
 
putative non ribosomal peptide synthetase 
protein [Ralstonia solanacearum CMR15] 
139/308 
(45%) 
185/308 
(60%) 
CBJ40245.1 
 
peptide synthetase 
[Ralstonia solanacearum GMI1000] 
139/308 
(45%) 
185/308 
(60%) 
NP_522203.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The C domains of Sb1 were aligned with related C domains from Fischerella, 
Ralstonia and Sorangium species revealing 7 signature sequences (Konz and 
Marahiel, 1999), whereby the histidine and the aspartate residues in the conserved 
motif H-H-X-X-X-D-G (motif III) are considered to be essential for the peptide bond 
formation (Bergendahl et al., 2002, Sieber and Marahiel, 2005). Regarding the C 
domains C1 and C2, C1 seems to be inactive due to the lack of the critical histidine 
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residue in motif C3, present for the second C domain (C2). As for the other core 
motifs for C domain C2, all motifs were present with few mutations, except motif C2, 
which could not be located. Phylogenetic analysis with NaPDos ( 3.1.14) classified the 
C domains as LCL-C domains, connecting two L-amino acids with each other. 
 
Motif C1 
 
    Motif C2  
            
              
Fischerella sp. S L V Q E R L W L L 57     R H E I L R T T F 102 
R. solanacearum S F A Q Q R L W F L 17     R H E A L R T C F 62 
C2 (N. pusilla) S L A Q E R L F F L 13 
    P P R V A A H D L 58 
S. cellulosum S L E Q E R A W V L 19     R Q A I L R T S F 64 
C1 (N. pusilla) S C E Q A L V W L R 16 
    R H D L L R T T F 61 
            
              
 
Motif C5 
 
  Motif C6   
             
           
Fischerella sp. L G C F I N T L V L R 340   H Q D L P F E 372  
R. solanacearum I G F F V N T L A L R 298   H Q D L P F E 330  
C2 (N. pusilla) V G F F V N M L P I R 295   H D A V P F D 327  
S. cellulosum I G A F G N L V T V R 296   N G D L S F T 328  
C1 (N. pusilla) L G P V A D R L M L R 292 
  H G - - A L A 324  
             
           
             
           
 
Motif C7 
 
 
           
 
Fischerella sp. R T L S H N P L F 389  
R. solanacearum R S L S H S P V F 347  
C2 (N. pusilla) R T L S H N P V V 344  
S. cellulosum R D P S R A P L V 347  
C1 (N. pusilla) A P G C Q V Y F H 340 
 
           
 
Figure  4.21 Multiple sequence alignment revealing the 7 conserved motifs for C domains. 
 
 
 
Motif C3 
  
   Motif C4  
          
           
Fischerella sp. H H I I C D G 161 
 
   Y A D F A L W 221 
R. solanacearum H H I V S D G 120 
 
   Y A D Y A V W 180 
C2 (N. pusilla) H H I V I D G 117 
 
   F A D Y A A W 176 
S. cellulosum H P L L S D G 123 
 
   Y Q D H A R R 178 
C1 (N. pusilla) H A L L A D A 121 
 
   Y T H H L R A 178 
  
* 
   
* 
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4.9.2.2 Adenylation domains from Sb1 
The NRPS adenylation (A) domain recognizes amino acids and activates them 
through adenylation. For the NRPS/PKS mixed gene product Sb1 two A domains 
were identified via BLAST analysis, predominantly related to proteins from 
cyanobacteria (for detailed results see table  4.20). The A domain A1 shows the 
highest identity to an amino acid adenylation domain protein from Pedosphaera 
parvula , A domain A2 shares 51% identity with an amino acid adenylation protein 
from Herpetosiphon aurantiacus.  
Table  4.20 BLAST search results for A domain A1 and A2 from Sb1 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids 
Positives of 
aligned 
amino acids 
GenBank 
accession 
number 
A1 
amino acid adenylation domain protein 
[Pedosphaera parvula strain Ellin514] 
211/409 
(52%) 
272/409 
(67%) 
ZP_03628586.1 
 
peptide synthetase 
[Nodularia spumigena CCY9414] 
194/407 
(48%) 
277/407 
(68%) 
ZP_01632065.1 
 
AMP-binding enzyme domain protein 
[Microcoleus chthonoplastes PCC 7420] 
198/405 
(49%) 
274/405 
(68%) 
ZP_05029395.1 
A2 
amino acid adenylation protein   
[Herpetosiphon aurantiacus DSM 785] 
205/402 
(51%) 
269/402    
(67%) 
YP_001545183.1 
 
amino acid adenylation protein        
[Cyanothece sp. PCC 7424] 
199/400 
(50%) 
264/400   
(66%) 
YP_002381151.1 
 
amino acid adenylation domain-containing 
protein [Cyanothece sp. PCC 7822] 
198/396 
(50%) 
269/396   
(68%) 
YP_003899892.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The highly conserved regions for the A domains are described as ten regions with the 
following motifs: A1: L[T/S]YxEL, A2: LKAGxAYL[V/L]P[L/I])D, A3: 
LAYxxYTSG[S/T]TGxPKG, A4: FDxS , A5: NxYGPTE, A6: GELxIxGxG[V/L]ARGYL, 
A7: Y[R/K]TGDL, A8: GRxDxQVKIRGxRIELGEIE, A9: LPxYM[I/V]P and A10:  
NGK[V/L]DR. The A domains of SB1 showed the presence of 8 conserved motifs 
(figure  4.2), located in a multiple sequence alignment with homologous sequences of 
A domains (table  4.20). 
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Motif A1   Motif A2  
 
                    
A2 (N. pusilla) S Y A E L 4   L K A G G A F V P L D 55 
H. aurantiacus S Y H E L 4   L K S G G A Y I P L D 55 
Cyanothece sp. T Y S Q L 4   L K A G A A Y L P L D 55 
N. spumigena T Y Q E L 4   L K A G G V C V P L D 55 
M. chthonoplastes T Y Q Q L 4   L K A G G A Y V P L D 55 
A1 (N. pusilla) T Y R E L 4   L M A G G T Y V P L D 55 
 
                    
 Motif A3 
 
  Motif A4  
 
                 
        
A2 (N. pusilla) A A Y V I Y T S G S T G R P K G 129   F D A F 167  
H. aurantiacus L A Y I V Y T S G S T G Q P K G 135   F D A A 173  
Cyanothece sp. L A Y V I Y T S G S T G K P K G 134   F D A C 172  
N. spumigena L A Y I V Y S S G S T G K P K G 135   F D V S 171  
M. chthonoplastes L L Y V I Y T S G S T G Q P K G 133   F D A S 169  
A1 (N. pusilla) L A Y I I Y T S G S T G R P K G 129   F D L C 165  
 
                 
        
 Motif A5      Motif A6    
 
       
                     
A2 (N. pusilla) N A Y G P T E 257 
   G E L Y V G G A G V A R G Y L 315  
H. aurantiacus N A Y G P S E 263    G E I Y V G G V G V A R G Y L 322  
Cyanothece sp. N A Y G P T E 262    G E I Y I G G V G V A R G Y L 319  
N. spumigena N F Y G P T E 271    G E L Y V S G Y G L A R G Y F 332  
M. chthonoplastes N H Y G P S E 269    G F L C I G G A N L A R G Y L 327  
A1 (N. pusilla) N H Y G P A E 265 
   G E L Y I G G E C L A R G Y W 326  
 
       
                     
 Motif A7   
 
       
  
A2 (N. pusilla) Y R T G D R 344   
H. aurantiacus Y R T G D L 351   
Cyanothece sp. Y K T G D L 348   
N. spumigena Y K T G D L 361   
M. chthonoplastes Y Q T G D M 356   
A1 (N. pusilla) Y R T G D I 355   
 
       
  
 Motif A8    
                       
A2 (N. pusilla) G R L D R Q V K V R G F R I E L G E V E 376  
H. aurantiacus G R I D Q Q I K L R G H R I E L G E I S 383  
Cyanothece sp. G R I D H Q V K V R G F R I E L G E I E 380  
N. spumigena G R I D D V V K I R G Y R V D L G E L E 392  
M. chthonoplastes G R V D H Q V K I R G F R I E L G E V E 388  
A1 (N. pusilla) G R R D D Q V K I R G V R V E L G E V L 387  
 
Figure  4.22 Multiple sequence alignment of A domains revealing 8 core motifs 
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Substrate specificity was predicted by AntiSMASH using the NRPS predictor2 
(Rausch et al., 2005) and the Minowa HMM method (Minowa et al., 2007). For the 
first adenylation domain proline (Stachelhaus Code: DLYITSHVV-) could be 
predicted as possible substrate, and for the second one the consensus prediction 
pointed towards phenylalanine (Stachelhaus code: DAFVVAAVC-) (for more details 
see Appendix, figure  8.3). 
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4.9.2.3 PCP domains 
The NRPS/PKS multienzyme Sb1 features three domains encoding for 
phosphopantetheine (PP) binding enzymes responsible for the delivery of the 
intermediates to other catalytic domains. BLAST search analysis showed similarities 
to PP-binding domains from proteobacteria and cyanobacteria (for results see table 
 4.21), all belonging to the ACP-like superfamily (clan: CL0314). 
Table  4.21 BLAST search results for PCP domains from Sb1 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino acids
1
 
Positives of 
aligned 
amino 
acids
2
 
GenBank 
accession number 
PCP1 
amino acid adenylation 
[Pseudomonas syringae pv. 
 japonica str. M301072PT] 
37/63 
(59%) 
46/63 
(73%) 
EGH34330.1 
 
cyanopeptolin synthetase 
[Planktothrix prolifica NIVA-CYA 406] 
37/63 
(59%) 
50/63 
(79%) 
CAQ77047.1 
 
cyanopeptolin synthetase 
[Planktothrix prolifica NIVA-CYA 401] 
37/63 
(59%) 
50/63 
(79%) 
CAQ77045.1 
PCP2 
 
unnamed protein product     
 [Sorangium cellulosum 'So ce 56'] 
43/63  
(68%) 
54/63      
(86%) 
YP_001617472.1 
 
unnamed protein product     
 [Sorangium cellulosum 'So ce 56'] 
44/63  
(70%) 
54/63  
(86%) 
YP_001610982.1 
 
peptide synthase           
   [Crocosphaera watsonii WH 0003] 
29/63     
(46%) 
44/63      
(70%) 
EHJ14209.1 
PCP3 
unnamed protein product 
 [Sorangium cellulosum 'So ce 56'] 
33/54     
(61%) 
42/54      
(78%) 
YP_001610982.1 
 
Non-ribosomal peptide synthetase 
[Pseudomonas putida KT2440] 
29/65 
(45%) 
43/65 
(66%) 
NP_746337.1 
 
hypothetical protein STIAU_0869 
[Stigmatella aurantiaca DW4/3-1] 
32/56 
(57%) 
38/56 
(68%) 
ZP_01462890.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
PP-binding domains are components of NRPS and PKS multienzymes and are 
named peptidyl carrier proteins (PCP) and acyl carrier proteins (ACP) domains 
respectively; this refers to the substrate they bind, i.e. either a peptide or an acyl 
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moiety. To distinguish between ACP and PCP domains CLUSEAN software was 
used. All three domains were annotated as PCP domains due to the calculated 
values obtained in an analysis with CLUSEAN. The results of this analysis are 
displayed in the table  4.22. Surprisingly, the last PP-binding enzyme was predicted to 
be a PCP and not an ACP domain. 
Table  4.22 CLUSEAN prediction for the phosphopantetheine binding enzymesPCP1 to PCP3 
domain PCP-C 
(Score/E-value) 
PCP-E 
(Score/ E-value) 
PKSI-ACP 
(Score/ E-value) 
PCP1 99.9/1.8e-29 67.4/1.1e-19 31.3/ 8e-09 
PCP2 90.9/ 9e-27. 49.4/2.9e-14 46.2/ 2.6e-13 
PCP3 68.5/ 5.1e-20. 29.0/ 3.2e-10 40.3/1.6e-11 
 
The most important conserved residue for the PCP domain is a serine, the putative 
4’-phosphopanthetine binding site, that could be identified for all of the three putative 
PCP domains in a multiple sequence alignment (figure  4.23). For PCP domains this 
serine residue is conserved in the motif D-X-F-F-X-X-L-G-G-[H/D]-S-[L/I] (Konz and 
Marahiel,1999).  
 
PCP1 (N. pusilla) D D F F A L G G H S L 26 
P. putida D D F F E L G G H S L 26 
PCP3 (N. pusilla) D N F F D L G G T S L 26 
S. cellulosum 
1
  N F F D L G G H S L 20 
PCP2 (N. pusilla) A P F F E L G G H S L 26 
S. cellulosum 
2
 D P F F E I G G H S L 24 
       
   
* 
 
 
 
Figure  4.23 Multiple sequence alignment of PCP domains and homologous proteins from S. cellulosum and P. 
putida [S. cellulosum 
1
(GenBank: YP_001610982.1), S. cellulosum 
2
(GenBank: YP_001617472.1)] 
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4.9.2.4 Ketosynthase domain (KS)  
KS domains in PKS assemblies belong to the superfamily of condensing enzymes 
(GenBank accession: cl09938).They form carbon-carbon-bonds, using a 
decarboxylative Claisen condensation. This requires an active centre, the triad C-H-
H, catalyzing the steps of acyl transfer, decarboxylation and condensation (Zhang et 
al., 2006). For the NRPS/PKS system Sb1 a single KS domains was identified. The 
protein sequence of this KS shares 66% identity with a KS domain from an unnamed 
protein product from S. cellulosum (table  4.23). Multiple sequence alignment of the 
deduced protein sequence of the KS domain proved the presence of the highly 
conserved catalytic triad C-H-H for KSSb1 (Zhang et al., 2006). 
Table  4.23 BLAST search result for KS domain from Sb1 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino 
acids
1
 
Positives 
of aligned 
amino 
acids
2
 
GenBank 
accession 
number 
KSSb1 
unnamed protein product  
[Sorangium cellulosum 'So ce 56'] 
280/427 
(66%) 
316/427 
(74%) 
YP_001610982.1 
 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
268/427 
(63%) 
313/427 
(73%) 
YP_001617472.1 
 
polyketide synthase 
[Oscillatoria sp. PCC 6506] 
221/427 
(52%) 
292/427 
(68%) 
ACJ46057.1 
 
6-deoxyerythronolide-B synthase 
[Fischerella sp. JSC-11] 
229/428 
(54%) 
303/428 
(71%) 
ZP_08985496.1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
 
 
 
 
 
Figure  4.24 Multiple sequence alignment of KS domain from Sb1 with homologous protein sequences[S. 
cellulosum 
1
(GenBank: YP_001610982.1), S. cellulosum 
2
(GenBank: YP_001617472.1)] 
Soce001610982.1 T A C S T 170  E G H G T G 301  G H L G A 348 
 
Soce001617472.1 T A C S T 172  E A H G A G 303  G H L R A 350  
KSSb1 S A C S T 169  E A H G T A 300  G H L S A 347  
Oscillatoria sp. T T C S T 175  E A H G T G 306  G H L N T 353  
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4.9.2.5 Acyltransferase (AT) 
In PKS assembly lines AT domains are responsible for the selection of extender units 
and the transfer of the latter onto the phosphopantetheine arm of the ACP domain. 
Sb1, a single AT domain, showed highest homology to an unnamed protein product 
from Sorangium cellulosum. The result of the BLAST analysis is shown in table 4.24. 
Table  4.24 BLAST search results for AT domain from Sb1 
1
: ratio of identical amino acids (first value) to all compared amino acids (second value) percentage in brackets    
2
: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The catalytic serine, positioned in the highly conserved motif GHSxG and the 
histidine from the conserved motif xAxH catalyze in a ping-pong bi-bi catalytic 
mechanism the transfer of acyl moieties (Ruch and Vagelos, 1973, Smith and Tsai, 
2007). The presence of these highly conserved motifs could be proved in a multiple 
sequence alignment for the AT domain in Sb1. 
Sequence analysis of numerous AT domains revealed conserved amino acids motifs 
that can be correlated to substrate specificity (Yadav et al., 2003, Smith and Tsai, 
2007). Three conserved motifs in AT domains are described to obtain informations 
about substrate specificity towards malonyl-CoA or methylmalonyl-CoA. 
 
 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino 
acids
1
 
Positives of 
aligned 
amino 
acids
2
 
GenBank 
accession 
number 
ATSb1 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
163/302 
 (54%) 
197/302 
(65%) 
YP_001610982.1 
 
polyketide synthase 
[Myxococcus xanthus DK 1622] 
146/302 
(48%) 
186/302 
(62%) 
YP_631807.1 
 
hypothetical protein  
[Planktothrix rubescens NIVA-CYA 98] 
126/303 
(42%) 
187/303 
(62%) 
CAQ48282.1 
 
ProE 
 [Planktothrix rubescens] 
126/303 
 (42%) 
187/303 
(62%) 
ACG63859.1 
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The conserved region for motif I in ATSb1 was found to be K-P-S-R-N-M. It was 
neither compatible with the motif I for methylmalonyl-CoA ([R/Q/S/E/D]-V-[D/E]-V-V-
Q), nor with the one for malonyl-CoA (Z-T-X-$-[A/T]-[Q/E]), where the abbreviations Z 
and $ stand for a hydrophilic (Q) and an aromatic residue (Y, H), respectively (Yadav 
et al., 2003).  
The highly conserved second motif GHSxG, is present in ATSb1 as G-H-S-L-G. 
Sequence alignments and crystal structure indicate that hydrophobic residues as 
valine, leucine or isoleucine in position five (x) refers to a malonyl-specific AT, 
whereas less bulky residues as glutamine or methionine are observed for the other 
AT domains (Haydock et al., 1995, Smith and Tsai, 2007). The leucine in motif II of 
ATSb1 indicates malonyl-CoA to be a possible substrate for this AT.  
The xAxH motif (motif III) with a conserved histidine is present in methylmalonate-
specific AT domains described as YASH motif and for the malonate-specific AT as 
HAFH motif. TASH, the present sequence motifs for ATSb , shares the conserved 
serine from the YASH motif. Yadav et al. claim this third amino acid in motif III to be 
crucial for the substrate prediction, especially for the distinction between malonyl-
CoA and methylmalonyl-CoA. For all 77 investigated methylmalonate specific AT 
residue 200 was identified as a serine. Only one from 98 malonate specific ATs was 
observed to carry a serine at this position (Yadav et al., 2003). The serine motif III of 
ATSb1 suggests methylmalonyl-CoA to be a possible substrate for this AT.  
M. xanthus G H S L G 97   V A A H 194 
ProE G H S I G 97   H A F H 195 
ATSb1 G H S L G 101   T A S H 198 
S. cellulosum G H S L G 97   T A A H 195 
 
Figure  4.25 Multiple sequence alignment of AT domain from N. pusilla with AT domains from homologous 
proteins (for GenBank accession no. see table  4.24) 
As the three motifs showed different results for the substrate specificity, a reliable 
prediction could not be made on base of these results. Therefore the amino acid 
sequence of ATSb1 was analyzed with two online tools: antiSMASH and ASMPKS. 
AntiSMASH identified the AT to select malonyl-CoA for the acyl transfer to the ACP 
domain. The identities shown by AntiSMASH with sequences from other malonate 
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specific ATs were only about 54%, whereas a previous analysis with sequences from 
Phn2 showed more than 80% identities for the malonate specific ATs. ASMPKS 
predicted it as a methylmalonate specific AT, but a closer to the detail informations, 
concerning the homologues sequences of this domain, indicated ATSb1 to share more 
identities with malonate specific ATs. The results of these queries lead to the 
assumption that ATSb1 accepts malonate as its substrate. 
4.9.2.6 Thioesterase domain  
For the downstream domain encoded on sb1 the BLAST search (results see table 
 4.25) uncovered a thioesterase activity. The TE domain belongs to the family of 
thioesterases, a member of the AB hydrolase clan (pfam: CL0028). TE domains are 
responsible for the hydrolytic release of the polyketide or non-ribosomal peptide 
chain resulting in an open-chained or in a cyclic PK or NRP.  
Table  4.25 BLAST search results for TE domain from Sb1 
Domain 
Highest homology 
(protein level) 
Identity of 
aligned 
amino 
acids
1
 
Positives of 
aligned 
amino 
acids
2
 
GenBank 
accession 
number 
TE 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
106/225 
(47%) 
147/225 
(65%) 
YP_001610982.1 
 
unnamed protein product 
[Sorangium cellulosum 'So ce 56'] 
98/230 
(43%) 
132/230 
(57%) 
YP_001617472.1 
 
NRPS/PKS hybrid 
[Nocardia brasiliensis ATCC 700358] 
71/220 
(32%) 
118/220 
(54%) 
EHY29995.1 
 
polyketide synthase type I 
[Crocosphaera watsonii WH 0003] 
73/252 
(29%) 
111/252 
(44%) 
EHJ09264.1 
1: ratio of identical amino acids (first value) to all compared amino acids (second value) (percentage in brackets). 
2: Positives are amino acid residues that are similar to each other concerning their chemical properties. 
The hydrolytic action is mediated by the active site triad S-D-H. The catalytic serine is 
located in the conserved motif GXSXG, 27 amino acids upstream of the serine the 
catalytic aspartate is found. The third catalytic residue, a histidine is located in the 
motif GXHF, reported to be conserved in NRPS-TE domains (Reimmann et al., 
2004).  
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Multiple sequence alignment of the TE domain from Sb1 with homologous amino acid 
sequences revealed the catalytic triad and the conserved motifs GHSAG and GDHF 
(figure  4.26). 
S. cellulosum 
1
 G H S A G 74  L L D T G 101  G N H F 206 
S. cellulosum 
2
 G H S A G 77  L L D T G 105  G N H F 208 
N. brasiliensis G H S S G 69  L L D T T 97  G N H F 202 
TE (N. pusilla) G H S A G 75  I L D A P 102  G D H F 207 
C. watsonii G S S F G 84  M V D P P 112  G D H F 242 
 
  
* 
  
    *       *   
Figure  4.26 Multiple sequence alignment of TE domain from N. pusilla with TE domains from homologous 
proteins (for GenBank accession no. see table 4.22) S. cellulosum 
1
(GenBank: YP_001610982.1),                         
S. cellulosum 
2
 (GenBank: YP_001617472.1) 
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4.10 Antibiotic selectivity test for N. pusilla B150 
For further experiments such as the construction of knock-out mutants selection 
markers, e.g. antibiotic resistance genes are required. Before choosing a selection 
marker for cloning experiments in bacterial strains, the resistance of the bacterium 
towards several antibiotics should be evaluated. 
To achieve this aim, N. pusilla B150was cultured with several antibiotics. Co-culturing 
with ampicillin, carbenicillin, gentamycine, kanamycin and nalidixic acid did not affect 
the growth of N. pusilla on solid agar. 
The growth of N. pusilla B150 in liquid was tested for chloramphenicol, streptomycin, 
tetracycline and carbenicillin. After 4 days, good growth was observed for the 
carbenicillin culture, but no growth was visible for the other antibiotic-containing 
cultures. After 14 days the liquid culture complemented with streptomycin, however, 
showed a slight growth. Table  4.26 shows the results of the antibiotic selectivity test: 
Table  4.26 Antibiotic selectivity test 
Antibiotic Solid agar Growth in liquid 
Ampicillin ++ n.t. 
Apramycin - n.t. 
Carbenicillin ++ + 
Chloramphenicol - -- 
Gentamycine + n.t. 
Kanamycin + n.t. 
Nalidixic acid +++ n.t. 
Streptomycin - + 
Tetracycline - -- 
n.t.: not tested, +++= fast & good growth, ++=mediate growth,+=moderate growth; -=no growth 
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4.11 Functional proof of the AMP-ligase from the PKS gene, phn2 
For the further elucidation of the biosynthesis of phenylnannolone A, functionality and 
substrate selectivity of the AMP-ligase of Phn2 were investigated. Therefore, the 
expression of the recombinant protein and a subsequent ATP exchange assay 
(Phelan et al., 2009) were necessary. 
4.11.1 Protein expression of the AMP-ligase from Phn2 
For the evaluation of the functionality of the AMP domain ( 4.8.3.1) a recombinant 
protein comprising the AMP and the proximate ACP domain was expressed in BL21 
StarTM E. coli. To achieve this, the pet151/D-TOPO® cloning vector kit was used. A 
PCR fragment (AMP-ACP) of 2.26 kb encoding for the two domains was cloned into 
the pet151/D-TOPO® cloning vector (figure  4.27) and transferred into BL21 StarTM E. 
coli cells ( 3.2.21).  
 
Figure  4.27 Construct for protein expression of the AMP-ligase for subsequent A domain-assay                 
A PCR fragment (AMP-ACP) with the sequences encoding for the AMP-ligase and the proximate ACP was cloned 
into pet151/D-TOPO
®
 cloning vector resulting in pet151AMP-ACP, the construct for heterologous protein 
expression. 
pet151AMPACP
8019 bps
2000
4000
6000
8000
Nde I
NsiI
PspXI
XhoI
AarI
SalI
Dra III
Bmt I
Nhe I
SspI
ScaI
PstI
IPci
ISap
1107IBst
10IBpu
AIFsp
IMsc
IBsm
IHpa
IApa
OMIPsp
IMlu
NIEco
ISph
T7 promotor
lacO
RBS
AMP-ACP
6xHis
V5 Epitope
TEV recognition site
bla promotor
bla(Ampicil l in)
pBR322 origin
ROP ORF
lacI ORF
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The expression of the recombinant protein with an add-on of 0.5mM IPTG took place 
at 37 °C and was stopped after 4 h. The obtained protein had a length of 785 amino 
acids, including a N-terminal 6xHis-tag, and was purified on Ni-NTA columns ( 3.2.23) 
concentrated and re-buffered ( 3.2.25). Determination of the 85 kDa AMP-ACP protein 
was possible by SDS-page gel electrophoresis ( 3.2.24). 
C          E         P         W          F          Z 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  4.28 SDS-Page electrophoresis gel picture of AMP-ACP protein. Purified (E) and concentrated (C) 
protein, protein ruler (P) for size estimation, wash fraction (W) and flow through fraction (F), were loaded onto a 
SDS-Page gel electrophoresis. As a reference for the insoluble fractions, the lysate of the cell pellet (Z) was 
applied. 
 
4.11.2  ATP exchange assay 
With the γ- 18O4-ATP pyrophosphate exchange assay the activity of the AMP domain 
towards various amino acids was determined ( 3.2.26). This method measures the 
isotopic back exchange of unlabeled py  p   p  te   t  γ–18O4-labeled ATP via 
MALDI-TOFMS (Phelan et al., 2009). The AMP-ACP protein showed activity for two 
tested substrates, namely cinnamic acid and hydrocinnamic acid, proving the 
85 kDa 
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functionality of the phn2-encoded AMP domain. The activity for cinnamic acid was 
significant, as an exchange of 47.4 % was measured. Hydrocinnamic acid showed 
only a third of this exchange activity (17.7%). For the other amino acids tested, no 
significant ATP/PPi exchange was detectable. The assay results are listed in table 
 4.27 and depicted in a diagram (figure  4.29). 
 
Figure  4.29 Relative activity of the AMP domain from Phn2, measured in an γ-
18
O4-ATP pyrophosphate 
exchange assay.  
Table  4.27  Results for the ATP/PPi exchange assay: Monoisotopic peak areas of ATP species were 
determined (506-536) for each substrate. Percent exchange was dete    ed by    p        f t e   t    f γ–
16
O4-
ATP (506) to the sum of all ATP species normalized with this modifier: % exchange = (100/0.833) x 
16
O/(
18
O + 
16
O). For the relative activity the exchange of cinnamic acid was set as 100%. 
Substrate 
Peak areas for ATP isotopes 
 506     508   510   512     514    528   530   532  534  536 
Exchange 
(%) 
Relative 
activity 
Phenylacetate 18 36 33 241 3368 11 46 24 28 463 0.5 1.1 
Phenylpyruvate 21 67 86 345 3772 8 20 27 38 456 0.5 1.1 
Phenyllactate 39 62 25 429 5454 13 37 32 29 322 0.7 1.5 
Hydro-
cinnamic acid 
1030 137 53 394 4457 111 63 48 84 603 17.7 37.4 
Cinnamic acid 2085 122 23 119 2334 228 49 54 75 189 47.4 100.0 
D-Phe 30 72 37 285 3503 25 47 23 61 468 0.8 1.7 
L-Phe 28 50 38 176 2595 16 29 6 16 240 1.1 2.2 
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5 Discussion 
Myxobacteria produce a wide range of structurally diverse compounds with unique 
modes of actions, and thus are an important source of novel secondary metabolites 
(Gerth et al., 2003). Most of these secondary metabolites that are synthesized by 
myxobacteria employ PKS and NRPS assembly lines or hybrids of both (Weissman 
and Müller, 2009). The understanding of the pathways leading to these unique 
myxobacterial compounds is of utmost interest, as the biosynthesis in these 
microorganisms deviates from those in other organisms and gives insight into new 
biochemical reactions. The identification of the corresponding biosynthetic gene 
clusters are facilitated by genome sequencing or screening of genomic libraries.  
The current study addressed the elucidation of the biosynthesis of phenylnannolone 
A from the myxobacterium Nannocystis pusilla B150, employing both strategies: 
genome sequencing and screening of a genomic library.  
5.1 Construction of the genomic library  
A genomic library is a set of clones that together represent the entire genome of an 
organism. Each clone of the library carries a DNA fragment from the desired 
organism. These libraries are used for the elucidation of biosynthetic gene clusters, 
the heterologous expression of the latter and for studies on the function of selected 
genes. 
The construction of a gene library of N. pusilla B150 turned out to be a real 
challenge. One of the major reasons, which made the fosmid library construction so 
difficult, was due to the delicate nature of the myxobacterial DNA. This could be 
observed during the DNA isolation step at the very beginning of the procedure. The 
latter turned out to be extremely tedious, as it resulted mostly in sheared, small DNA 
fragments. To obtain DNA fragments of around 36 kb, several adjustments were 
made to the DNA isolation procedure. The use of cut tips and decreased 
centrifugation speed finally led to less sheared DNA. The delicate character of this 
myxobacterial DNA was not only observed during the DNA isolation process, but also 
in several cloning and sequencing experiments. Myxobacteria are microorganisms 
with high GC-content in their DNA, which leads to secondary intramolecular 
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structures and hair-pin loops that resist denaturation (Bravo et al., 2010). However, 
this could not be the sole reason for the delicate nature of N. pusilla’s DNA, as 
handling other DNA from myxobacterial strains with high GC-contents was not as 
difficult as experienced in the current case. 
In addition to the DNA isolation, another factor, i.e. the ligation reaction, made the 
library construction difficult. In general, the blunt-end ligation of large fragments (~36 
kb) is quite sensitive and challenging, and ligation of these fragments to the fosmid 
vector DNA determines the success of gene library construction. Several factors may 
complicate or abolish this ligation reaction. Therefore, it is important to remove 
contaminants that inhibit the activity of the T4-DNA ligase. Salt residues resulting 
from DNA recovery from LMP-agarose or former enzyme reactions may interfere with 
the ligation reaction, as they change buffer conditions and hence abolish enzyme 
activity of the T4-DNA ligase. An incomplete end-repair reaction of the selected DNA 
fragments impedes ligation, as only blunt-end DNA fragments are ligated to the blunt-
ends of the fosmid vector. In this work the end-repair enzyme kit provided with the 
C pyC  t  l™ F    d L b   y P  du t    kit ( 3.1.2) was, after several unsuccessful 
trials, replaced by the Quick blunting kit from NEB ( 3.1.2). The benefit that this kit 
provided was the immediate use of the reaction mixtures after enzyme reaction and 
subsequent heat-inactivation for ligation. As each step of purification led to a loss of 
DNA quantity, the immediate use of processed DNA avoided further waste of DNA. 
The molar ratio of vector to template is another parameter for a successful ligation 
that must be strictly followed. 
Even if genome sequencing is getting easier and cheaper, the availability of genomic 
libraries is still important. They are necessary for physically obtaining biosynthetic 
gene clusters, which allows further investigations of the different biochemical steps 
involved in the biosynthesis of natural products.  
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5.2 Sequencing of DNA from N. pusilla B150  
During this project different sequencing strategies were employed to elucidate 
p e yl     l  e’  b   y t et    e e  lu te , such as fosmid sequencing and 
genome sequencing with Roche 454 or sequencing of PCR fragments with the aim to 
close gaps between contigs with the Sanger method.  
As already mentioned, handling the DNA of N. pusilla B150 was not an easy task. 
This was also observed during sequencing. A possible reason for this might be the 
high GC-content (70%) of this strain, which leads to intramolecular secondary 
structures and hair-pin loops hindering the polymerase, and hence stopping the chain 
elongation and sequencing reaction.  
 
Figure  5.1Seconary intramolecular structure (hair-pin loop) stops DNA-polymerase and hence sequencing 
High GC-content in DNA demands special sequencing conditions and chemical 
additives. Dimethyl sulfoxide (DMSO), glycerol, polyethylene glycol, formamide, 
betaine, 7-deaza-dGTP and dITP improve the amplification of GC-rich DNA 
sequences. A combination of betaine, DMSO and 7-deaza-dGTP showed best 
results in the prevention of intramolecular stable stem loops in GC-rich templates. 
Each additive acts differently: DMSO is believed to disrupt base pairing, betaine acts 
as an isostabilizing agent, whereas 7-deaza-dGTP is partially substituting dGTP and 
hence reduces the number of hydrogen bonds with complementary dCTP (Musso et 
al., 2006). 
In our laboratory PCR amplifications of GC-rich DNA were supplemented with 
DMSO, which helped to overcome the problem of intramolecular secondary 
structures and resulted in distinct bands of PCR fragments. High-throughput 
sequencing of cloned PCR fragments or partial sequencing (BIGrun) on fosmid DNA 
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(performed by GATC Biotech AG, Konstanz) mostly failed. Better results were 
obtained with customized cycling conditions and “special chemistry” used for 
sequencing (Eurofins MWG Operon, Ebersberg). T e  dd t ve  f   t e “ pe   l 
  e   t y”  e v  e p  v ded by Eurofins MWG Operon surely include some of the 
above mentioned compounds, but the exact composition remains unknown as every 
sequencing company keeps it as a well guarded secret. For next generation 
sequencing of the N. pusilla B150 genome and fosmid DNA on the Genome 
Sequencer (GS) FLX titanium (Roche/454), special kits for GC-rich DNA sequences 
also of unknown composition were applied for genome (Roche) and fosmid (IIT 
Biotech) sequencing. 
The de-novo-sequencing of N. pusilla’s genome yielded a 16.6 fold coverage. The 
very limited average size (3 kb) of contiguous DNA sequences (contigs) in the draft 
genome complicated genome mining for the phenylnannolone biosynthetic genes. 
Biosynthetic gene clusters of secondary metabolites usually exhibit sizes between 30 
and 80 kb. The high incidence of repetitive regions in PKS genes impedes the 
assembly of sequences encoding PKS domains. Hence contigs harboring genes that 
code for PKS domains were very short, in average 1-2 kb. Assembling these contigs 
to a coherent gene cluster was nearly impossible, as some sequences were falsely 
assembled and hence a lot of the sequence information necessary to build the PKS 
gene cluster was lost. Albeit genome sequencing could not be used for the 
identification of the phenylnannolone biosynthetic gene cluster, the sequence 
information of two contigs was used for a screening of the fosmid library. The 
screening resulted in two fosmid clones, one harboring a NRPS/PKS gene (21H12) 
and the other encoding the putative biosynthetic genes for the formation of 
phenylnannolone A (12A9).  
The obtained 16.6 fold coverage of the N. pusilla B150 genome reflects a quite low 
coverage of a de-novo sequencing. Higher coverage might help to achieve better 
results for the data assembly and hence longer contiguous DNA. Genome coverages 
of 20-25x are generally preferred for the use of next generation sequencing devices. 
Indeed for our 454 sequence data from fosmid sequencing a better assembly was 
achieved. This resulted in one contig for fosmid 12A9 and two contigs for fosmid 
21H12. The higher coverage of the fosmid DNA sequences (i.e. 29.3x and 19.4x) is 
the major reason for the improved results.  
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Comparing the different sequencing approaches during the current project, a high 
coverage and special additives (of unknown composition) are the main factors for 
success. Sequencing GC-rich DNA is still challenging and for some strains genome 
sequencing can hardly be accomplished, not even with the new techniques 
developed for sequencing (personal communication, Dr. Christian Rückert, CeBiTec, 
Uni Bielefeld). 
5.3 The biosynthetic gene cluster for the phenylnannolones  
The putative phenylnannolone gene cluster with an approximate size of 24 kb was 
identified on fosmid clone 12A9. It comprises a putative carboxyl-transferase gene 
(phn1) and a modular type I PKS gene (phn2), putatively responsible for the 
formation of phenylnannolone A.  
The carboxyl-transferase encoded by phn1 is probably responsible for the precursor 
supply, further discussed in section  5.3.1. The adjacent PKS enzyme comprises 5 
modules, i.e. a loading module and 4 extension modules. From the domain order of 
the PKS encoded by phn2 the following biosynthetic pathway is proposed for the 
formation of phenylnannolone A (figure  5.2). The loading module comprises an AMP-
dependent ligase and synthetase (AMP) that adenylates the putative starter cinnamic 
acid ( 5.3.2) and hence enables the loading to the adjacent acyl carrier protein 
(ACPLM) domain. In the following step the ketosynthase (KS1) of the first extension 
module prolongs the starter unit with a butyrate moiety ( 5.3.3) in a decarboxylative 
Claisen condensation, which is followed by reduction and dehydration, caused by the 
corresponding ketoreductase (KR1) and dehydratase (DH1) domains, forming a trans-
configurated C-C double bond. In the second elongation step (module 2) the growing 
chain is extended by an acetate unit, which is reduced and dehydrated in the same 
manner as in the step before. The third elongation module is once again responsible 
for the extension of the polyketide with an acetate, with the difference that the ß-keto 
group of the thioester remains and is not further reduced. This is important for the 
lactone ring formation, discussed in section  5.3.5. The extender unit of the last step is 
again malonyl-CoA, prolonging the polyketide chain with a final acetate unit. The 
corresponding KR reduces the ß-keto group to an L-hydroxyl-group, that is then 
dehydrated by DH4, forming a cis-double bond. The so generated stereochemistry is 
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necessary forl lactone ring formation and thereby for the release of the polyketide 
from the assembly line through the thioesterase domain ( 5.3.5). 
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Figure  5.2  Hypothetical pathway for the biosynthesis of phenylnannolone A: BCC=butyryl-CoA carboxylase 
AMP=AMP-dependent ligase, ACP=acyl carrier protein, KS=ketosynthase domain, AT=acyltransferase domain, 
DH=dehydratase domain, KR=ketoreductase domain, TE=thioesterase domain 
5.3.1 Precursor supply - ethylmalonyl-CoA formation  
In contrast to polyketide starter units, which comprise a wide variety of structures, 
extender units are much less chemically diverse (Wilson and Moore, 2012). Most 
common PKS extender units are malonyl-CoA and methylmalonyl-CoA, derived from 
fatty acid metabolism and other primary metabolism pathways (Quade et al., 2011). 
PKS extender units such as methoxymalonyl-CoA, hydroxymalonyl-CoA and 
ethylmalonyl-CoA are less common in polyketide biosynthesis. The supply with 
specific precursors, e.g. ethylmalonyl-CoA, is a limiting factor in polyketide 
biosynthesis, as their availability is not comparable to that of the common malonyl-
CoA or methylmalonyl-CoA.  
loading 
module 
module 1 
module 2 module 4 
module 3 
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Figure  5.3 Polyketides with an ethyl-side chain built by modular PKS (ethy-side chains are framed). 
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For the biosynthesis of ethyl-substituted natural products the supply of the PKS 
extender unit ethylmalonyl-CoA is crucial. The fact that ethylmalonyl-CoA can be 
derived from crotonyl-CoA through the action of the enzyme crotonyl-CoA 
carboxylase/reductase (CCR), was described for Rhodobacter sphaeroides by Erb et 
al. in 2007. These authors also defined later the complete CCR containing 
ethylmalonyl-CoA pathway, which is only represented in 5% (57 species) of the fully 
sequenced bacteria (1215 species) (Erb et al., 2009). As only few bacteria contain an 
operating ethylmalonyl-CoA pathway, most biosynthetic gene clusters of 
ethylsubstituted polyketides, harbor a gene encoding a CCR homolog. The 
associated CCR supplies the PKS with ethylmalonyl-CoA or even longer chained 
acyl-CoA, such as hexylmalonyl-CoA, for the biosynthesis of the respective natural 
product. It is thought that these enzymes are capable to form dicarboxylic acids with 
any side chain from a respective unsaturated fatty acid precursor (enoyl-CoA). 
Analysis of the crystal structure of CinF, a CCR homolog responsible for the supply 
with hexylmalonyl-CoA in cinnabaramide biosynthesis, revealed two positions in the 
binding pocket that determine substrate specificity. Thus mutations in these active 
site residues may lead to a variety of PKS extender units (Quade et al., 2012).  
Besides the mentioned CCR pathway, there are also other pathways proposed for 
the formation of ethylmalonyl-CoA. They require the carboxylation of butyryl-CoA to 
ethylmalonyl-CoA, in which butyryl-CoA may be derived either from L-valine that is 
catabolized to isobutyryl-CoA and then converted to butyryl-CoA or from the ß-
oxidation of even-chain fatty acids (Vrijbloed et al., 1999, Chan et al., 2009). For both 
pathways acyl-CoA carboxylases are possible enzymes for the carboxylation 
reaction.  
Discussion 
 
123 
 
CCR
crotonyl-CoA
L-valine
keto-isobutyrate
isobutyryl-CoA
ICM
ß-oxidation of even-chain fatty acids
PCC / BCC
butyryl-CoA
(2S)-ethylmalonyl-CoA
O
O-
O
S-CoA
O
O
S-CoA
O
-O
O
S-CoA
O
S-CoA
O-
O
NH3+
-CO2
transaminase
alpha-keto acid 
dehydrogenase
 
Figure  5.4 Biosynthetic pathways leading to the formation of ethylmalonyl-CoA (adapted from Chan et al., 
2009); CCR=crotonyl-CoA reductase/dehydrogenase, PCC=propionyl-CoA carboxylase, BCC=butyryl-CoA 
carboxylase, ICM=isobutyryl-CoA mutase 
Carboxyl transferases such as the acyl-CoA carboxylases (ACCs) are known to 
carboxylate acetyl-, propionyl- or butyryl-CoA to malonyl-, methylmalonyl or 
ethylmalonyl-CoA. Acetyl-CoA carboxylases (AcCCs) are carboxyl transferases that 
accept besides acetyl-CoA also propionyl-CoA and butyryl-CoA as substrates. The 
active site residue in ACC is an isoleucine in position 422. Propionyl-CoA 
carboxylases (PCC) are known to accept propionyl-CoA, and with a lower affinity also 
butyryl-CoA, but not acetyl-CoA (Diacovich et al., 2004). Butyryl-CoA as a substrate 
is favored in PCC, when a mutation transforms the active site residue aspartate 
Discussion 
 
124 
 
(D422) into alanine or cysteine. This leads to changes in the binding pocket and 
directs the substrate specificity towards butyryl-CoA (Arabolaza et al., 2010).  
As mentioned before, most biosynthetic gene clusters of ethyl-substituted polyketides 
are associated with CCRs, like concanamycin, oligomycin, tylosin and several others 
(figure  5.3, table  5.1). 
Table  5.1 Biosynthetic gene clusters of ethylsubstituted natural compounds that harbor crotonyl-CoA 
reductases (CCRs) and acyl-CoA carboxylases (ACCs) for supply with ethylmalonyl-CoA 
Natural compound CCR ACC 
Elaiophylin +  
Tylosin +  
Spiramycin +  
Concanamycin +  
Indanomycin + + 
Tautomycetin +  
Midecamycin +  
Rosaramicin +  
Phoslactomycin A +  
Oligomycin +  
Tiacumicin B + + 
Lasalocid A  +  
Kirromycin +  
Ascomycin (FK520) +  
Sangifehrin +  
Divergolides  +  
Monensin A +  
The recently elucidated biosynthetic gene clusters of indanomycin and tiacumicin 
were found to harbor both types of enzymes, i.e. the CCR and the ACC. In the case 
of indanomycin Kelly and colleagues discussed an acyl-CoA carboxylase (IdmB) to 
be responsible for the supply of both, ethylmalonyl-CoA and methylmalonyl-CoA. 
This carboxyl-transferase harbors an isoleucine at position 422, instead of the 
conserved aspartate, which changes the specificity of the binding pocket of IdmB. 
Thus, they postulated IdmB to accept substrates such as acetyl-CoA, propionyl-CoA 
and butyryl-CoA with an almost equal affinity, just like acetyl-CoA carboxylases (Li et 
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al., 2009). For the precursor supply in tiacumicin B biosynthesis three genes were 
identified to encode for enzymes of the ethylmalonyl-CoA pathway: a hydroxybutyryl-
CoA dehydrogenase (TiaJ), a crotonyl-CoA hydratase (TiaN) and a crotonyl-CoA 
carboxylase (TiaK). Beside these three enzymes that form ethylmalonyl-CoA, another 
enzyme, a PCC encoded by tiaL, is believed to supply the PKS with methylmalonyl-
CoA (Xiao et al., 2010). Multiple sequence alignment (figure  4.6) with sequences of 
different PCCs revealed the active site residue for TiaL to be an isoleucine. Thus the 
affinity of this PCC is suggested to be comparable to the one of IdmB. This 
conclusion is supported by crystal structure and mutational analysis of the ß-subunit 
of a PCC from S. coelicolor, which revealed similar kinetic parameters for ACC and 
PCCI422D mutants (Diacovich et al., 2004, Arabolaza et al., 2010). 
As for the biosynthesis of phenylnannolone A the supply with ethylmalonyl-CoA 
putatively results from Phn1, a protein with an identity of 70% to a putative ß-subunit 
of a propionyl-CoA carboxylase from Plesiocystis pacifica SIR-1. Acyl-CoA 
carboxylases in actinomycetes consist of two polypeptides: an α and β-subunit. The 
α subunit harbors the biotin-carboxylase (BC) and biotin-carboxylase-carrier protein 
(BCCP) domain, whereas the β-subunit acts as a carboxyl-transferase (Diacovich et 
al., 2004). The ACC from S. antibioticus (IdmB) also displays only the ß-subunit of an 
acyl-CoA carboxylase. Li et al. mentioned that the formation of an active complex 
may be possible with partnering BC and BCCP, encoded elsewhere within the 
genome of the respective strain (Li et al., 2009). 
O
O
O
O
Phenylnannolone A Phenylnannolone B
 0.4 mg/L2.8mg/L  
Figure  5.5 Structures of Phenylnannolone A and B. The concentration of the produced amount of natural 
products in the culture broth is given. 
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The active site residue of Phn1 comprises an alanine instead of the conserved 
aspartate. Mutational experiments for a PCC in S. coelicolor showed that mutations 
of this type led to a clear shift in substrate preference from propionyl-CoA to butyryl-
CoA. The kinetic parameters for the mutant PCCA422D showed a 2.3 fold higher 
substrate specificity towards butyryl-CoA as compared to propionyl-CoA (Diacovich 
et al., 2004, Arabolaza et al., 2010). Thus, Phn1 is more likely a buytryl-CoA 
carboxylase (BCC) than a PCC, and hence provides preferentially ethylmalonyl-CoA 
for the PKS assembly line. This is also corroborated by the ratio of in vivo produced 
amounts of phenylnannolone A (2.8 mg/ l) and phenylnannolone B (0.4 mg/ l), 
showing a 7x higher prevalence for ethylmalonyl-CoA than methylmalonyl-CoA 
(Ohlendorf et al., 2008). Phn1 is to our knowledge the first BCC found in a 
biosynthetic gene cluster for an ethylsubstituted natural compound. 
5.3.2 AMP-ligase activating cinnamic acid (starter unit) 
The PKS assembly line encoded on phn2 starts with a loading module, a didomain 
that comprises an AMP-ligase and an acyl carrier protein. AMP-ligases belong to the 
same class of enzymes as adenylation (A) domains, called the AMP binding 
enzymes. Both act in the same way, i.e. they adenylate their substrates, which 
enables the loading onto PKS or NRPS assembly lines. 
Previous feeding experiments (Ohlendorf, 2008) with labeled building blocks showed 
that eight carbon atoms from phenylalanine, i.e. a C6C2 (phenylethyl) unit, was 
incorporated into the structure of phenylnannolone A, whereas the carbonyl-C atom 
(C1) of phenylalanine was not retrieved in the labeled molecule.  
To investigate the substrate selectivity of the AMP-ligase heterlogous expression of 
the recombinant protein and subsequent performance of an ATP-PPi exchange 
assay (Phelan et al., 2009) were necessary. For the latter several phenylpropanoids 
(C6C3) were tested as well as phenylacetate (C6C2) and some amino acids. The 
selectivity for cinnamic acid was striking, as an exchange of 47% was measured. 
Hydrocinnamic acid showed only a third of this exchange activity (17.7%). All the 
other measured substrates did not reach more than 1.1% exchange activity, hence 
the selectivity for the AMP-ligase in Phn2 is significantly pointing towards cinnamic 
acid. This outcome supports the hypothesis for phenylnannolone A biosynthesis 
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(figure  5.2) that can be postulated from the domain order of the PKS assembly line 
  d t e   le ule’   t u tu e.  
 
Figure  5.6 Activation of cinnamic acid by the AMP-ligase and loading onto the ACP domain 
As far as we can conclude from the results of the ATP-PPi exchange assay on the 
apo-enzyme, cinnamic acid is adenylated by the AMP-ligase and subsequently 
loaded to the the neighboring ACP domain (figure  5.6). Imitating the in vivo 
conditions, where the activated holo-enzyme loads its substrate and is subsequently 
analyzed with mass spectrometry, would give more clarity regarding the starter unit. 
For this purpose, the purified apo-AMP-ACP didomain has to be incubated with an 
ACP transferase or with a phosphopantetheinyl transferase to form the holo-form. 
When a mixture of substrates is then offered to this holo-enzyme, the favored 
substrate should then be bound to the pantetheine arm. A subsequent trypsin digest 
should then enable the characterization of the ACP active site via MALDI-TOF, as it 
was described for the didomain from the NRPS/PKS system forming microcystin 
(Hicks et al., 2006).  
Regarding the feeding experiments reported by Ohlendorf et al. however, there are 
still some open questions to be answered. Similar results for feeding experiments 
were observed in the cyanobacterium Microcystis aeruginosa, where phenylalanine 
was incorporated in the same manner into microcystin. The incorporation of the C6C2 
unit gave rise to the hypothesis that phenylacetate might be the correct starter unit. 
This hypothesis could be dismissed as feeding experiments with labeled 
phenylacetate failed for microcystin. This was also the case for phenylnannolone A 
(Ohlendorf, 2008, Hicks et al., 2006). Same applies to the starter units in nodularin 
and cryptophycin biosynthesis, both isolated from cyanobacteria (Rinehart et al., 
1994; Moffitt and Neilan, 2004; Magarvey et al., 2006) (figure  5.7).  
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Figure  5.7 Natural compounds believed to initate biosynthesis with a phenylalanine-derived C6C2 starter 
unit (C6C2 unit is framed)  
Biochemical characterization of an A-PCP didomain from McyG, a NRPS/PKS 
system involved in microcystin biosynthesis, revealed that several phenylpropanoids 
(C6C3) are preferentially activated and loaded onto the PCP domain, and not the 
estimated phenylacetate (C6C2). Interestingly the result of the ATP-PPi exchange 
assay for the apo MycG A-PCP didomain did not coincide with the loading 
experiments of the in vitro and in vivo generated holo- A-PCP. To analyze substrate 
loading onto the PCP of the didomain Hicks and co-workers generated the holo A-
PCP didomain in vitro by adding the PPTase Sfp from Bacillus subtilis or co-
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expressed the didomain with the Svp PPTAse protein from Streptomyces verticillus to 
obtain the in vivo generated holo form. The ATP-PPi exchange assay with the apo-
didomain revealed trans-cinnamic acid as a putative substrate, whereas the in vitro 
generated holo A-PCP seemed to load substrates such as phenyllactate, 
hydrocinnamate and D-phenylalanine likewise. However, the results of the in vivo 
loading experiments pointed towards 3-phenyllactate, which is considered to be the 
true starter unit. The latter result was achieved by changing the Terrific Broth (TB) 
fermentation medium with a glucose-defined medium, as Hicks and co-workers 
suspected the hydrocinnamic acid to be derived from the TB medium (Hicks et al., 
2006). Even though these results are to some extent inconsistent, it seems clear that 
initially a C6C3 unit is employed as a starter. 
*
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Figure  5.8 Carbon truncation of the C6-C3 starter unit, proposed for microcystin and cryptophycin 
biosynthesis: The mechanism for this reaction remains unclear according to Hicks et al., 2006 (asterisk marks 
C-2 of phenylalanine) 
A remaining mystery is the mechanistic basis for an unprecedented one-carbon 
truncation within the biosynthesis of cryptophycin, microcystin and nodularin. If the 
phenylpropanoid is chain extended with malonyl‑CoA by the PKS machinery, then 
the phenylalanine-derived carboxyl carbon would need to be excised, resulting in the 
cleavage of two C–C bonds and the formation of a new C–C bond (Hicks et al., 2006; 
Magarvey et al., 2006) (figure  5.8). In contrast to these cyanobacterial secondary 
metabolites, the phenylalanine derived-carboxyl carbon should not only be cleaved, 
but after the extension with an acetate only a single carbon atom (C-2) should 
remain, to explain the results of former feeding studies. This requires then a cleavage 
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of two carbon atoms, the carbonyl-atom from the C6C3 starter unit and the carbonyl-
thioester (C-1). 
From the domain order of the PKS encoded by phn2 and the   le ule’   t u ture the 
starter unit should be a cinnamic acid that is then elongated in four steps. The 
biosynthetic origin of cinnamic acid in bacteria as myxobacteria and cyanobacteria is 
reported to be a phenylalanine ammonia lyase (PAL). In a single reaction the PAL 
reduces phenylalanine to trans-cinnamic acid, while every carbon atom is preserved 
and no carbon cleavage takes place. However, this does not explain the unusual 
results of feeding experiments, where a single carbon atom derived from acetate is 
incorporated. As the feeding experiments were only carried out once, feeding with 
labeled precursor should be repeated, considering also cinnamic acid as a putative 
precursor. 
The Stachelhaus code of the A domains, involved in nodularin (NdaC), microcystin 
(McyG) and cryptophycin (CrpA) biosynthesis, all with nearly identical signatures, 
was compared with the AMP-ligase of Phn2, put t vely   v lved    p e yl     l  e’  
biosynthesis. The comparision showed no similarities between the AMP-ligase from 
Phn2 and the A domains of NdaC, CrpA or McyG. This supports the hypothesis that 
the starter units for nodularin, microcystin and cryptophycin biosynthesis are the 
same, but different from the one of phenylnannolone (table  5.2).  
Table  5.2 Stachelhaus code of A domains activating phenylalanine-derived starter units 
Protein  Stachelhaus code Natural compound Expected starter unit * 
NdaC L W V A A S G K Nodularin Phenylacetate 
McyG L W V A A S G Microcystin Phenylacetate 
CrpA L W V A A S G Cryptophycin Phenylacetate 
Phn2 D L V G F G C G M Phenylnannolone Cinnamic acid 
       *: from domain order and molecule structure 
This outcome corroborates that the AMP-ligase in Phn2 activates a different starter 
unit, than those activated by the A domains of the cyanobacterial compounds and 
might not share the mysterious mechanism for carbon truncation, postulated for 
cyanobacteria. 
In type III PKS of plants and bacteria cinnamoyl-CoA is a quite common starter unit 
for stilbenes, curcumin and flavonoid biosynthesis (Dewick, p.109, Hertweck, 2009). 
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For the modular type I PKS however, it was not yet described to be involved in the 
PKS assembly line. 
5.3.3 AT1 domain loading ethylmalonyl-CoA 
Acyltransferases (AT) in type I modular PKS extender units recognize, and load 
specific substrates onto the corresponding acyl carrier proteins (ACP). Each AT 
shows a high selecitivity towards its desired substrate, which is based on the 
p  te  ’   eque  e   d  t u tu e. I   e e  l  exte de  u  t       l  yl-CoA and 
methylmalonyl-CoA are used for chain elongation. The motifs in ATs specific for 
malonyl-CoA and methylmalonyl-CoA are quite well known, as they were intensely 
investigated and a large number of sequence data for those ATs is available (Yadav 
et al., 2003). Albeit distinguishing between a malonyl (m) - and methylmalonyl-CoA 
(mm) specific AT on the molecular level is relatively reliable, there are always 
exceptions to the rule. However, there are less differences between methylmalonyl-
CoA and ethylmalonyl-CoA (em) specific ATs; hence distinction between these two 
types of ATs is rather difficult. 
T  ee   t f    e de    bed t  dete    e  ub t  te  pe  f   ty    AT : T e ‘RDVVQ’ 
motif, the GHSXG motif and the YASH motif. The first and the second motif are 
nearly identical and thus not useful for the discrimination between mmATs and 
emAT. For the third motif (YASH) there are some slight variations between mmATs 
and emATs. The serine in the YASH motif is highly conserved in mmATs, in some 
emATs it is also present but often replaced by some other small amino acid, i.e. 
glycine, threonine and alanine (see figure  4.14). In the case of AT1, this amino acid is 
a threonine, just as in emATs from oligomycin and ascomycin biosynthesis. The 
tyrosine (Y) in this motif is also indicative for a mmAT, which is required for the 
formation of a hydrophobic pocket that is important for the binding of methylmalonyl-
CoA. In some cases this residue is altered and replaced by a valine or tryptophan 
(Yadav et al., 2003, Smith and Tsai, 2007). Multiple sequence alignments revealed 
for emATs at this position amino acids such as valine, cysteine, threonine or 
isoleucine (see figure  4.14). 
Multiple sequence alignment with malonyl-, methylmalonyl- and ethylmalonyl-CoA 
specific ATs showed that mATs and mmATs are clearly divided into different clusters 
in phylogenetic trees. But ATs specific for ethylmalonyl-CoA and methoxymalonyl-
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CoA are in the same cluster of mmATs, therefore a clear distinguishing between 
these three types of ATs is not possible (Minowa et al., 2007). Phylogenetic analysis 
of three types of ATs (mAT, mmAt and emAT)   t  t   e f    p e yl     l  e’  
gene cluster showed that AT2, AT3 and AT4 cluster with those specific for malonyl-
CoA, whereas AT1 clusters with ATs specific for methylmalonyl-CoA as well with 
those specific for ethylmalonyl-CoA. 
Computational analysis of the AT domains from Phn2 with AntiSMASH, using two 
different methods for substrate prediction, yielded contradictory results. The forecast 
  t  Y d v’   et  d p   t     the direction of methoxymalonyl-CoA, whereas 
      ’   et  d p ed  ted either methylmalonyl-CoA (score: 175.2) or ethylmalonyl-
CoA (score: 173.9) as possible substrate (figure  8.3). Yadav and co-workers used 13 
diagnostic amino acids and 11 conserved residues, extracted from multiple sequence 
alignments, for computational prediction of substrate specificity (Yadav et al., 2003). 
Minowa and collaborators used homology search with Hidden Markov Model (HMM) 
profiles, which is a more sensitive method then BLAST used by Yadav and co-
workers (Thesis Zucko, 2010). 
Summarizing the above, the methods available for substrate prediction could not 
clearly distinguish, whether the AT1 domain in Phn2 has prevalence for 
methylmalonyl-CoA or ethylmalonyl-CoA. But the analysis of the YASH motif of AT1 
described above and in section  4.8.3.4, suggests it to be responsible for the loading 
of ethylmalonyl-CoA to the corresponding ACP. This is supported by the feeding 
experiments with 1-13C-butyrate, which was incorporated in phenylnannolone A 
forming the ethylside chain (Ohlendorf et al., 2008).  
Furthermore, substrate prevalence for ethylmalonyl-CoA is corroborated by the 
production rate of the different phenylnannolone derivatives. A 7x higher production 
rate was observed for the ethyl-branched phenylnannolone A than for the methyl-
branched phenylnannolone B (Ohlendorf et al., 2008).This might not only result from 
the higher specificity of the AT towards ethylmalonyl-CoA, but also, as discussed in 
section  5.3.1, result from a higher supply of the precursor ethylmalonyl-CoA.  
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5.3.4 Stereochemistry of double bonds 
Ketoreductase (KR) domains catalyze the stereospecific reduction of the ß-keto 
function to a ß-hydroxyl group. Subsequent to this NADPH dependent reduction, 
water elimination is initated by a dehydratase domain (DH) that forms the C-C double 
bond. The classification of KRs is depending on the resulting stereochemistry. An A-
type KR generates L-hydroxyl-groups, whereas B-type KRs introduce a D-hydroxyl 
group (Keatinge-Clay, 2007, Caffrey, 2003). Some KR domains in extension modules 
with propionate extender units are able to epimerize the α-carbon during polyketide 
synthesis. These domains that introduce a stereochemical change of the 
methylgroup (α-substituent)   e de  ted   t    ‘2’ (A2 and B2). Whereas KRs, which 
perform a reduction on an unepimerized D-α-substituent, are de  ted   t    ‘1’ (A1 
and B1).  
 
Figure  5.9 Stereochemistry of ketoreduction and double-bond formation 
α 
β 
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A t   d    up  f  R    e  l    f ed    ‘C-type’   d  ep e e t t e  edu t  e-
incompetent d       p e e t       e   dul   P S.  R  de  ted    ‘C1-type’      
no reduction and no epimerization and are only mentioned for the sake of 
   plete e  . T e    e ‘C2-type’  R     eve     e  ble t  ep e  ze D-α-
substituents and act as racemases (Zheng et al., 2011). In general most of the KRs 
in PKS gene clusters are  f ‘ 1-type’. Therefore, most of the double bonds in 
polyketides are trans configurated. Cis-configured double bonds are rather rare in 
polyketides. Such Z double bonds are present in pikromycin, chivosazol, disorazole 
and etnangien (figure  5.10) (Kittendorf and Sherman, 2009; Perlova et al., 2006; 
Elnakady et al., 2004; Carvalho et al., 2005; Menche et al., 2008). 
The KR domains of the phenylnannolone A gene cluster were characterized by 
several conserved motifs that allowed  te e   e    l p ed  t    (‘A-’    ‘ -type’)  f 
the resulting hydroxyl bearing carbon atom. KR1 and KR2 were identified as B1-type 
ketoreductase domains. Such a B1-type KR domain results an D-hydroxyl-substituted 
thioester; a neighboring DH domain may then form in a syn dehydration a trans 
double bond. However, KR4 lacks the LDD motif, present in KR1 and KR2 that is found 
i  ‘ -type’  R . Although tryptophan is present in nearly all A-type KRs, there are a 
few examples of KR domains that generate L-hydroxyl-groups despite the missing 
tryptophan-motif. Such domains are found in stigmatellin, chivosazol and disorazol 
biosynthesis (Gaitatzis et al., 2002; Perlova et al., 2006; Carvalho et al., 2005). 
He  e  eve   f t e ‘A-type’       te   t   t ypt p    (W)      t p e e t     R4 and is 
replaced by an isoleucine, it is still likely that this domain reduces the ß-hydroxyl 
   up       ‘A-type’-style and results a cis double bond after dehydration. KR4 from 
Phn2 showed in a BLAST analysis (table  4.14) the highest identity to a KR from StiD, 
involved in stigmatellin biosynthesis in Stigmatella aurantiaca. This KR from StiD 
converts the ß-keto group to an L-hydroxyl-group, which is subsequently methylated 
via a methyltransferase (Gaitatzis et al., 1999). Multiple sequence alignment (figure 
 4.15) could show that the tryptophan-motif is replaced by   et      e    St D’   R.  
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In chivosazol biosynthesis KR4 and KR14 are classified as A-type KRs which 
catalyte the formation of cis-double bonds. Both KRs lack the tryptophan-motif, which 
is replaced by leucine and valine, respectively. 
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Figure  5.10 Natural compounds with cis-double bonds or L-methoxy-group derived from A-type KRs: 
Disorazole A and chivosazol A from Sorangium cellulosum and stigmatellin A from Stigamtella aurantiaca; cis 
double bonds and the L-methoxy group are circled. 
Perlova and co-workers characterized the KRs in 2001 with a simpler method, where 
the presence or absence of the last aspartate in the LDD-motif was used for 
distinction between A-type and B-type KRs. A third KR, KR11, was due to the 
presence of the key aspartatic acid in position 151 predicted to be of B-type, but is 
b  ed    t e   le ule’   t u tu e supposed to produce an L-hydroxyl- moiety. Albeit 
structural and functional analysis for ketoreductases was until then not available, they 
mentioned that the diagnostic aspartate residue might not always define the direction 
of reduction (Perlova et al., 2006). A multiple sequence alignment of KRs from gene 
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clusters of chivosazol, disorazole and phenylnannolone A (data not shown) revealed 
for this domain (KR11) the characteristic A-type tryptophan-motif. 
A third example for A-type KRs lacking the tryptophan-motif is found in the disorazole 
gene cluster, where the tryptophan is replaced in KR4, KR5 and KR7 each by valine, 
methionine and leucine. If we appreciate all these examples of A-type KRs without 
tryptophan-motifs, it is very likely that KR4 in Phn2 generates an L-hydroxyl-group, 
which is further reduced by DH4 to a cis-double bond. To support this assertion the 
functional proof via heterologous expression of this domain and subsequent enzyme 
assay is necessary. Summarizing the above, it can be said that, most of the KRs can 
be annotated with the described classification system (table  4.13) but some 
exceptions are known.  
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5.3.5 Lactone ring formation through TE 
Thioesterase domains in PKS release the polyketide chain from the PKS 
multienzyme either by hydrolysis (intermolecular release) or cyclization 
(intramolecular release). For lactonization a hydroxyl group of the polyketide chain 
acts as an internal nucleophile that attacks the carbonyl carbon of acyl-O-TE (Du and 
Lou, 2009). Structure elucidation of phenylnannolone A revealed a terminal pyrone 
ring. For the formation of this pyrone ring keto-enol tautomerism of the unreduced 
carbonyl group (module 3) is expected, resulting in an enol functionality. The so 
formed hydroxyl group acts therefore as a nucleophile, which forms together with the 
carbonyl carbon of the thioester the lactone ring (figure  5.11).  
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Figure  5.11 Proposed pyrone ring formation for phenylnannolone A by TE domain 
A TE-induced pyrone ring formation is somehow uncommon for modular type I PKS. 
In literature triketide lactonization is studied for DEBS 1-TE, a truncated form of the 
erythromycin polyketide synthase (Bycroft et al., 2001, Moffet et al., 2006). Although 
TE-induced pyrone lactonization is not reported for modular type I PKS, there exists 
one example for pyrane formation in type I PKS, the jerangolid biosynthesis (figure 
 5.12), following the same mechanism as the one proposed for phenylnannolone A 
(Julien et al., 2006). 
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Figure  5.12 Hypothetical scheme for completion of jerangolid biosynthesis (figure origin: Julien et al., 2006) 
 
From the results obtained, we conclude that the biosynthesis of phenylnannolone A 
in N. pusilla B150 involves a PKS and not a NRPS/PKS system. The bioinformatical 
analysis of the biosynthetic genes phn1 and phn2 showed that the domain order of 
the identified gene cluster is consistent with the putative biosynthesis that we 
postulated for phenylnannolone A. Biochemical studies on the loading module of the 
putative phenylnannolone gene cluster were performed, and indicate cinnamic acid 
to be the starter unit for phenylnannolone A biosynthesis. Further investigations on 
the formation of the precursor ethylmalonyl-CoA including heterologous expression of 
the putative butyryl-CoA carboxylase (BCC), would corroborate our findings and 
would represent the first BCC in a microbial biosynthetic gene cluster. 
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5.4 A mixed NRPS/PKS biosynthetic gene cluster 
Looking for the putative biosynthetic gene cluster of phenylnannolone A, a small 
NRPS/PKS gene (sb1) was identified on fosmid 21H12. The gene sb1 covers 10 kb 
sequence information. The corresponding gene product consists of 3 modules: The 
first two modules belong to the NRPS part, whereas the third module forms the PKS 
part. From the domain structure and rule of colinearity a putative biosynthetic 
pathway and a corresponding metabolite are proposed. The first module is comprised 
of a condensation (C), adenylation (A) and a peptidyl carrier protein (PCP). This is 
somehow unusual as loading modules in NRPS usually consist only of an A domain 
with an adjacent PCP. Sequence alignment revealed this C1 domain to be inactive, 
as it lacks the conserved histidine. Computational analysis on substrate specificity of 
the A domain from the loading module revealed proline as a possible starter unit. The 
adenylated proline is thus expected to be initially loaded to the neighborring PCP 
domain. In the second module the A domain activates possibly a phenylalanine unit 
that will be attached to the pantetheine arm of the adjacent PCP. The C2 domain then 
would form a peptide bond between the proline and phenylalanine. The peptide chain 
is elongated with an acetate or a propionate unit by the KS from the PKS module in 
the last step. The TE domain in the PKS module terminates chain elongation and 
releases the chain by cyclization from the multienzyme.  
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Figure  5.13 NRPS/PKS assembly line encoded by sb1 with proposal for a corresponding structure 
S/T=serine/threonine kinase, C=condensation domain, A= adenylation domain, PCP=peptidyl carrier protein 
domain, KS= ketosynthase, AT=acyltransferase, TE=thioesterase, GST=glutathione S-transferase, 
TetR=transcriptional regulator TetR, PK=protein kinase, CYP=cytochrome P450, hypo.=hypothetical protein 
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Post-modifications by the neighboring CYP 450 are possible, and may lead to 
another structure than the one proposed in figure 5.13. The other surrounding 
enzymes, such as the the transcriptional regulator TetR and the serine/threonine 
kinase (S/T) are usually present in biosynthetic gene clusters and are responsible for 
the transcriptional control of the biosynthetic pathway and signal transduction. They 
are usually located on the borders of biosynthetic gene clusters. 
This small NRPS/PKS gene demonstrates the other way for the identification of a 
biosynthetic gene cluster, where genes are identified by bioinformatical analysis of 
genome sequences. From the bioinformatical analysis structure predictions for 
modular assembly lines are possible, following the rule of colinearity, but not always 
match the later identified structures. This approach, where the genomes of 
microorganisms are screened for biosynthetic genes with the aim to identify novel 
 e   d  y  et b l te       lled “ e           ”. 
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6 Summary 
Myxobacteria are gliding microorganisms known for their unique biosynthetic 
capabilities. Nannocystis pusilla B150 is a myxobacterial strain that produces a new 
group of natural products, named phenylnannolones. Phenylnannolone A shows 
inhibitory activity towards the ABCB1 gene product p-glycoprotein and reverses 
daunorubicin resistance in cultured cancer cells. Previous feeding experiments with 
13C-labeled precursors showed the incorporation of acetate and butyrate, but also of 
phenylalanine into phenylnannolone A (Ohlendorf et al., 2008). Thus, a mixed non-
ribosomal peptide synthetase/polyketide synthase (NRPS/PKS) system or a 
polyketide synthase (PKS) was suggested to be responsible for the biosynthesis of 
this natural product. 
The aim of this research project was to elucidate the genetic information encoding 
the biosynthetic enzymes responsible for phenylnannolone A formation. 454 
sequencing of the N. pusilla B150 genome proved to be extremely difficult due to the 
GC-rich myxobacterial DNA. 3804 contigs were obtained, but were too small to 
delineate the complete biosynthetic gene cluster for phenylnannolone A. Therefore, a 
genomic library of N. pusilla B150 was constructed and screened with suitable primer 
pairs, deduced from sequences of the 454 assembly.  
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Phenylnannolone A
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Figure  6.1 Molecular structure of phenylnannolone A with biosynthetic building blocks (in bold). Feeding 
experiments in N. pusilla B150 with 
13
C-labeled building blocks showed incorporation of a phenylalanine derived 
starter unit, one butyrate and three acetate building blocks. Unprecedented and unusual is the incorporation of a 
C-2 of acetate in position 9 
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Fosmid sequencing revealed a PKS gene cluster (24 kb), whose domain order is 
consistent with the putative biosynthesis that we postulated for phenylnannolone A. It 
comprises a putative carboxyl-transferase gene (phn1) and a modular type I PKS 
gene (phn2), putatively responsible for the formation of phenylnannolone A. Phn2 
has a gene size of 22 kb and its gene product consists of 5 modules: A loading 
module and four modules for the extension of the polyketide chain (figure  6.2).  
phn1      phn2 
 2kb      22 kb  
OS
O
H3C
O
S
O
H3C
H3C
O
O
ATKS
DH KR
ATKS
DH KR
AT ATKS
DH KR
AMP KS
OS
H3C
OS O
S
H3C
BCC ACP ACP ACP ACP ACP TE
Phenylnannolone A
 
Figure  6.2 Hypothetical pathway for the biosynthesis of phenylnannolone A: BCC=butyryl-CoA carboxylase 
AMP=AMP-dependent ligase, ACP=acyl carrier protein, KS=ketosynthase domain, AT=acyltransferase domain, 
DH=dehydratase domain, KR=ketoreductase domain, TE=thioesterase domain 
From the results obtained, we concluded that the biosynthesis of phenylnannolone A 
in N. pusilla B150 involves a PKS and not a NRPS/PKS system. However, the 
putative loading module comprises an AMP-synthetase/ligase that activates the 
aromatic starter unit. To investigate the functionality and substrate selectivity of the 
AMP-ligase, a recombinant protein was expressed. In a subsequent γ-18O4-ATP 
pyrophosphate exchange assay (Phelan et al., 2009) with putative substrates the 
specific activation of cinnamic acid by this AMP-ligase was shown.  
loading 
module 
module 1 
module 2 module 4 
module 3 
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During the bioinformatic analysis of the genomic library for the phenylnannolone 
gene cluster, a small NRPS/PKS gene (10 kb) was identified on another fosmid 
clone. Sequence analysis of the gene and its corresponding protein product led to 
the prediction of an unknown peptide with three putative building blocks: proline, 
phenylalanine and acetate.  
The current project led to the identification of two biosynthetic gene clusters from the 
myxobacterium N. pusilla B150. Biochemical studies on the loading module of the 
putative phenylnannolone gene cluster were performed, and indicate cinnamic acid 
to be the starter unit for phenylnannolone A biosynthesis. 
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8 Appendix 
8.1 Amino acid sequences for the phenylnannolone A gene cluster 
Sequences of genes phn1 and phn2 were obtained from 454 fosmid sequencing of 
the fosmid clone 12A9 and translated into protein sequences. 
8.1.1 Amino acid sequence of Phn1, the putative butyryl-CoA Carboxylase 
GARMSSELRNAAIKEISESQPVRELKRVPEHPHRVHDRRERLAHACAGPAQVAAG
DRGVAAAEARARDAEAKLHAGGRRTARERVEELLDPDSFVEMDEFVTHQCPDFDM
PDRKAYGDGVLTGHGTVDGRPVFVYAQQPQVLGGSLGLAHAMKICKVMDMAMTV
GAPVVGLNDSGGARIQEGVASLAGYAEIFKRNVLASGVVPQLSLILGPCAGGAVYSP
ALTDLVLMVEDHSYMFITGPEVIRAVTHEEVTKEQLGGAATHNERSGVAHFSCASET
VAMVMARELLSFMPSNNMEDAPRRATLDDPRRPTPELAEFVPVDTTKPYDMRTIVK
AIADDGYFFEVQESYARNIVIGFIRVDGRSVGVVANQPLVLAGCLNIDASVKAARFVR
MCDAFNIPLLTLVDVPGLLPGVEQEYAGIIRHGAKLLYAYVEATVPKITLVTRKAYGG
AYAVMSSKHIRGDVNLAYPTAEIAVMGAEGAVNIIYRREIAEAADPAARRAELLAEYR
DLFATPYKAAELGFIDKIIRPEETdRREIARSLALMGNKRQENPRRKHGNIPL 
8.1.2 Amino acid sequence of the Phn2, the putative PKS assembly line 
ASIRPRVPWLAPPDVNSETRSMQSQSHGRFERASRNLLDLLDEQATAFAGKIAYAF
LERGEHVTAQVSFAALRERAYVIAAELAKHCRPGDRAVLAFPPGIEFVEAFWGCLC
AGVIAVPSYLPEPGNQQRHLHRLYGTVDDARPAVILTSAGAHDRLQRLLLAAPNPVA
APCLATDAIREDPSAERPSLPASVSSETLATLIYTSGSTGDPKGVCVTHGNALHNIEL
VRDKFDNDEDATYVSWLPLFHDLGLIVVMLGAFQCGATCYLMDAVDFIRDPICWLR
AISRYRGRNAGGPNFAFELCARKVTPEQLGELDLRCWDVAFNGAEPVRADTMERF
AQVFAPCGFRSTAFYPCYGMAEATGMISGGASRAAPVVELFDEQSLGRGVVKVAD
KGGASADDDTVASRSHGRSLVGNGTAGGGQEIAIVDPDTYERCPPLTVGEVWLRG
PSIGPGYWQRPEATRETYGETIAHEDDGTYLRTGDLGFVRDGEVFLTGRLKDLIIIRG
ANHYPQDIELSVERSHAALRGGGCVVFPVETDTEERVGIIAETLSDRDPGEQSAEIL
RSIRAAVTREHEVGVAVIALVPPRTVLKTTSGKPRRRANRSTLFAGQFPVWAEWRD
AQRPAGDTAAPPDAPRPSPIPKHKLARRRDELFQLVHGVVAARLNAPEILPDRPLQE
LGFDSLAAVEIQAQLAKQLGVELPATLLYDHPTLRALTSFLLQTVLLAPHESAEEASE
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DGRGLSTLADPDEPIAVIAMACRLPGGIKEPDAYWRVLAQALDVIAPFPADRWDAEA
LYDPDPDHKGKTYCTQGGFLADLEQFDAAFFGISPREAQAMDPQQRLVLETAWEA
LERAGIVPETLYGSQTGVYIGAMDSDYHLWGEDARALGLLDGYVSTGNTGSVLSGR
VSYVLGLQGPALTVDTACSSSLVALHLAAQGLRNGECDLALCGGVQVMNTPAAFVE
LSRLRALAPDGRSKSFSAQADGAGWSEGCGMVLLKRLSDAQRQGDRVLAVIRGTA
VNQDGRSQGLTAPNGPSQERVIRRALERSQLAPRDIDVVEAHGTGTALGDPIEAGA
LSAVFGSDRPAEQPLYLGSVKSNLGHTQAAAGVTAIIKMVLALQHEVLPRTLHAEEP
SPHIRWEGSPLALLQAAHSWPRGERPRRAGVSSFGISGTNAHVILEEAPAEGPHIEP
DVALAASPDAVPLVLSARSPEALRAQASQLGAHLSAHPEQSLVDVAHSLVTTRSLF
GHRAVVLATSREAATEKLAALALGATDSRTIAGVAAQTRGKLAFVFPGQGGQWPH
MARALLRGSQLFREQIEQCNEALSPYCDWSLIDMLDGTLGAEAWERIEVVQPALFA
MWVSLAALWRDMGVEPDGVIGHSQGEIAAACVAGALPLAEAARISALRSRTFKKLE
GRGAMAAVEMGEEELEARLRALGTGVEVAVNNGTNSCVVSGTPAAIEAFVAQLTR
DGVFARRLQTTCATHWAQAEEIRDELLTSLGAVRRADGSIPIYSTVLAAPIGGGELD
AQYWYANTRERVRMRQTVETMLADGFRYFVEVSSHPVLTMAVERSLAGAKLAGAA
VGSLRRDEGQPEKLLEGLAELHVAGLEVDWTRLLPPARVVELPTYPFERHRFWKKE
WREREPDVGTAGMTQVDHPLLVGATGLADAEGVLFTTELSQHTVPWLKDHRVLDL
LLVPGTAILEMMMVAGQLLGTPEVRDLTLMSGLVLPERGSLHVQFRASAGEPDGGR
RIALYSRPAEAPLELSWTCHATGHLGPASAARGASLDAWPAPGAEAVATDNLYDQL
AQQGLVYGPTFQGLKQLAVRDQAWFAEIKPRLTTHEASRYRIHPGLLDAALHGLSL
ALPSAGADALWLPFGFEDVAVWNTGAAELRVRVRLHQQPGDGDEVAQAELDLFD
GQGEAVGRVGTLRLRRASRAQVRASRTGEPPLHRLAWTARALEVTQNIATSEVVVL
GAGRLAARLGVRAVSEVAELLAGPAPRIVVIDASEAIERTGSNEHALKGMSGATYHS
PDELRAQLGAALEPLQQLLAQPSLEAAQLVWVTEQAVSTGPADPVASLAQAGLWG
MIRSARNETSRPLRLMDVEAGSSSELLWNALSQPEAPELAVRGSAVLRPRLEPCAA
DEATSPALRKDGTVLLTGGTGELGQTVARHLVREHGIRHLVLTSRRGRDAAGVEAL
LAELADLGAQVEVVRCDVSQREAVADLLATLDPPLSAVFHCAAVLDDGLVPALTPP
RMDVVLRAKVDSALHLDALTAELPLDAFVMFSSVAGVIGSAGQANYAAANTVLDAL
ASQRRARGQAGQSLAWGLWHPQGLGMTARLSPAQLQRLKRQGLNALRVATGMR
LLDAALRRPDALLVPIERATGELDESAPFLIRDGQPRKARAADAKVATGLWAALRGL
DAPARQQKLLEWVQTETAGVLGLQGRQAVAADRPLKELGLDSLMAVELRNRLAAR
AELSLPSTLAFDYPTARQIAEQIAARRAPETAAAPVATSRPATDVDAPIAIVAMSCRL
PGGVDTLEAFWELLEHGRDAIEPCPRGRWDLEALYDPDPEQRGTTYCTQGGFLAD
VAGFDASFFGISPREAQAMDPQQRLVLETAWEVLESAGIVPAQLQRSQTGVYIGAM
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ASDYHVFGRRPDDLEALDGYRVTGNAGSVISGRIAYVLGLQGPALTVDTACSSSLV
ALHLAAQGLRNGECDLALCGGVQVMNAPTTFIEFSRLRGMAPDGRCKSFSADADG
AGWSEGCGMLLLKRLPDAERDGDRILAVLRGSAVNQDGRSQGLTAPNGPSQERVI
RRALELSHLEPQAIDAVEAHGTGTVLGDPIEAGALSAVFGARDEGPLYLGSVKSNLG
HTQAAAGVTGVIKMVLALQHELLPRTLHAQQATPHIAWEQSGLQLLQAPLPWPRGS
RVRRAGISSFGISGTNAHLILEEAPAPVEPARATPTDDKTAWPLLLSARSATTLAAQA
ARLQTHLRQHPEQSLVDVAFSLATARTQFEHRAVVLAASSEAAIEQLARLQQGRFD
RTILGPPRSDALEPSGKLALLFSGQGAQRPAMGRALRRYPVFARALEAVFAELADR
LPSLPAVMLADPDTPEAALLEQTLYTQTGLFALQVALYRLWESMGLVPDVLLGHSV
GEIAVAHVAGILSLADACTLVAERARLMQALPSGGAMVSVVASERAVLDVLADCPEP
VDIAGVNGPLSTVISGSEAAVLHAVHALELHGYKTTRLRVSHAFHSARMEPMLADFA
RVARGLTYHSPQRAIVSTRTGALVDPDELCDPEYWVRQIREPVRFADGVRALADLG
VSTYLELGPHGVLCGLASACLDAPRPSVFVPSLHADEPADHGFLAAAAALHTHGLD
LRWTALLPVDARRVELPTYPFERQSYWLDEQRTAELSAASLGMTAIEHPLLFGAIRP
ADTESVLFTSRLSQRAIPWFTEHRVFETTLVPGTALLELAMAAGQALDMPALNDLAL
VSALAWPETDAIHVQVQVSAEGPDGDRQVDLYSRPEDAAMASAWTRHATGRLGP
SSTSRPPQLGPWPPPDSDPVDLAGHYERTARLGLDYGPSFRGLRQLFRAEREPTL
WYAEASLLPEQVAEASRYRIHPALLDAALHGLSLALPAAGGDALWLPFGFEDVAVW
HTGAAELRVRVRLHQQPGDGDEVAQAELDLYDGQGEAIGRIGGLRLRRASRAQVR
ASRTGEPPLHRLAWSPSRALDITPSPSEVVVLGAGRLAARLGLRGVSEVAELLAGP
APRTVVIDATELARRADELRAQSSHTIEWTGSNGHGSMGMSDATGQDPDELRAQL
SAALMPLQQLLAQPSLEAAQLVWVTEQAVSTGPADPVVALAQAGLWGLIRSARNET
SRPLRLVDVEADSSSDLLWNALSQAEAPELAVRGAAVLRPRLEPCAADTETTPALR
TDGTVLLTGGTGELGQAVARHLVREHGIRHLVLTSRRGRDAAGVEALLAELANLGA
QVEVVRCDVSQREAVADLLAAIDPPLSAVFHCAAVLDDGLVPTLTPARMDVVLRAK
VDSALHLDALTAELPLDAFVMFSSVAGVIGSAGQANYAAANTVLDALASQRRARGQ
AGQSLAWGLWHPQGLGMTARLSSAQLQRLKRQGLSALRVPTGMRLLDAALRRPD
ALLVPIERATGELDESAPFLIRDGQPRKARPVDANVSTGLWAALRGLDASARQQKLL
EWVQTETAGVLGLQGRQAVAADRPLKELGLDSLMAVDLRNRLATRAELSLASTLAF
DYPTARQIAEHIAARRAPEAVAAAAPVTTSRPTDVDAPIAIVAMACRLPGGVDTLESF
WELLEHGRDVIEPCARWDLEALYDPDPEHRGKTYCTQGGFLADVAGFDASFFGISP
REAQAMDPQQRLVLETAWEVLERAGIVPAQLQRSQTGVYIGAMGSDYHVFGRGPD
DLEALDGYCVTGNAGSVISGRIAYVLGLQGPALTVDTACSSSLVALHLAAQGLRNGE
CDLALCGGVQVMNGPTTFIEFSRLRGVAPDGRCKSFSADADGAGWSEGCGMLLLK
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RLPDAERDGDRILAVLRGSAVNQDGRSQGLTAPNGPSQERVIRRALEQSRLGPEAI
DAVEAHGTGTVLGDPIEAGALSAVFGARDDRPLYLGSVKSNLGHTQAAAGVTGVIK
MVLAMQHELLPRTLHAQQASPHIAWASSGLQLLQAPLPWPRGSRVRRAGISSFGIS
GTNAHLILEEAPAPVEPARTTITNAHLILEEAPAPVEPTQWTANDKTVWPLLISARSA
TTLVAQATRLQAHLRQHPEQSLRDVAFSLATARTQFEHRAVVLADSSQAAIERLAKL
QQDPRSDVLEPSGKLALLFSGQGAQRPAMGRALRRYPVFARALEAVFAELADRLP
SLPAVMLADADAPEAALLEQTLYTQTGLFALQVALFRLWDSMGLVPDVLLGHSVGEI
AVAHVAGILSLADACTLVAERARLMQALPSGGAMVSVVASERAVLDVLASCPEPVDI
AGVNGPLSTVISGSEAAVLHAVHALELQGYKTTRLRVSHAFHSARMEPMLADFARV
ARGLTYHSPQRAIVSTRTGALVDPDELCDPDYWVRQVREPVRFADGVRALADLGV
STFLELGPHGVLCGLASACLDAPRPSIFVPSLRADEPADHSFLTAAAALHTHGLDLR
WTGLLPVDARRVELPTYPFERQSYWLEPPSSATVSRAVDSQRATTTSRGPDSRGT
SMFLKHLDGFAREDRLRHLLQLVLGESAATLGHPDASQVDPDRGFADLGMNSLMA
VQLRERLQARTGLHIPATVAFDHPSPARVASFLLERSEATLHERVEAAPDVHPVNSS
ADDEPIAIVGVGLRLPGGCVDLTSLWRLLEHGVDAVTTIPADRWALDDFYDPVAGEP
GKSYVREAGFLSGIDEFDPGFFHISPREAKSIDPQHRMLLQVAWQTLEMAGVVPGS
LRDSQTGVFVACGASEYGLHMGAGEDPYEFTRALQSFSAGRLAYTLGLQGPALSV
ETACSSSLVALHLACQSLRSGECSLALAAGAQLMISPEPFLMLSRIRALAPDGRCKT
FSEQADGYGRGEGVVVLALERLSAARANGRRILALVRGSAINHDGASSGLTVPNGL
SQQKVLRAALRAAGVDAATVDYVECHGTGTHLGDPIEVQALGDVYGAARPLEQRV
KLGTIKPNIGHLEFAAGLAGVAKVIAAFQQQALPATIHTLPRNGHIEWDRLAVSVVDS
LTPWPSRPQEQPRRAGVSSFGLSGMNAHVILEEAPPAISPPAAATASEPAAVPLLLS
ARSEAALAMQASRLAEHLGQQPGQRLLDVAWSLATTRTHFEHRAVVLADSHESAR
ARLHELTQGARISSRVSRTAASGSVAFLFTGQGSQRCGMGQELARRFPVFRAALD
EVLAHLAPQLPTLRDIMFAPADSAEGRSLHQTGHTQPALFALQIALFRLWEDLGVRP
GWLLGHSVGEIAAAHAAGVLSLADACKLVAARGRLMQGLTARGVMYSVLAAEADV
REQLGERAGLVDIAGVNGPRSTVIAGDEHAVDELVRALAERGIKSSRLQVSHAFHSP
LMEPMLAELREVAQGLDYRAPALRLVSTRTGRAAAPEDFVTAEYWVRQAREAVQF
AAAMRTLADNNVDTYIELGPDGVLSRMGVKCLTEADQRRSRFLPSLRAGEAEAETL
LTAAGKLHTEGHEVNWASLFAGARSVELPTYAFERQRYWLDPRPSATAAAPRTLH
PFLSSRIDAADGNVTLFSGHLDLESTPWLRDHRVAGSVILPTTAYMDLMLSVGAKSL
GPVPLELEGLIVERPLLLAAEQSAEIQVDVQSTPGPDGGLTASVHSRRPDARAWQF
HARARVHHRPWQQPEPARKQRLDAIRQRAERVMEGSEFYAAWRARGNDWGPAF
QTIERLWIDGRTCVAQLRVRPTQSPRADGADFFAQPALLDGCGQALGVFALDRPAS
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SFVGHRARVVRFKGALRGETFFCLIELDELDAAAPTLRGDIAIHDEHGELLGEALGAE
IELLEARRSDAAEPRRWLYEQQWVLAERAAERRQQVGHWLVLGSPVIAPLRDAMR
ERGVTTTFADSIRDPRALEALAHADLLGVSYLAPALEYALSPPEQAADAIDRVSRALE
ESLEPLRHLTASRPGFPVQLSWLTQGCWLVRPDDVPGAEGQAALWGLGKSCTAE
HPEYGGRLIDLPAGALLGEPSPTVIDHLVSSLLDEVAEKQLAIREDGIFLNRLTRHTPA
IGGEALRFRPDATYLVTGGLGGIGLALAEWLAERGACRLILVGRTPLPARRRWSALD
PRSKEGIAVDVIRRLERRGVSVQVAALDVANEAEVQRFLADHRDEAWPAIRGVVHA
AGVATGGPLRDMTATAFAQQLRPKLQAAWILQRALAEESLDFFVLCSSAAALIPSPL
VGAYAAANACLDALVERRRRAGQSGLSIAFGPWAEVGMAAEYQQQQARASTSPST
MTPMKTADALHLIGQLWQGTCGRPAILPIDWSLWQTRYRRLLEQPLFARFAAPAAA
RADDADLDPAADLASLPVAVQGQGLLAGLSRLIQQVLGHHGELDVEKSFSELGVDS
LMAFEAKEKIARVWSVDLPVLELLHAANIAELAQLVERRLAGSAPVDVRWPRLPTPC
EFPSLDGLTIHGHLSLPTGPGPHPAIVVHTADTGGALDDQGRYVHLFEHEPLVRAGF
AVLTVDQRGAPGHGDAYAGAADLGGADVEDLLAAARYLADRPDIDDARIGLVGTSR
GAYAGLLALQRAPDRFRAAVLRMGFYDPLEYGRNERQLRPETAPLLKLLPSWDAW
FERMGAPERNPLNRLDQVTASLFVIHGEDDRIADVEHSRRLVSAMTAAGRPTELRTI
PGVGHDIEEVHPVWREIWDEITSFLHNHLSPASETEAAE 
Trimmed sequences of the identified domains on Phn2 gene 
AMP-ligase 
FAALRERAYVIAAELAKHCRPGDRAVLAFPPGIEFVEAFWGCLCAGVIAVPSYLPEP
GNQQRHLHRLYGTVDDARPAVILTSAGAHDRLQRLLLAAPNPVAAPCLATDAIREDP
SAERPSLPASVSSETLATLIYTSGSTGDPKGVCVTHGNALHNIELVRDKFDNDEDAT
YVSWLPLFHDLGLIVVMLGAFQCGATCYLMDAVDFIRDPICWLRAISRYRGRNAGG
PNFAFELCARKVTPEQLGELDLRCWDVAFNGAEPVRADTMERFAQVFAPCGFRST
AFYPCYGMAEATGMISGGASRAAPVVELFDEQSLGRGVVKVADKGGASADDDTVA
SRSHGRSLVGNGTAGGGQEIAIVDPDTYERCPPLTVGEVWLRGPSIGPGYWQRPE
ATRETYGETIAHEDDGTYLRTGDLGFVRDGEVFLTGRLKDLIIIRGANHYPQDIELSV
ERSHAALRGGG 
ACPLM 
QLVHGVVAARLNAPEILPDRPLQELGFDSLAAVEIQAQLAKQLGVELPATLLYDHPTL
RALTSFLL 
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KS1 
EPIAVIAMACRLPGGIKEPDAYWRVLAQALDVIAPFPADRWDAEALYDPDPDHKGKT
YCTQGGFLADLEQFDAAFFGISPREAQAMDPQQRLVLETAWEALERAGIVPETLYG
SQTGVYIGAMDSDYHLWGEDARALGLLDGYVSTGNTGSVLSGRVSYVLGLQGPAL
TVDTACSSSLVALHLAAQGLRNGECDLALCGGVQVMNTPAAFVELSRLRALAPDGR
SKSFSAQADGAGWSEGCGMVLLKRLSDAQRQGDRVLAVIRGTAVNQDGRSQGLT
APNGPSQERVIRRALERSQLAPRDIDVVEAHGTGTALGDPIEAGALSAVFGSDRPAE
QPLYLGSVKSNLGHTQAAAGVTAIIKMVLALQHEVLPRTLHAEEPSPHIRWEGSPLA
LLQAAHSWPRGERPRRAGVSSFGISGTNAHVILEE 
AT1 
FPGQGGQWPHMARALLRGSQLFREQIEQCNEALSPYCDWSLIDMLDGTLGAEAW
ERIEVVQPALFAMWVSLAALWRDMGVEPDGVIGHSQGEIAAACVAGALPLAEAARI
SALRSRTFKKLEGRGAMAAVEMGEEELEARLRALGTGVEVAVNNGTNSCVVSGTP
AAIEAFVAQLTRDGVFARRLQTTCATHWAQAEEIRDELLTSLGAVRRADGSIPIYSTV
LAAPIGGGELDAQYWYANTRERVRMRQTVETMLADGFRYFVEVSSHPVLTMAVER
SLAGAKLAGAAVGSLRRD 
DH1 
AGMTQVDHPLLVGATGLADAEGVLFTTELSQHTVPWLKDHRVLDLLLVPGTAILEM
MMVAGQLLGTPEVRDLTLMSGLVLPERGSLHVQFRASAGEPDGGRRIALYSRPAE
APLELSWTCHATGHLGPASAARGASLDAWPAPGAEAVATDNLYDQLAQQGLVYGP
TFQG 
KR1 
ATSPALRKDGTVLLTGGTGELGQTVARHLVREHGIRHLVLTSRRGRDAAGVEALLA
ELADLGAQVEVVRCDVSQREAVADLLATLDPPLSAVFHCAAVLDDGLVPALTPPRM
DVVLRAKVDSALHLDALTAELPLDAFVMFSSVAGVIGSAGQANYAAANTVLDALASQ
RRARGQAGQSLAWGLWHPQ 
ACP1 
LRGLDAPARQQKLLEWVQTETAGVLGLQGRQAVAADRPLKELGLDSLMAVELRNR
LAARAELSLPSTLAFDYPTARQIAEQIAAR 
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KS2 
APIAIVAMSCRLPGGVDTLEAFWELLEHGRDAIEPCPRGRWDLEALYDPDPEQRGT
TYCTQGGFLADVAGFDASFFGISPREAQAMDPQQRLVLETAWEVLESAGIVPAQLQ
RSQTGVYIGAMASDYHVFGRRPDDLEALDGYRVTGNAGSVISGRIAYVLGLQGPAL
TVDTACSSSLVALHLAAQGLRNGECDLALCGGVQVMNAPTTFIEFSRLRGMAPDGR
CKSFSADADGAGWSEGCGMLLLKRLPDAERDGDRILAVLRGSAVNQDGRSQGLTA
PNGPSQERVIRRALELSHLEPQAIDAVEAHGTGTVLGDPIEAGALSAVFGARDEGPL
YLGSVKSNLGHTQAAAGVTGVIKMVLALQHELLPRTLHAQQATPHIAWEQSGLQLL
QAPLPWPRGSRVRRAGISSFGISGTNAHLILE 
AT2 
FSGQGAQRPAMGRALRRYPVFARALEAVFAELADRLPSLPAVMLADPDTPEAALLE
QTLYTQTGLFALQVALYRLWESMGLVPDVLLGHSVGEIAVAHVAGILSLADACTLVA
ERARLMQALPSGGAMVSVVASERAVLDVLADCPEPVDIAGVNGPLSTVISGSEAAV
LHAVHALELHGYKTTRLRVSHAFHSARMEPMLADFARVARGLTYHSPQRAIVSTRT
GALVDPDELCDPEYWVRQIREPVRFADGVRALADLGVSTYLELGPHGVLCGLASAC
LDAPRPSVFVPSLHAD 
DH2 
LGMTAIEHPLLFGAIRPADTESVLFTSRLSQRAIPWFTEHRVFETTLVPGTALLELAM
AAGQALDMPALNDLALVSALAWPETDAIHVQVQVSAEGPDGDRQVDLYSRPEDAA
MASAWTRHATGRLGPSSTSRPPQLGPWPPPDSDPVDLAGHYERTARLGLDYGPS
FRG 
KR2 
TETTPALRTDGTVLLTGGTGELGQAVARHLVREHGIRHLVLTSRRGRDAAGVEALL
AELANLGAQVEVVRCDVSQREAVADLLAAIDPPLSAVFHCAAVLDDGLVPTLTPAR
MDVVLRAKVDSALHLDALTAELPLDAFVMFSSVAGVIGSAGQANYAAANTVLDALAS
QRRARGQAGQSLAWGLWHPQ 
ACP2  
LRGLDASARQQKLLEWVQTETAGVLGLQGRQAVAADRPLKELGLDSLMAVDLRNR
LATRAELSLASTLAFDYPTARQIAEHIAAR 
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KS3 
APIAIVAMACRLPGGVDTLESFWELLEHGRDVIEPCARWDLEALYDPDPEHRGKTY
CTQGGFLADVAGFDASFFGISPREAQAMDPQQRLVLETAWEVLERAGIVPAQLQRS
QTGVYIGAMGSDYHVFGRGPDDLEALDGYCVTGNAGSVISGRIAYVLGLQGPALTV
DTACSSSLVALHLAAQGLRNGECDLALCGGVQVMNGPTTFIEFSRLRGVAPDGRC
KSFSADADGAGWSEGCGMLLLKRLPDAERDGDRILAVLRGSAVNQDGRSQGLTAP
NGPSQERVIRRALEQSRLGPEAIDAVEAHGTGTVLGDPIEAGALSAVFGARDDRPLY
LGSVKSNLGHTQAAAGVTGVIKMVLAMQHELLPRTLHAQQASPHIAWASSGLQLLQ
APLPWPRGSRVRRAGISSFGISGTNAHLILE 
AT3 
FSGQGAQRPAMGRALRRYPVFARALEAVFAELADRLPSLPAVMLADADAPEAALLE
QTLYTQTGLFALQVALFRLWDSMGLVPDVLLGHSVGEIAVAHVAGILSLADACTLVA
ERARLMQALPSGGAMVSVVASERAVLDVLASCPEPVDIAGVNGPLSTVISGSEAAV
LHAVHALELQGYKTTRLRVSHAFHSARMEPMLADFARVARGLTYHSPQRAIVSTRT
GALVDPDELCDPDYWVRQVREPVRFADGVRALADLGVSTFLELGPHGVLCGLASA
CLDAPRPSIFVPSLRAD 
ACP3  
DGFAREDRLRHLLQLVLGESAATLGHPDASQVDPDRGFADLGMNSLMAVQLRERL
QARTGLHIPATVAFDHPSPARVASFLLER 
KS4 
IAIVGVGLRLPGGCVDLTSLWRLLEHGVDAVTTIPADRWALDDFYDPVAGEPGKSYV
REAGFLSGIDEFDPGFFHISPREAKSIDPQHRMLLQVAWQTLEMAGVVPGSLRDSQ
TGVFVACGASEYGLHMGAGEDPYEFTRALQSFSAGRLAYTLGLQGPALSVETACS
SSLVALHLACQSLRSGECSLALAAGAQLMISPEPFLMLSRIRALAPDGRCKTFSEQA
DGYGRGEGVVVLALERLSAARANGRRILALVRGSAINHDGASSGLTVPNGLSQQKV
LRAALRAAGVDAATVDYVECHGTGTHLGDPIEVQALGDVYGAARPLEQRVKLGTIK
PNIGHLEFAAGLAGVAKVIAAFQQQALPATIHTLPRNGHIEWDRLAVSVVDSLTPWP
SRPQEQPRRAGVSSFGLSGMNAHVILEEAP 
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AT4 
FTGQGSQRCGMGQELARRFPVFRAALDEVLAHLAPQLPTLRDIMFAPADSAEGRSL
HQTGHTQPALFALQIALFRLWEDLGVRPGWLLGHSVGEIAAAHAAGVLSLADACKL
VAARGRLMQGLTARGVMYSVLAAEADVREQLGERAGLVDIAGVNGPRSTVIAGDE
HAVDELVRALAERGIKSSRLQVSHAFHSPLMEPMLAELREVAQGLDYRAPALRLVS
TRTGRAAAPEDFVTAEYWVRQAREAVQFAAAMRTLADNNVDTYIELGPDGVLSRM
GVKCLTEADQRRSRFLPSLRAG 
DH4  
AAAPRTLHPFLSSRIDAADGNVTLFSGHLDLESTPWLRDHRVAGSVILPTTAYMDLM
LSVGAKSLGPVPLELEGLIVERPLLLAAEQSAEIQVDVQSTPGPDGGLTASVHSRRP
DARAWQFHARARVHHRPWQQPEPARKQRLDAIRQRAERVMEGSEFYAAWRARG
NDWGPAFQT 
KR4 
PDATYLVTGGLGGIGLALAEWLAERGACRLILVGRTPLPARRRWSALDPRSKEGIAV
DVIRRLERRGVSVQVAALDVANEAEVQRFLADHRDEAWPAIRGVVHAAGVATGGP
LRDMTATAFAQQLRPKLQAAWILQRALAEESLDFFVLCSSAAALIPSPLVGAYAAAN
ACLDALVERRRRAGQSGLSIAFGPWA 
ACP4 
LAGLSRLIQQVLGHHGELDVEKSFSELGVDSLMAFEAKEKIARVWSVDLPVLELLHA
ANIAELAQLV 
TE 
EFPSLDGLTIHGHLSLPTGPGPHPAIVVHTADTGGALDDQGRYVHLFEHEPLVRAGF
AVLTVDQRGAPGHGDAYAGAADLGGADVEDLLAAARYLADRPDIDDARIGLVGTSR
GAYAGLLALQRAPDRFRAAVLRMGFYDPLEYGRNERQLRPETAPLLKLLPSWDAW
FERMGAPERNPLNRLDQVTASLFVIHGEDDRIADVEHSRRLVSAMTAAGRPTELRTI
PGVGHDIEEVHPVWREIWDEITSFLHNHLSPASETEAAE 
 
 
Appendix 
 
163 
 
AMPPCP(protein) 
MHHHHHHGKPIPNPLLGLDSTENLYFQGIDPFTASIRPRVPWLAPPDVNSETRSMQ
SQSHGRFERASRNLLDLLDEQATAFAGKIAYAFLERGEHVTAQVSFAALRERAYVIA
AELAKHCRPGDRAVLAFPPGIEFVEAFWGCLCAGVIAVPSYLPEPGNQQRHLHRLY
GTVDDARPAVILTSAGAHDRLQRLLLAAPNPVAAPCLATDAIREDPSAERPSLPASV
SSETLATLIYTSGSTGDPKGVCVTHGNALHNIELVRDKFDNDEDATYVSWLPLFHDL
GLIVVMLGAFQCGATCYLMDAVDFIRDPICWLRAISRYRGRNAGGPNFAFELCARK
VTPEQLGELDLRCWDVAFNGAEPVRADTMERFAQVFAPCGFRSTAFYPCYGMAEA
TGMISGGASRAAPVVELFDEQSLGRGVVKVADKGGASADDDTVASRSHGRSLVGN
GTAGGGQEIAIVDPDTYERCPPLTVGEVWLRGPSIGPGYWQRPEATRETYGETIAH
EDDGTYLRTGDLGFVRDGEVFLTGRLKDLIIIRGANHYPQDIELSVERSHAALRGGG
CVVFPVETDTEERVGIIAETLSDRDPGEQSAEILRSIRAAVTREHEVGVAVIALVPPRT
VLKTTSGKPRRRANRSTLFAGQFPVWAEWRDAQRPAGDTAAPPDAPRPSPIPKHK
LARRRDELFQLVHGVVAARLNAPEILPDRPLQELGFDSLAAVEIQAQLAKQLGVELP
ATLLYDHPTLRALTSFLLQTVLLAPHESAEEASEDGRGLSTLADPDEPIAVI 
8.2 Amino acid sequences for the mixed NRPS/PKS protein Sb1 
Sequences of the gene sb1 were obtained from 454 fosmid sequencing of the fosmid 
clone 21H12 and translated into protein sequence. 
NYLWLHDYGHFTLGATYPSPGGSCRWSALQRVPFAHKGGNVHLRRSDVYTGVDC
MDVDPPPRGDAGAGYTIAASCEQALVWLRLGLFGPSPVNHRCAGAWIDGPLDAAAI
EQATLRLGERHDLLRTTFCEQTDGNGEPRLVQVIAPTASPRLTRVDGGELGEEQVL
RRAGEAARQHLDPREEPPWRIYLIRQRPGRHLAVLVVHALLADADSDAASLLKEWQ
MLVEGTGRMTGQVTGPYTHHLRAQAESLESPQTRGSIAWWQAQHASAPPLLELPV
DRPRSPVPARAGARVSRRIDAGLLAALTSASTQLDADAVTLALTGLFAVLYRYTGQP
ELVVEARVPGGANGLGPVADRLMLRVAVAPELGFAALLERTRRAAQTAQEHGALA
SLVAAMTTRAPGCQVYFHGACAEPSAVALDLGFVAHELELAVDLRQGRLVAAFDRD
LFEHDTVQRLLGHWEVALAAALAEPQRAIAGLPLLVPAEQQTIVHAWNATGAAYGG
PDCLQGLGLFAAQAARTPEAPAVVDASGCLTYRELAARATRLAWRLRALGVGADV
PVGLFLDRSLDLAVGVLAILMAGGTYVPLDPAYPAERLQWIVGDSGALAMVTCSRLA
AALPPSQAQSVLVDVEVEAPAVTLPRTLPGDLAYIIYTSGSTGRPKGIGMPHAALVNL
IEWHAAELLGGARTLQFAALGFDLCFYELFTAWRTGGVVHMIDEAVRHDVARLGATI
AGEAIEKVILPVVVLQQLAEEYAERPEVLRSLKEVTTSGEQMHLTAPVIALFERLPGC
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TLHNHYGPAESHVVTAYALPEARAQWVPHPPIGRPIANTRVLVLDPHMNLCPVGVP
GELYIGGECLARGYWNRPDLTAERFVPDPFAVAPGARLYRTGDITRQRADGTVEYL
GRRDDQVKIRGVRVELGEVLSALSRHPRVQEAVVIAREDAPGERRLVAYFVATGGE
VGDLASELRLFLRRSLTEAMIPTAFVALPAMPLSPNGKIDKRALPRPEDDTATSTSVP
PRSELEASIAGIWQDVLKVERVGAHDDFFALGGHSLTATQVLARVRRTFGVEVALA
QLYAGPTVAGLAGLVRAGRAPVQARAPIEPAPRSGPLPLSLAQERLFFLHRLAPDST
AYNCPHGFRVRGPLDAAALRAGRRRAGGPPRVAAHDLRRGRRGGAAGDRGARG
GAAAALRPAQPAGGAAGLELERRLATEVRRPFDLSRGPLVRGCLVQLADDEHFLLL
DLHHIVIDGWSMRLLLDELAALYDAERRGTPAALAPLGLQFADYAAWERARLQDGL
QAAIAWWKQTLADAPRLLPLPTDRPRPNTQSFRGGAITLKPDADTSAGLRRLGAPA
GLSASLVLLAGFAALLHRYTGEPTIVLGMPTAARDQVELEGLVGFFVNMLPIRVDLA
GDPSFVQLLAQVRRVTLDAFDHDAVPFDRIVQELRPERTLSHNPVVQVGFAPQPPG
ARDLRLAGLQVESVEADVPRAIFDLTLYVREDGGELTALLEYSTDLFERATIERMGG
HLLALLREVSARPQRRVSQVPLLGDEEREDVVVRWNTTGPSASPPEMVQALVSRA
AAVDPERPAVVIGEARLSYAELERRARSLARLLRARGVGPESLVAISVEKSLDLIVAV
VAVLKAGGAFVPLDPAYPAERLAFMLADSGARLVLTHARLAERFAGRELIRLDEPQE
EVEVELPPIADDPTRAAYVIYTSGSTGRPKGVVVEHRSAVNLARAQRVMFGLTTDS
VVLQFSALSFDAFVFELLLAWGVGATLCLVPPALPIPGREFSEMLRAQRVSICVLPPS
LLAAMSDDPLPDLVHVVAAGEACSAELVARWGRGRRFVNAYGPTETTVCATWAPC
EPGEGPPPIGKPLVDVQVYVLDPAGNPAPIGVFGELYVGGAGVARGYLARPELTAE
RFVPDPFSGAAGARLYRTGDRVRWRADGQLEFAGRLDRQVKVRGFRIELGEVEAV
VRAHPEVQDAVVVAREDLVAYVVPREPGTSLKTAVREFAQARLPGHMVPAAVVTV
EAFPTLPNGKVDVRALAERSPRSEARATEQPRSQIERTLAEIWREVLAIEAVGLDAP
FFELGGHSLLLAKVRTAIEARLGRRLDMVELFQHPTIRSLAARLSGGEQEVAPARTAI
RAEAGGDAIAIVGLAGRFPGAADVEALWSNLLAGVEGIHFAGADELAAAGVDPSLR
GSSGFVPAFGALADAFCFDAAFFGYSPQEARLMDPQQRVFLEAAFAALEDAGCDP
SRGQLRVGVFGGCDAPRHWLELGGASGIDEFQRGVANIPDNLTSRVAYKLGLRGP
AVTVLSACSTSLVAVHLASQSLRAGECDVALAGGAAVAPATVLGHVHEDGSILSAD
GHCRPFDADAGGTVAASGVGVVVLKRLADALADGDAIRAVIRGSAIGNDGADKVGY
TAPGLQGQVDVLRRAYAAADVAPASVALVEAHGTATRLGDPIEVAALTQVFGDATG
RTGWCALGSIKSNLGHLSAAAGVAGLIKATLAVERGQIPPTLHFRAPNPELRLEDSP
FFVNAGPVAWPDGGPRRAGVSAFGVGGTNAHVVLEEAPAPAPSEPGRAWQMLPL
SARTSAALATRAELLAGYLRERPTLPLADVAFTLQQRTALSPARCVVVCCDGEGAQ
AALTARRGPLVVSGQVRSRAPRLVFVFPGGGSQHVDMGRELYAQAPPFRAALDAC
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AELFARELGEDIRGLMFAPAGEAEAAAQRLQKPSRNMAAIFAVEYALAHLLIAWGLR
PAAVLGHSLGGHSLGEYAAAAIAGVMSLADAVALVATRGALCDAAPPAAMLSVPLA
PAAATKLLRPGLSLAAVNGPEACVVAGAAADIEAFAATLAAAGVEARRLPIATASHS
ELMQPLVGRLVERARTVELPAPQIAMVSGVTGTWIGDEVRDPAYWGRHLRDTVRF
ADGVATLHADLDHVCIEVGPGAHLASLLRNHPDAGPERLVVSAMANPRAGRGELEA
LMLALAQLWCAGVTIDWQAVSAGERRRKVPLPTYPFARTRHALELRPAAPVLSLVT
PPPPVDAADEAMPRESPRDAVAQAVAQIWQENLGVAAVHDGDNFFDLGGTSLIAV
KIRARVRERLGVTTPVHALLEHPRFDAFVDSLRAHLGGLTEGRRSSLLVALRPGRP
GTRPIFLVQPIGGTVYTYLPLARHLDAGGAAIFGVRASGTDPGEPVIDDVPTMAERY
VEDILREQPVGPYTVGGHSAGGITAYEVARQLEARGHAVRVLILDAPSMPAVYDDVI
ETIDDFMRSHEAFATSESASYQSFVAALETDPALRQIVLATCLAEQRYRPRPIGAEV
VYFAASEQRDARDTHAGMYWLDLAEGPFSLYRTPGDHFTMMDEPRVETLARLIDQ
HLARDLYRRAS 
8.3 Sequences obtained from end-sequencing of fosmid clones 
end12A9 
KLACLQVDSRGSHVERVRAVLDEPPVWPLFWPSLVDVERVGPRRNGVDGGRFLL
RWRAPGGYSLAHEVVITAVGERVIESLSHGQLEGAGRWELEPIEGGTRVRYHWHV
DTNRLWMAALRPVLAGWFAKNHDALMAEGGAGLAAYLGARLLAVRHHAGERARA
MWTRLPAPVADTGRSPGELGAAVLSAYAGPRPAGPWTTLQRWRDLVFLHWRVEP
GVLGPLLGGLAPEHIDGSPWVTLVCMRTPRIVTAHGVPLSVGEFSQVNLRTYVRHG
GRPMVSFLHVCCGSRLVAAMVRRLGRMPYRAARVATKRELLTHSYTCRGPGTLDV
DFRPRGPRPRSVGVEAELLERYAFVEARGRRVSVGELAHAPWEVCDADVAVRTNT
LLGALGIAGIDPLRPELVSFAPAASVVAW 
end12A9rp 
RQGFPSHDVVKRRPVNCNTTHYRANSSSVPGDPTLVELLTPLFPDGLREPPALDAH
VDQSRRSSDLSHPLAQVGREPEAAAMREVAVRLNLERRRPAGLINSLGDRSESLAA
AGRTHAAMHTWAVVDRLMHAHGEEHWGPLQRRAELATDLGRWDEAEADMQALG
KEHDTIVLDLCRAAIAFARGEDAVHFIKEASVYLTLGWSASIAARWNLLYGRIKLADG
EFAAALANLSNAVQLARRMGSDSARAQAWRAVCLANLDRPAEARQALADARLVAT
RHDNRRVAGILAAAHLALGERDLAEPLALAGYREAWADGPQYSWFDDLRVCEGVL
AELGLPPPELPTFDPTRAPPLPLADEIEAFIAELAARRPASGSRLLHLDPMLCEPPAQ
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PDQGPPPAPGPPAFAVHERVKIATDAPWQADVNGLEGVVFWREPMQDHTAVAET
QRWKYVVYLPAQQVYRTLIERHLTAQGGSVEPSFFFAERAEISYDVVVTDASTIVEG
CLRLPGETWRTFYAEKTDDLDEARLETFDWENGIRGLTLEMPEDEPMNKAALEQAF
AALLGVEQIVEVPGPDSMMMRP 
11.3T7 
GcCGCCaTGGCCGCGGGatTCGAGCGCGAGCTGTTCGCGGCCTGGGTGTCGaan
nnnAangAGTGCGAGTTCTGAACGCGGGCCCACGGCGCGGTCGCGTCGAAGGT
GATGGGCGAGACGGCGGTCGCGGCGGCGCTGGCCGACCCCGACGGCGCCGA
CCTGCCCGAGAAGGTCAAGGCGACGCTGCGCCTGCTGACGAAGGTGACGCGC
GCCCGCGAGGCGCTCGGGCCCGAGGACTTCGAGCCGGTGCTCGCGGCCGGG
GTGTCGCGCCAGGGGGTGATCGACGCGCTGATGGTGGGGTTCGCGTTCAACG
TGATCACCCGCCTGGCCGACGCGTTCGAGTTCGAGGTCCCACCGCAGGCGTC
GTTCGACGCGTCGGCGAAGACGCTGCTGTCGCGCGGCTACAAGTGAAGGGAG
TGGTGACATGTCCGAAGGGACATGTCACCGCGCGCGCCCGCGGACGGACGCG
CCCTGCGGGGAGCCGTGACATGGTCGGAGGGCCATGTCCGTGCGAAGAGGTG
CGGGCGGTGCGAGGCCGTGGATCGTCTCGCCGACGTCGGCGAGAGGAGCCC
GTTCGGTCCTGTCgCCGTGGGTCGTCgACAGGACCgAanGGACnTGGGGCGATC 
11A3RP 
GCTATGAccnTGAtTACGCCaAGCTATTTAGGTGAGACTATAGAATACTCAAGCTT
GCATGCCTGCAGGTCGACTCTAGAGGATCCCACCGAACTTGCCGATCTTCTGAT
AGGCGTTGCGCAGGTGCGGGACCTTCATGGTCTGCACGAATTCGGTGCCGACA
TACGAACCGTCGGAGCCGAAGAAGCCCGGGCGATCGACGCCGTACTGGGCGT
TTCCGGTCGGGTCGAGCACATGACAGAAATTGCAGGTCATGCCGAGCGTGGCC
GGCTTGTTCATGTAGAGGTCGCGGCCGGCCACCTGATCGGGGGTGAGCGAGTT
GTCgAGGTTGCGGATCGGGTTCGGCGGgTAgGTCAgCTGCcncGCGAAGn 
21H12T7 
GCTGACTGGTCGGGGAGCACGTTCGGCTGGGCGTTGGGCGGGAAGTTCGGGC
TGGTCTTGTCGCCGCGCCAGTGCATCGCCCCGTGGTTGGCCATACCGCGCAGG
CTCTGGGTCGTCATCGGCCCCTTGATCGGGTGGAAGTCGATCGGGAAGTCGGG
CAGGAAGATGGTCTTGAACGGCCCGGGCGCGATCGTCACGTCGCCGTCGGGG
TTGCCGAGGTCCCACGCGAGGTGGTCCATGTCGCCGTAGACGTGGCAGGTGG
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CGCAGGCCGAGTCGCCGCGGCCCGAGGTGAACCGCGCGTCGTAGAGGAACCG
GCGGCCCTGCGTCACGCTGGCCGGCTCGGGGTTGTGCATCGACAGGTGCTGG
ATCTCGTCGCCGTCGTCGGTGTCGATGATCGAGACCGCGTTGTCGAAGCGGGT
CATCACATACAGGCGGTCGCGCGACTCGTCGAGCAGCACCCCGGTCGGGCCG
CCGCCGCTGACCTGGAGCTGCTCGCACGGGTCGGGCCAGATCGCGTCGTTCT
CGAGCGCGGCGGTGTCGTAGACGCCGATCTTGTCGGAGCCGAGCGCGGCGAC
GTAGAGCGTGTTGCCGTTGCCCGTGATCGCCATGCCCTGCGGGAGGGCCATG
CTGAGCTCGTTGTCCTCGTTGGGCAGCGGCTGGAACGGCGCCTCGTAGTCGAG
GTGCGGGTTCATGTGATGGGTGGTGACTGGTTGGATCTGCGTGACGAGGAATA
ATTGCTGGTCCCCCTCATT 
21H12RP 
GCTATGaccnTGATTACGCCaaGCTATTTAGGTGAGACTATAGAATACTCAaGCTT
GCATGCCTGCAGGTCGACTCTAGAGGATCCCACGGAAGAAATAGGCGAAGAAC
CACACCATGGTGTAGGCGACGCCGTCGAAGCCGGGGAACACGTCGTAGGCCA
GCGAGGCGCCGCGGGTGGCGAGGACGTGGCCGGCGGTGAAGACGAGCAGGA
CGACGGCGGTGACCCGCTGCCAGCGCAGGCGCGGCGCGGCGGGCCCGGGCG
CGCCGCGACGGCGCCGCCGGACCATGCGCCACACGCTGACGACGATGTGCAC
GAGCAGCGGGGCGATCACGCAGGCGAGCTCGACCAGCGGGGCCTGATAGGC
GGCGCGCAGCTGGACCTGCATGTCGTCGTACACCGCAGGGCCGGCGGCGGCG
AACATCTGATTGACGAGGTGGGCCACGAGGAACACGGCGAACAGGGCGCCGC
TGGCGGCCTGGATGCGGATCAGCGCGCGTTCGCGCGCGGCGTCGCGGGAGG
GGTCGGTGGGGCTCATGGCGACCAGACGAGGCGGTCCTCGGCGCCGTGACAC
GGAAAAATCGCGCATCgATCGGcCGATGCAGGCGGGCCCGATCGCGgcCGTCgt
GCCggcgATcgCCGCGGcTGccgcagGt 
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8.4  16S rDNA sequence 
tggcCGcgGnnttagaGTTTGATCCTGGCtcagAGCGAACGTTTGcngcggGCctaACACA
TGCAAGTcGaAcGGGttaGCAATAACCagtGGCGCAcGGgTGCgtaACacgtaGgTaATC
AACCCctCGGtTcGGGATAACGTTCTGAAagGaGCGctAATACCGGACGTGTCttCG
GgagCttcggctcCtgtcgAGAAAgaCCCtCAaGGGTTGCCnaGGGacgaGCCTGCGGCC
CATcAGctaGTTGGCGAGGTAATaGctCacCAAGGCGaagacGggtAGCTGgtCTGaga
GGaTGATCAgtCACacTGGaACTGAGACACGGTCCAGACTCCTACGGGagGcaGC
AGTGGGGAATATTGCGCAATGGGCGAAAGCCTGACGCAGCCACGCCGCGTGA
GCGATgaAGGCCTTCGGGTCgtaAAGCTCTGTGGGGAGAGGCGAAGaagcCTGTG
AAGagagGCCTTgaCGgttCTCCTtacAagacCGGCTAACTCCGTGCcacAGCCGcGna
atcgGAGgggCGAAcGttcTCGGAatattgGGCgtaAAGCGCACGTAGgcgCGGCGtagCG
GGATgTGAAAGCccngGGctCAACcctGGAAgtGCATCCCgnnacTGtgTCGCTTGantnt
CGGAGGgGGACAGAGAATTCCCGGTGTAGAGGTGAAattCGTAGATATCGGGAG
GAatnccAGTGGCGAAGGCGCTGTCCTGGACGAAGATTGACGCTGAGGTGCGAG
AGCGTGGGGAGCAAACAGGATTAGATACcCTGGTAGTCCACGCTGTAaACGATG
AGTGCTGGACGGTGGAGGATTTGACCCCTTCGCTGTCGAAGCTAACGCGTTAA
GCACTCCGCCTGGGGAGTACGGTCGCAAGACTAAAACTCAAAGGAATTGACGG
GGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGACGCAACGCGCAGAAC
CTTACCTGGGTTAAATCCACTGGAACCTGGCTGAAAGGCTGGGGTGCCCTTCG
GGGAGCCGGTGAGAAGGTGCTGCATGGCTGTCGTCAGCTCGTGTCGTGAGATG
TTGGGTTAAGTCCCGCAACGAGCGCAACCCCTATCGCCAGTTGCCACCATTGA
GTTGGGAACTCTGGCGAGACTGCCGGTCTAAACCGGAGGAAGGTGGGGACGA
CGTCAAGTCCTCATGGCCCTTATGCCCAGGGCTACACATGTGCTACAATGGCTG
GTACAAAGAGCCGCAAGCCCGCGAGGGTGAGCAAATCTCAAAAAACCAGTCTC
AGTTCGGATTGCAGTCTGCAACTCGACTGCATGAAGCTGGAATCGCTAGTAATC
GGAGATCAGCACGCTCCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCG
TCACACCATGGGAGTCGGCTGCTCCAGAAGTAGGAACCTCAACCGCAAGGAAA
GGCCCTACCAAGGAGCGGTCGGTGACTGGGGTGAAGTCGTAaCAAGGTAGCCG
TagGGGAACCTGGGGCTGGannACCTCCTTAATCACTAGTGCGGCCGCCTGCAG
GtCGACCAtAtggaGAGctcCCaAACgcgtga 
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8.5 Mass spectrometry data of the A domain assay 
cinnamic acid                     hydrocinnamic acid 
phenylpyruvate                                                       phenylacetate 
phenylalanine               phenyllactate 
 
  
no exchange 
 
Figure  8.1 C) shows MS-spectra from the repeated ATP/PPi -exchange assay of AMPACP with cinnamic acid, 
phenylacetate and other phenylpropanoids (hydrocinnamic acid, phenylpyruvate, phenyllactate, and 
phenylalanine). Exchange activity was only observed for cinnamic acid and in a lower content also for 
hydrocinnamic acid. On the base of these data the relative exchange ATP/PPi was calculated as shown in 
section  4.11.2. 
exchange 
 
exchange 
 
no exchange 
 
no exchange 
 
no exchange 
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8.6 Substrate predictions of some domains by bioinformatical online 
tools 
8.6.1 Prediction for the substrate specificity of the AMP-ligase from Phn2  
 
Figure  8.2 Analysis of the AMP-Ligase of the loading module from Phn2 with the NRPS Predictor 2 online 
tool (http://nrps.informatik.uni-tuebingen.de). 
 
8.6.2 Substrate prediction for the AT1 domain from Phn2  
 
Figure  8.3 Subtrate prediction for AT1 by AntiSMASH, using two different methods for substrate 
prediction 
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8.6.3 Substrate prediction for the A domains of Sb1 the NRPS/PKS hybrid
Figure  8.4 Subtrate prediction for the A domains of the NRPS/PKS mixed Sb1 by AntiSMASH, 
using two different methods for substrate prediction 
 
  
 
 
